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Studies on chemically modified oligonucleotides: Modified DNA as a 
substrate for the DNA repair enzyme 0 6-methyl-G-transferase 
The interactions between modified oligonucleotides and DNA binding proteins can provide 
important information on the mode of binding and the structure of the enzyme-substrate 
complex. In collaboration with Dr M. Moore at York University studies were carried out to 
determine the interaction of DNA with 0 6-methyl-G-transferase, a DNA repair enzyme which 
removes the alkyl group from guanine residues which are alkylated on the 0 6-position. 
A series of modified ol igonucleotides have been synthesised containing 0 6-methylguanine, 
06-ethylguanine and N6-methyl-2,6-diaminopurine. The oligonucleotides were obtained in high 
purity. UV melting (thermal denaturing) experiments have been carried out on duplexes 
containing the modified bases paired with cytosine and thymine respectively. These 
oligonucleotides were prepared in order to study their interactions with a mutant 0 6-methyl-G-
transferase enzyme lacking DNA repair activity. Gel shift experiments suggest that the above 
oligonucleotides are recognised by the enzyme. Attempts were made to crystallise the 
enzyme-DNA complex. 
Studies on DNA Triplexes 
Triplex DNA is formed by the specific binding of a DNA strand in the major groove of a 
preformed DNA duplex. It has been suggested that such structures might have a biological role, 
especially in gene regulation, and that there is potential for therapeutic applications in which 
gene expression is repressed by triplex formation. 
One difficulty encountered in the studies of DNA triplexes is their low thermodynamic stability. 
In order to overcome this problem oligonucleotides with appropriate triplex forming sequences 
have been synthesised with the three strands linked by hexaethyleneglycol or I ,8-octanediol 
chains. These molecules are capable of folding back on themselves to give intramolecular 
triplexes with significantly increased stabilities compared to intermolecular triplexes. 
UV melting studies have been carried out to determine the thermal stability of these triplexes, in 
the presence and in the absence of the DNA triplex binding drug coralyne. Circular dichroism 
and NMR studies were carried out in collaborarion with Dr A. Lane at the National Institute of 
Medical Research, London. 
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Part 1. Studies on Chemically Modified Oligonucleotides: 
Modified DNA as a Substrate for 0 6-Methylguanine DNA 
Methyl Trans ferase 
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1. Introduction 
1.1 Introduction to DNA 
The elucidation of the DNA secondary structure by Watson and Crick (1953) is a historical 
landmark in modem biochemistry. DNA has the shape of a double helix with antiparallel 
strands which consist of a phosphodiester backbone and four types of heterocyclic bases - 
adenine (A), cytosine (C), thymine (T) and guanine (G) - linked to the backbone by a sugar 
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Figure 1. Chemical Structure of the DNA bases 
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Adenine and guanine are purines, and cytosine and thymine are pyrimidines. The basic mono-
meric unit of DNA is called a nucleotide. The nucleotides are joined together by 3'-).5' 
phosphodiester linkages, which gives the nucleic acid chains a directional nature. 
The two strands of the DNA double helix are held together by the hydrogen bonds between the 
bases. Only two types of base pairs involving the major tautomeric forms of the bases can 
occur: guanine always pairs with cytosine and adenine with thymine (Figure 2), which 
explains the findings of Chargaff and co-workers (Zamenhof et al., 1952) that the guanine to 
cytosine and adenine to thymine ratios were always very close to 1:1, irrespective of the 
species the DNA was obtained from. As a consequence, the sequence of bases in one strand 
determines the sequence in the other - complementary - strand. A schematic representation of 
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Figure 3. Schematic representation of the DNA double helix 
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DNA is the carrier of genetic information for all cellular organisms and for some categories of 
viruses. The genome size varies between a few thousand base pairs in some viruses to 2.9 
million in humans, and even more in some other organisms. It undergoes replication, in which 
each parent strand serves as a template for the synthesis of a complementary daughter strand 
by DNA polymerases, thus ensuring that following cell division the daughter cells will have 
the same amount of genetic material as the parent cell. The genetic information contained in 
DNA is expressed during protein synthesis, when the DNA template is transcribed to give 
mRNA with a complementary sequence, which is in turn translated with the help of tRNA and 
ribosomes to synthesise proteins. 
1.2 DNA Damage 
The DNA sequence is crucial for protein synthesis, as one single modification may lead to a 
wrong amino acid being incorporated into a protein or, in some cases, to premature termination 
of the amino acid chain, both of which could give rise to a reduction in the activity or to the 
inactivation of that particular protein, and which are often detrimental to the cell. Therefore, 
high fidelity of DNA replication is essential if it is to maintain its capability of encoding for 
'correct' proteins. 
However, DNA has limited chemical stability. Hydrolysis, oxidation and non-enzymatic 
methylation of DNA occur at a significant rate in vivo (Lindahl, 1993), and are counteracted by 
specific DNA repair processes. The spontaneous decay of DNA is likely to be a major factor in 
mutagenesis, carcinogenesis and ageing (Lindahl, 1993). In addition, DNA is subject to 
spontaneous mutations, which usually arise from the mispairing of bases during replication. 
This process, however, has a very small error rate; this ranges generally from one misincor-
poration in 108  to one in 1011  replicated bases (Drake, 1969). 
Exposure to environmental factors, such as radiation, various chemicals and even viruses, 
induces damage in the DNA, which might lead to cancer and ultimately to death. 
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1.3 Carcinogens 
A mutation is defined as one heritable change. Agents that interact with DNA and result in 
damage to the molecule, are referred to as mutagens. If they cause mutations which alter 
normal cell function and give rise to cancer, they are called carcinogens. 
Carcinogens are responsible for the change from a normal to a malignant cell pattern. They 
can be physical carcinogens, viral agents or chemical carcinogens. Since the discoveries of the 
first naturally-occurring chemical carcinogen (tobacco for snuff taking) around the middle of 
the 18th century and the first industrially-generated chemical carcinogen (a component of coal 
tar) more than sixty years ago, awareness of the human risk of cancer arising from exposure to 
environmental agents has increased dramatically. 
1.3.1 Physical Carcinogens 
Physical carcinogens include ionising radiation, X-rays -and UV light, which lead to chemical 
modifications of DNA. Ionising radiation generates hydroxyl radicals, which convert thymine 
into hydroperoxides and cause imidazole ring opening in adenine and guanine. In addition, it 
leads to cleavage of the phosphodiester backbone with the formation of single strand breaks 
(SSB) and double strand breaks (DSB), which seem to have greater damaging effect than the 
reactions at the base residues (Blackburn and Kellard, 1986c). Exposure to UV light leads to 
the formation of pyrimidine photodimers, pyrimidine photohydration, crosslinking of DNA to 
protein and photochemical addition of chemicals to DNA bases. 
Asbestos fibres and wood dust also belong to this category, and are thought to work via 
irritation or physical abrasion of the cell (Blackburn and Kellard, 1986a). 
1.3.2 Viral Agents 
Viruses such as Epstein-Barr virus (EBV) and Herpes Simplex Virus Type II (HSV-II) have 
been proven to cause certain types of cancer, and Human T-cell Leukaemia Virus (HTLV) is 
the cause of some types of leukaemia. It is likely that other viruses are also involved in 
carcinogenesis, the papilloma viruses being prime suspects (Blackburn and Kellard, 1986a). 
1.3.3 Chemical Carcinogens 
Chemicals are by far the greatest threat in causing cancer. Chemical carcinogens are 
compounds that interact directly or indirectly with the cellular target molecule, which is 
usually DNA, RNA or proteins. They can be alkylating agents, polycyclic aromatic hydrocar-
bons, N-aryl compounds, halocarbons or hormones (Blackburn and Kellard, 1986a,b,c). If 
they combine spontaneously with DNA, they are called primary or ultimate carcinogens; these 
are typically electrophilic alkylating agents. Most chemical carcinogens, however, require a 
structural change which can occur either spontaneously under physiological conditions, or 
through oxidative metabolic activation by enzymes involved in detoxification pathways (Mitra 
and Kaina, 1993); such compounds are called secondary carcinogens or precarcinogens. 
In addition, there are chemicals which are not carcinogenic themselves, but they promote the 
carcinogenic activity of other compounds; these are called co-carcinogens. 
Chemical carcinogens which affect nucleic acids bind to the bases and cause a change in the 
normal Watson-Crick (W/C) base pairing pattern, which, if not repaired, will result in 
mutations after replication. It has been proposed that mutations may also arise by chemical 
modification of the DNA precursors in the cell and their subsequent incorporation into DNA 
(Dodson etal., 1982; Eadie etal., 1984). In vitro experiments have shown that modified 
nucleotides are much more difficult to incorporate into DNA than unmodified ones. 
Consequently, this mechanism may not be as important as the direct modification of DNA 
itself; however, its relevance is still to be determined (Saffhill etal., 1985). 
1.4 Alkylating Agents and Their Interactions with DNA 
1.4.1 Sites of DNA Alkylation 
DNA is considered the most important target of alkylating compounds, since its modification 
can lead to alterations in gene expression, replication and repair, ultimately resulting in 
permanent heritable changes - mutations - which may represent the initiation step of the 
carcinogenic process (Basu and Essigmann, 1988). 
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DNA offers a wide range of sites for attack by electrophiles: the base residues react at all the 
ring nitrogens (except the ones involved in the glycosyl bond) and at the oxygen atoms 
(Figure 4). Chemical (as opposed to biological) DNA alkylation at carbon centres has not 
been observed (Blackburn and Kellard, 1986a). In addition, alkylation at the oxygen atoms of 
the phosphodiester bonds by 'hard' electrophiles, occurs to a significant extent. The terms 
'hard' and 'soft' are defined in Section 1.4.2. 
0 	 NH2f 
H 
/NNH 	 N 
< G C), 
N NNH2 	 N 0 
dR 	 dR 
NH2 	 0 




N N N 0 
dR dR 
dR = 2'-deoxyribose 
—* targets for 'hard' electrophiles 
VvWv. targets for 'soft' electrophiles 
Figure 4. Principal sites of alkylation of the DNA bases 
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1.4.2 Categories of Alkylating Agents 
The majority of alkylating agents are direct electrophiles. Monofunctional alkylating agents 
(Figure 5a) such as dialkyl sulphate, alkyl alkane sulphonates and epoxides, can only react at 
one nucleophilic site. Bifunctional alkylating agents (Figure 5b) can alkylate twice, and may 
crosslink a nucleic acid base either with protein or with another base within the same or the 
alternate strand, or they may lead to the formation of cyclic DNA adducts. Typical examples 
are sulphur mustard, nitrogen mustards, bis-chioromethylether and cis-diamminedichioro-
platinum(II) (cisplatin). 
0 0— Me 	 0 0— MeNN 
(a) 	 0 
0 0—Me 	 0 Me 	 L 
Dimethyl sulfate 	Methyl methane-sulphonate 	Oxirane 
H3N / Cl 	Me \ 
(b) 	 Pt I 
Cl0Cl 	
H3N Cl ci N 1 
	
Cl 
Bis-cliloromethyl ether 	Cisplatin 	Nitrogen mustard 	Sulphur mustard 
Figure 5. (a) Monofunctional and (b) bifunctional alkylating agents 
In addition, Pearson and Songstad's (1967) concept of 'hard and soft' acids (electrophilic 
species) and bases (nucleophilic species) can be applied. This states that hard acids react 
preferentially with hard bases, and soft acids react preferentially with soft bases. According to 
this theory, alkylating species have intermediate acidity and the ring nitrogens and exocyclic 
oxygens of the nucleic acid bases have intermediate basicity, which is why alkylating agents 
react preferentially at these sites (Saffhill etal., 1985). Moreover, within the intermediate 
classification, carbonium ions are harder acids than compounds such as alkanesuiphonates; 
therefore alkylating agents are considered 'hard' if their reactions have more SNI  character and 
'soft' if they have more S N2 character. The oxygen atoms of both the nucleic acid bases and 
the phosphodiester backbone are considered harder bases than the ring nitrogens, therefore 
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'hard'electrophiles will react more at the oxygens and 'soft' electrophules at the ring nitrogens 
(Saffhill etal., 1985). 
1.4.3 The Activation in Vivo of Secondary Carcinogens 
Simple alkylating agents are generated from secondary carcinogens in vivo either spontane-
ously or in metabolic processes catalysed by enzymes of the cytochrome P-450 class. Typical 
examples of secondary carcinogens are represented in Figure 6 below. 
Me NO 	 Et 
N 
 NO 	Cl NO 
ON Cl 
0 	 0 
H 
N-methyl-N-nitrosourea N-ethyl-N-nitrosourea 1 ,3-Bis-(2-chloroethyl)-N-nitrosourea 
(M1'TU) 	 (ENU) 	 (BCNU) 
Me NO 





N-methyl-N'-nitro-N-nitrosoguanidine Methyl phenyltriazole 	Vinyl chloride 
(MNNG) 	 (MPT) 	 (VC) 
Figure 6. Secondary carcinogens 
N-nitroso compounds, which are part of this group, are very widely spread in the environment, 
both from natural and pollutant sources. They include nitrosamines, nitrosoureas and nitroso-
guanidines. Some, such as 1,3-bis-(2-chloroethyl)-N-nitrosourea (BCNU), are used in cancer 
chemotherapy, but they can themselves give rise to secondary tumors. In addition, 
nitrosamines can be formed in the stomach by nitrosation of secondary amines, ideally at a pH 
around 4 to 5. These amines are usually protonated at the normal pH value of 3 in the 
stomach. However, processes such as ulcer treatment may result in a higher than normal 
stomach pH when the amines are no longer protonated and can therefore react with the nitrous 
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acid and nitrites (Figure 7) generated through bacterial degradation of nitrates present in food 
(Blackburn and Kellard, 1986a; Bartsch and Montesano, 1984). It has been suggested that 
alcohol consumption may increase the risk of cancer from nitrosamines in primates by 
suppressing or reducing the detoxification of these compounds by the liver (Anderson et al., 
1996), whereas certain organosuiphur compounds present in garlic and cruciferous vegetables 
(Lin etal., 1994; Schaffer etal., 1996), as well as vitamin C (Bartsch and Montesano, 1984; 
Dyke et al., 1994), may reduce the risk. 
H2 —NO 
R 1 —R2 
I-I 
pH=4-5 	R1\
00 	 N — NO + H3O 
R2 
R 1 , R2 = alkyl 
Figure 7. Formation of nitrosamines in the stomach 
The activation of nitrosoureas, nitrosoguanidines and methyl phenyltriazole occurs through 
spontaneous hydrolysis and generates alkyl diazohydroxides. Other compounds require one 
(Figure 8a) or several (Figure 8b) oxidations by cytochrome P-450 to give the primary 
carcinogen, which is also alkyl diazohydroxide. The latter compound rearranges to positively 
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H3C —NN-0H 	 H3C—NN-0H 
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Figure 8. Metabolic activation of (a) dimethylnitrosamine and (b) N,N'-dimethylhydrazine by 
cytochrome P-450 
ffl- 	~ + 	 + 	 + H3C—NN-0H 	H3C—NN-0—H1120 
	 -N2 
[H3C—N
—N] H C 
HI- 
Figure 9. Spontaneous rearrangement of methyldiazohydroxide 
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Vinyl chloride, another secondary carcinogen, is a major industrial chemical produced in large 
quantities around the world. It is also metabolised by enzymes of the cytochrome P-450 class 
to 2-chioroethyleneoxide (CEO), which spontaneously rearranges to chloroacetaldehyde 
(CAA) (Guengerich et al., 1979), which is less hazardous and is detoxified by reaction with 
glutathione (Figure 10). Both CEO and CAA are bifunctional alkylating agents. 
[0] 	o 






Adducts 	 Extracellular 
products 
Figure 10. Metabolic activation of vinyl chloride 
1.4.4 Products of DNA Alkylation and Their Effects 
Most alkylation reactions of nucleic acids are methylations. The reactions of methylating and 
ethylating agents with DNA have been studied extensively both in vitro and in vivo. The 
mutagenic properties of alkylating agents are thought to arise mainly as a consequence of the 
modification of the Watson-Crick base pairing pattern (Saffhill etal., 1985), with some 
sequences being more prone to mutation than others (Basu and Essigmann, 1988). The most 
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Figure 11. The most common DNA base alkylation products 
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N-A!kylation 
N-alkylpurines appear not to be directly mutagenic. However, they can lead to mutagenesis 
indirectly because their removal, either in spontaneous chemical reactions or during excision 
repair, leads to apurinic sites which normally create replication blocks, but under some 
circumstances they can lead to mutations (Mitra and Kaina, 1993). 
It should be noted that DNA damage is caused not only by chemicals taken up by the cells 
from the environment, but also by some endogenous small molecules, such as 
S-adenosylmethionine (SAM), which serves as methyl donor in most cellular enzymatic 
transmethylation reactions (Lindahl, 1993). SAM is a weak alkylating agent, and it can 
methylate proteins and DNA nonenzymatically. It mainly targets ring nitrogens of purine 
residues, generating mostly two of the modified bases discussed below: 7-methylguanine and 
3-methyladenine. 
The major alkylation product in DNA is 7-methylguanine. It does not cause mispairing and 
does not appear to be mutagenic; however it has been implicated in the ageing process on the 
basis of circumstancial evidence (Mitra and Kaina, 1993). It is poorly repaired and may tend 
to accumulate in cells, although the lability of the N-glycosyl bond leads to a significant 
amount of depurination (Lindahl, 1993). However, cross-linking of of two neighbouring 
guanines at N 7 by a bifunctional alkylating agent such as nitrogen mustard is a lesion which 
can lead to cell death (Blackburn, 1990). 
3-Methyladenine is also generated to a significant extent. Although the methyl group is 
located in the minor groove where it would not hinder normal base pairing, this lesion blocks 
DNA replication and is cytotoxic (Lindahl, 1993). 
1 -Alkyladenine, 3-alkylcytosine and 3 -alkylthym inc are minor products of N-alkylation of the 
DNA bases. They were not found to be mutagenic, but their alkyl groups are located within 
the base pairing region and as a result disrupt hydrogen bonding. They are inhibitors of DNA 
polymerase and may therefore play a role in determining the toxicity of alkylating agents 
(Safthill etal., 1985). 
Chemical alkylation of the 1-position of guanine and of the exocyclic amino groups have been 
found to occur, although to a very limited extent, but they have only been detected in in vitro 
experiments (Singer, 1996). 
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The metabolites of vinyl chloride can lead to the formation of exocyclic DNA adducts as well 
as to cross links either with protein or with another base. CEO is more reactive towards DNA 
in vivo than CAA, and the two compounds are thought to give rise to different patterns of DNA 
modifications (Barbin and Bartsch, 1986). 
The major lesion generated by CEO is 7-(2-oxoethyl)guanine (oxet-G). This has been 
postulated to lead, after formation of a hemiacetal (Scherer etal., 1981), to a modification at 
the 06-position of guanine (Figure 12). It was found, however, that the hemiacetal structure is 
highly unlikely under physiological conditions (Politzer etal., 1986), and misincorporation of 
bases tends to occur opposite cytosine rather than opposite the modified guanine residues 
(Barbin and Bartsch, 1986). This may be due to the formation of intrastrand links between 
oxet-G and an adjacent cytosine, which changes the base pairing properties of the latter, 
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/ N, N NH 
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Figure 12. Formation of 0 6 ,7-(1'-hydroxyethano)guanine from oxet-G 
Exposure to vinyl chloride also leads to the formation of the cyclic adducts 1,N 6-etheno-
adenine (CA), 3,N4-ethenocytosine (CC) (Eberle etal., 1989) and N2,3-ethenoguanine (CG) 
(Laib, 1986) in DNA (Figure 13a), but sites involved in base pairing in double-stranded DNA 
are generally protected from reaction. Heavily transcribed sequences and single-stranded 
regions of DNA arising due to 'breathing' or the formation of unusual DNA structures, are 
thought to be most at risk (Palejwala etal., 1991). 
In vitro experiments have shown CA and CC to be non-instructional lesions, as their hydrogen 
bonding properties are severly disrupted by the formation of the etheno bridge, CA having low 
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but EC high mutagenic activity (Jacobsen et al., 1989). They create kinetic pause sites rather 
than absolute replication blocks (Jacobsen and Humayun, 1990). 
cG can form two hydrogen bonds with thymine and with cytosine (Oesch and Doerjer, 1982) 
(Figure 13b) and is mutagenic (Singer etal., 1987). Although in vitro CAA reacts with 
guanine to give mainly 1,N 2-ethenoguanine (Sattsangi etal., 1977), this has not been detected 
in vivo, possibly because of efficient repair (Khazanchi etal., 1993). 
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Figure 13. (a) Cyclic DNA adducts of vinyl chloride metabolites and 
(b) GT and EGC base pairs 
0-Alkylation 
The attack of DNA by 'hard' electrophiles generates a significant amount of phosphotriesters, 
but the base residues are still preferentially alkylated on nitrogen. However, a larger 
proportion of 0-alkylated products is formed (Blackburn and Kellard, 1986a), primarily at 
G-06, but also at T-02 and to a lesser extent at T-0 4 and C-02 . The nature of the alkyl group 
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influences the distribution of adducts at various sites as well; ethylation generates a higher 
proportion of modification at oxygens than methylation (Singer, 1996; Mitra and Kaina, 1993). 
The major 0-alkylation product of DNA bases is 0 6-alkylguanine. This modified base directs 
the misincorporation of thymine to a significant extent during nucleic acid synthesis which, if 
left unrepaired, would lead to &C->AT transition mutations upon further replication (see 
Section 1.5 below). The existence of minor miscoding pathways leading to incorporation of 
guanine and adenine opposite 0 6-alkyl-G has also been reported (Safthill, 1986). 
Another miscoding lesion is 0 4-alkylthymine. As in the case of 0 6-alkylguanine, 04-alkyl-
thymine has a tautomeric form different from that of the unmodified base, and consequently its 
hydrogen bonding properties are changed. It leads preferentially to misincorporation of 
guanine, resulting in AT-GC transitions (Saf(hill etal., 1985). 04-Alkylthymine is repaired 
in vivo by the same enzyme as 0 6-alkylguanine, but at a much slower rate (Basu and 
Essigmann, 1988). 
02-Alkylthymine and 02-alkylcytosine have low mutagenic efficiency, but they also inhibit 
DNA synthesis to a significant extent. Modelling studies have shown that the 0 2-alkyl group 
interferes sterically with the DNA sugar-phosphate backbone, and this interference may lead to 
distortions of the DNA structure (Saffhill et al., 1985). 
Phosphotriesters could lead to changes in the binding of proteins to DNA due to neutralisation 
of negative charge along the phosphodiester backbone (Saffhill etal., 1985). They may 
hydrolyse with the cleavage of a nucleoside-phosphate link resulting in single strand breaks 
(Blackburn and Kellard, 1986a). Their role in carcinogenesis is not clear. 
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1.5 06-Alkylguanine Lesions 
1.5.1 Biological Significance 
Alkylation of DNA at the 0 6-position of guanine is regarded as one of the most critical events 
leading to mutations and cancers. 0 6-alkyl-G directs the incorporation of either thymine or 
cytosine residues without blocking DNA replication (Lindahl etal., 1988). Where 0 6-alkyl-G 
pairs with thymine, a GC—.AT transition mutation will occur. It has been suggested that the 
potency of carcinogens may depend on their ability to form 0 6-alkylguanine (Loveless, 1969). 
06-alkyl-G in DNA has also been linked with increased chromosome instability. This appears 
to be caused, at least in part, by futile cycles of mismatch repair of the newly synthesised 
strand which leave persistent single-stranded regions in the DNA (Rehakrantz and Nonay, 
1995). Genetic experiments indicated the active removal by mismatch repair of both cytosine 
and thymine when paired with an 0 6-methylguanine residue in newly replicated DNA. It is 
assumed, therefore, that it is a matter of chance which pyrimidine will escape this correction 
system (Lindahl et al., 1988). 
The mutagenic potential of 0 6-alkyl-G, especially in the case of 0 6-methyl-G and 06-ethyl-G, 
has been proved both in vitro, in templates copied by RNA and DNA polymerases (Mehta and 
Ludlum, 1978; Abbott and Safthill, 1979), and in vivo, through site-directed mutagenesis 
(Chambers etal., 1985; Essigmann et al., 1986). DNA precursor pool alkylation is not thought 
to be relevant to mutagenesis in this case (Basu and Essigmann, 1988). 
1.5.2 Consequences of 0 6-Guanine Alkylation on DNA Structure 
NMR studies on double-stranded oligonucleotides of B-DNA have shown that 0 6-methyl-
guanine causes a small helical distortion and altered hydrogen bonding when opposite either 
cytosine or thymine; with thymine it forms a Watson-Crick pair, and with cytosine it forms a 
wobble pair (Patel etal., 1986a,b). The 0 6-methyl-G-C wobble pair distorts the DNA helix 
more than the pair with thymine does. The hydrogen bonding possibilities 0 6-methyl-G with 
T and C are illustrated in Figure 14a, in comparison with the normal GC and the wobble GT 
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Figure 14. Hydrogen bonding scheme (a) of 0 6-methyl-G with C and T and 
(b) of G with C and T 
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The alkyl group of 0 6-alkyl-G can adopt one of two conformations in the plane of the base: 
either proximal, pointing away from the hydrogen bonding region, or distal, pointing towards 
it; these conformations are also called anti and syn (relative to N' of the base) respectively. 
NMR studies indicated that in solution the preferred conformation is distal (Kalnik et al., 
1989a,b). In contrast, the X-ray structure of a self-complementary DNA duplex containing 
06-methyl-G paired with thymine, showed that the methyl group was in the proximal 
orientation (Leonard etal., 1990; Vojtechovsky etal., 1995). It is possible that the difference 
between the structures determined by X-rays and NMR respectively reflects the differences 
between the solution and crystal environments (Vojtechovsky etal., 1995). 
The X-ray structure of a short Z-DNA duplex revealed that 0 6-methyl-G paired with cytosine 
adopted a Watson-Crick configuration, with the methyl group in the proximal orientation, but 
the hydrogen bonds could not be defined. It is unclear, therefore, if in this structure cytosine 
exists as a minor tautomer, if it is protonated or if there is no hydrogen bond at all between N 1 
of 06-methyl-G and N3 of C (Ginell etal., 1990). 
Molecular modelling and computational studies have indicated that when 0 6-methyl-G is 
paired with thymine, the energy difference between the two conformations of the methyl group 
is likely to be very small (Dosanjh et al., 1993), with the result that the methyl group stays in 
the conformation in the plane of the base, either distal or proximal, which was adopted prior to 
base pairing (Cruzeiro-Hansson etal., 1995). 
The local conformation of the base pair is more disrupted when the alkyl group adopts the 
distal conformation. The latter conformation affects the base pairing with thymine to a greater 
extent than that with cytosine; the steric clashes between the 0 6-alkyl group of guanine and the 
4-amino group of cytosine are relieved through wobble pairing (Kalnik etal., 1989b), whereas 
in the case of thymine the base pair spreads apart slightly in the major groove, with the result 
that 	of 06-methyl-G and N3 of T are no longer within hydrogen bonding distance - they 
may at best form a very weak hydrogen bond, leaving one single intact hydrogen bond 
between the two bases (Kalnik etal., 1989a). 
Support for the existence of the two conformations comes also from data obtained from in 
vitro experiments, which show that in some cases 0 6-methyl-G is replicated quickly, and in 
others replication is virtually blocked; the latter was presumed to arise due to the methyl group 
in the distal conformation interfering with replication to a significant extent, explaining thus 
the observation that 0 6-methyl-G lesions can be lethal as well as mutagenic (Dosanjh et al., 
1993). 
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NIMIR (Kalnik et al., 1989a,b) and computer modelling studies (Sayle and Goodfellow, 1996) 
showed that although the ethyl group at the 0 6-position of guanine introduces a slightly bigger 
local distortion of the phosphodiester backbone than methyl, the base pair containing the lesion 
was well contained within the double helix. 
The 06-alkyl-GC base pair has distorted phosphodiester links both 3' and 5' to the cytosine 
(Kalnik etal., 1989b), whereas the 0 6-alkyl-GT base pair is accomodated within the DNA 
helix with minimal distortion (Kalnik etal., 1989a). The slow incorporation of C opposite 
06-methyl-G, and of the next correct nucleotide following the incorporation of C, can be 
ascribed to the stereochemical problems encountered when these distorted phosphodiester 
links are formed (Tan etal., 1994). 
The flanking sequence of the modified base pairs can influence the extent of the DNA 
structure perturbations, because the final dynamic structure of the helix will be influenced by 
the adjustment of stacking interactions, as the more hydrophobic 0 6-alkyl-G will tend to stack 
towards the centre of the helix (Wong etal., 1992). In addition, the alkyl group is likely to 
disrupt the spine of hydration in the major groove (Ginell etal., 1990). 
1.5.3 Stability of DNA Containing 06-Alkylguanine 
UV melting (thermal denaturing) studies of DNA oligomers containing 0 6-methylguanine 
paired in turn with A, C, T and G, showed that the duplexes were significantly destabilised 
compared to the one containing a normal GC base pair and even compared to the GT base 
pair, the order of stability being C > A> G> T, but the difference in the stability of the 
modified duplexes was very small (Gaffney etal., 1984). The thermal destabilisation of DNA 
brought about by alkylation at the 0 6-position of guanine shows little sequence dependence 
(Gaffney and Jones, 1989). 
The fact that the 0 6-alkyl-&T base pair is thermodynamically the least stable, combined with 
structural information from NMR studies - which showed that it is stabilised by one hydrogen 
bond and possibly another weak one while maintaining a Watson-Crick configuration of the 
bases - indicate that certain structural features, such as the alignment of the bases at the active 
site of the polymerase during replication, play a role in the preferential pairing of 0 6-alkyl-
guanine with thymine, rather than the number of hydrogen bonds that can be formed between 
the two bases (Kalnik et al., 1989a). 
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The stability profile of a DNA oligomer containing 0 6-methylguanine paired with cytosine - 
studied over a wide pH range - showed that at lower pH the duplex is stabilised, probably 
because of the protonation of the cytosine N 3-position, which enables the formation of a 
Watson-Crick pair between the bases, as represented in Figure 15 (Leonard etal., 1990). 
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Figure 15. Protonated 06-aIkyI-GC base pair 
The 06-alkyl-GC wobble base pair, which predominates at physiological pH, is likely to be 
removed by normal proofreading and repair enzymes, whereas 0 6-alkyl-&C, which is 
probably present to some extent at physiological pH, may escape detection (Brown and 
Kennard, 1992). 
1.6 DNA Repair 
Another factor regarding the biological relevance of DNA adducts is the mechanism of repair, 
because repair processes can also introduce errors into the DNA. There are three main types of 
repair mechanisms in vivo, which are widely, if not universally, distributed, and which 
maintain the integrity of the genome as long as repair occurs before replication: nucleotide 
excision repair, base excision repair and the direct reversal of damage to bases (Lindahl, 
1982). The first two are so-called 'short patch' repair systems and are generally error-free. 
There are 'long patch' repair systems as well. These are switched on after replication and are 
error-prone; their mode of action is best understood in bacteria (Blackburn, 1990). Mismatch 
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repair systems also occur universally in cells; they are very complex and involve a multitude 
of proteins (Lindahl, 1982). 
1.6.1 Nucleotide Excision Repair 
The incision-excision mechanism of nucleases cleaves phosphodiester bonds resulting in 
single strand breaks (Lindahl, 1982). After removal of the modified nucleotide, exonucleases 
enlarge the gap to 30-60 nucleotides long, and the DNA sequence is reconstructed by 
polymerases and DNA ligase (Blackburn, 1990). It is mainly bulky DNA lesions which cause 
major helix distortions that are removed by this mechanism, such as those caused by 
polycyclic aromatic hydrocarbons, aromatic amines and amides, and some photoadducts. 
1.6.2 Base Excision Repair 
A second mechanism requires the action of DNA N-glycosylases which are highly substrate 
specific and generate apurinic/apyrimidinic (AP) sites. These in turn are recognised by AP 
endonucleases which produce strand breaks usually on the 5'-end of the base-free sites, then 
excised by a phosphodiesterase, and the gap is filled by a polymerase and DNA ligase 
(Lindahl, 1993). 
N-alkylpurines are generally repaired by this mechanism. 3-Methyladenine, which is a 
potentially lethal lesion because it blocks DNA synthesis, is removed in Escherichia coli by 
two different glycosylases, one of which is constitutively expressed and only recognises 3-
methyladenine, and one which is inducible and - unusually for a N-glycosylase - cleaves other 
alkylated bases as well, such as 3-methylguanine, 7-methylguanine and 0 2-methylpyrimidines 
(Mitra and Kaina, 1993). In mammals, 3-methyladenine appears to be released by only one 
glycosylase, which is similar to the inducible E.coli enzyme in its broader substrate specificity 
(Mitra and Kaina, 1993). 
7-Methylguanine is susceptible to imidazole ring-opening, and the resulting secondary lesion 
is removed by formamidopyrimidine-DNA glycosylase. This secondary lesion is formed to a 
very limited extent, but the reaction could be significant because 7-methylguanine is the main 
alkylation product of DNA bases (Lindahl, 1982). 
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Another important lesion repaired by this mechanism is uracil generated by hydrolytic 
deamination of cytosine. The enzyme responsible is uracil-DNA glycosylase. There is also a 
glycosylase specific for hypoxanthine formed by adenine deamination. 
The release of exocyclic etheno base adducts by N-glycosylases has first been observed a 
decade ago in a rat brain tumour cell line (Oesch et al., 1986), but it was only recently shown 
in vitro that these lesions are repaired by glycosylases in human cell extracts (Dosanjh et al., 
1994). 
1.6.3 Direct Reversal of Damage to Bases 
Direct reversal of damage to bases has been observed for 0 6-alkylguanine modifications, 
especially for small alkyl groups - such as methyl and ethyl - and for 0 4-alkylthymine, but to a 
lesser extent (Lindahl, 1982). The enzyme responsible for this particular repair mechanism is 
06-methylguanine DNA methyl transferase (MGMT) or 0 6-methyl-G-transferase. In E.coli, 
MGMT is also called Ada-protein, as it was found to be the product of the ada gene, which is 
responsible for the adaptive response of the bacterium. 
Photoreactivation is another example of this type of repair mechanism. Photolyase cleaves 
pyrimidine photodimers to their constituent pyrimidines. Light with a wavelength in the range 
of 340-400nm is required for this process (Lindahl, 1982). 
1.6.4 Post-Replicative Repair 
When the DNA polymerase encounters a base modification that inhibits it, a long gap is left 
opposite the lesion before replication starts again. This gap is repaired by the induction of the 
SOS response or by recombination-repair, both of which are error-prone. The filling of this 
gap is determined by several factors, such as the type of lesion, the template sequence, the type 
of polymerase and its 3'—*5' proofreading activity (Blackburn, 1990). The latter is usually 
diminished in this type of repair in order to let the polymerase bypass the lesion. 
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1.7 06-Methyl-G-Transferase 
An inducible DNA repair pathway that protects specifically against the damaging effects 
especially of 'hard' alkylating agents, such as MNU and MNNG, was discovered in E.coli by 
Samson and Cairns (1977), and it was termed 'adaptive response'. The major mutagenic 
lesion generated by these chemicals is 0 6-methylguanine, and the repair of this lesion is 
induced as part of the adaptive response, leading to increased resistance to alkylation 
mutagenesis (Lindahl etal., 1988). 
1.7.1 Mechanism of 06-Methylguanine Demethylation 
06-Alkylguanine is repaired in vivo by direct transfer of the methyl (or ethyl) group from the 
alkylated DNA to a protein, which is 0 6-methyl-G-transferase. This repair mechanism is 
unusual because it represents an enzymatic methyl group transfer to a protein without the 
involvement of the cofactor S-adenosylmethionine (Lindahl, 1982). The methyl group is 
accepted by one of the protein's cysteine residues, and an unmodified guanine is 
simultaneously regenerated in DNA (Olsson and Lindahl, 1980; Demple et al., 1982). Bulkier 
alkyl groups are also removed, but more slowly, and with the increase in bulk, other DNA 
repair systems become involved in their removal; however, the extent to which an adduct is 
repaired by the alkyltransferase rather than by excision repair depends on the organism (Pegg 
and Byers, 1992). The rates of reaction of MGMT with a given alkyl group are different in 
different organisms (Mitra and Kaina, 1993). 
06-methyl-G-transferase acts as a suicidal enzyme, i.e. it undergoes irreversible inactivation in 
its reaction with an 0 6-methylguanine residue, because no mechanism appears to exist to 
demethylate the resulting S-methylcysteine moiety, which is chemically very stable (Lindahl 
etal., 1988). As a consequence, cells become sensitive to the mutagenic effects of alkylating 
agents when the number of 0 6-alkylguanine lesions generated in their DNA exceeds the 
number of MGMT molecules they contain (Lindahl etal., 1988). 
The preferred substrate for MGMT is double-stranded DNA. MGMT also reacts with single-
stranded DNA, albeit at a slower rate (Lindahl etal., 1988). This suggests that the 
conformation of the phosphodiester backbone may play a role in the recognition of the 
substrate by the protein (Pegg and Byers, 1992): The free 0 6-alkylguanine base and the free 
nucleoside are very poor substrates for the enzyme, but they are still recognised. 
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It has been proposed that the methyl transfer reaction follows an SN2  mechanism, the active 
site cysteine in its thiolate form acting as the nucleophile and guanine as the leaving group 
(Spratt and de los Santos, 1992) (Figure 16). Studies on the interactions of MGMT with 
06-methyl-guanine analogues containing sulfur or selenium instead of the 0 6-atom, or with 
the ring nitrogens replaced, as well as with oligonucleotides containing these modified bases, 
suggested that 0 6-methyl-G binds to the active site of the protein with hydrogen bonds to 06 
and N 1 , and that the methyl group is then displaced from the guanine as a proton is transferred 
to the oxygen, neutralising the charge on the leaving group (Spratt and de los Santos, 1992; 
Spratt and Campbell, 1994). 
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Figure 16. Proposed mechanism for 06-methylguanine demethylation 
1.7.2 Structure and Putative Mode of Action of 0 6-Methyl-G4ransferase 
The 06-methyl-G-transferase of E.coli or Ada-protein, is the most extensively studied MGMT. 
It is a 39 kDa protein with two distinct domains: a 19 kDa C-terminal domain responsible for 
the repair of 06-alkylguanine and 0 4-alkylthymine, and a 20 kDa N-terminal domain which 
demethylates one of the two diastereoisomers of the methylphosphotriesters generated by the 
action of 'hard' alkylating agents on DNA (Sedgwick et al., 1988). 
Cys-32 1 has been identified as the methyl acceptor in the reaction with 0 6-methyl-G (Demple 
et al., 1985). The active site Pro-Cys-His-Arg sequence is conserved in all known MGMT 
proteins (Sedgwick et al., 1988) and seems to be essential for the alkyl transfer function, as 
site directed mutagenesis studies have shown (Ihara etal., 1994). Cys-69 has been found to be 
the methyl acceptor in the reaction with methyiphosphotriesters (Sedgwick et al., 1988). 
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The human MGMT has a molecular weight of 24 kDa and has only retained the 0 6-alkyl-G-
transferase activity, but not the capacity to repair the methylated phosphodiester backbone, and 
is more similar to the C-terminal domain of Ada rather than to the whole Ada-protein (Lindahi 
etal., 1988). 
Mammalian MGMTs repair bulkier adducts more readily than bacterial ones. They also have 
the ability to repair 06-benzylguanine, which the bacterial enzymes cannot. This fact has been 
exploited in cancer treatment, as many tumours are resistant to alkylating agents used in 
chemotherapy because of their high MGMT levels (Pegg and Byers, 1992). Resistance is 
aquired not only towards methylating agents, but also towards chloroethylating agents, such as 
BCNU. The main cytotoxic lesion caused by chloroethylating agents is an intrastrand cross-
link from the N' of guanine to N 3 of cytosine in the opposite strand. Intermediates in the 
formation of this cross-link are 0 6-chloroethylguanine and 1,0 6-ethanoguanine (Figure 17), 
and both these adducts are substrates for MGMT (Ludlum, 1990). Depletion of the 
alkyltransferase activity with 0 6-benzylguanine renders the tumour cells more susceptible to 
the action of the drugs. 
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Figure 17. Formation of interstrarid cross-links by chioroethylating agents 
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The ability of human 0 6-methyl-G-transferase to generate guanine from 0 6-benzylguanine is 
significantly enhanced in the presence of DNA, which suggests that it undergoes a conforma-
tional change upon DNA binding; this may facilitate the reaction of the 0 6-position of the 
modified guanine with the protein's acceptor site cysteine (Goodtzova etal., 1994). This also 
indicates that MGMT binds DNA in a non-specific manner, regardless of its 0 6-methyl-G 
content, in addition to the specific binding for dealkylation. 
The tertiary structure of the 19 kDa C-terminal domain of the Ada-protein has recently been 
elucidated by X-ray crystallography (Moore et al., 1994). Surprisingly, the active site cysteine 
is buried. As a consequence, it has been proposed that part of the protein would swivel to 
expose a DNA binding site and provide access to the active site (Moore et al., 1994). 
The crystal structure of a mammalian MGMT has not been obtained yet; however, a homology 
model of the three-dimensional structure of human MGMT based on the crystal structure of 
the C-terminal domain of the MGMT of E.coli (Ada-protein) and on the sequences of the two 
proteins has been proposed (Wibley etal., 1995). This and other studies with 0 6-methyl-G 
analogues containing different alkyl groups (Arris etal., 1994) suggest that there is a hydro-
phobic pocket with strict constraints at the active site of the human MGMT which, in additon 
to the stabilisation of the negative charge by the aromatic ring, facilitates reaction with 
06-benzylguanine rather than that with 0 6-methylguanine; this is why the former compound is 
used as an aid in chemotherapy to deplete tumour cells of MGMT. 
The DNA may undergo a conformational change as well during repair of a 0 6-alkylguanine 
residue. The proposal that N' of the modified guanine is involved in hydrogen bonding with 
the enzyme during the alkyltransfer suggests that the double helix must open up for the 
dealkylation reaction to take place. This has been shown to happen in case of Hhal methyl-
transferase, which is part of a restriction-modification system from Haemophilus haemolyticus 
(Klimasauskas et al., 1994). This enzyme catalyses the transfer of a methyl group from 
S-adenosylmethionine to the 5-position of cytosine within a certain DNA sequence. The 
crystal structure of the Hhal bound to an oligonucleotide containing fluorocytosine (C5F) 
shows a disrupted G.C5.F  base pair, with the modified cytosine flipped out of the double helix 
and situated in the active site, which itself has undergone a large conformational change 
(Klimasauskas et al., 1994). 
A similar suitable substrate-bound complex of MGMT would be required in order to elucidate 
the protein's mode of action, but such stable complexes are difficult to obtain because in the 
SN2 alkyl transfer reaction there is a single transition state and no chemical intermediates 
(Moore et al., 1994). 
1.7.3 Regulation of 0 6-Methyl-G-transferase Expression 
The adaptive response of E.coli protects the cells against the toxic and mutagenic effects of 
certain alkylating agents. The Ada-protein itself is regulating this response, acting as a strong 
transcriptional activator of the ada gene when methylated at its Cys-69 residue, and as an 
inhibitor in its unmethylated state (Saget and Walker, 1994). 
In mammals, the level of expression of 0 6-methyl-G-transferase varies between organs and 
even between types of cells within a particular organ (Pegg and Byers, 1992). Some 
mammalian cell lines do not express the protein at all; it is thought that this is due to switching 
off of the corresponding gene. 
It is not clear how the expression of the gene for MGMT is regulated in mammals. Induction 
of the enzyme has been observed in mammals in some circumstances, but its mechanism is 
likely to be quite different from the adaptive response in E.coli, and the increase in MGMT 
levels are more modest (Lindahl etal., 1988). However, the number of transferase molecules 
in unadapted bacterial cells is much lower than that in mammalian cells: about 20 compared to 
30,000 - 200,000 (Lindahl, 1982; Mitra and Kaina, 1993). 
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1.8 Aims 
It is difficult to obtain a DNA-MGMT complex for X-ray studies, because the rate of reaction 
of 06-methyl-G-transferase with 0 6-methylguanine is extremely high. In addition, substrate 
analogues that bind without methyl transfer have not been identified yet. 
In collaboration with Dr M.Moore from York University, this study proposes to synthesise an 
analogue of 0 6-methylguanine with a nitrogen atom instead of the oxygen at the 6-position 
and incorporate it in oligonucleotides, in order to test it for MGMT binding. Analogues 
containing sulfur and selenium at the 6-position have been found to undergo demethylation 
(Spratt and de los Santos, 1992; Spratt and Campbell, 1994). Bacteria generate 6-
methyladenine enzymatically for the modulation of gene expression (Lindahl, 1993), and this 
base is not recognised by 0 6-methyl-G-transferases. However, N 6-methyldiaminopurine 
(N6-MeDAP) has similarities to both 6-methyladenine and 0 6-methylguanine, and could 
therefore perhaps be a substrate for MGMT. If it is recognised by the enzyme and if the 
methyl group is not cleaved, oligonucleotides containing this modification could be used to 
obtain the enzyme-DNA complex for crystallisation studies. 
In addition, oligonucleotides containing 0 6-methyl and 06-ethylguanine have been synthesised 
to be used as substrates for a mutant MGMT containing an alanine instead of cysteine at the 
active site, to be cloned and isolated by the research group of Dr M.Moore. This protein 
should retain its DNA binding properties but not its dealkylation function. 
It is hoped that at least one of these two approaches will give stable DNA-enzyme complexes 
which could then be investigated by NMR and X-ray crystallography to provide information 
on the structural change the protein and/or the DNA must undergo upon binding. 
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2. Results and Discussion 
Modified oligonucleotides can be used in conjunction with DNA binding proteins to provide 
useful information on binding and structure of the enzymes. In collaboration with 
Dr M.Moore at York University, studies were carried out to determine the interaction of DNA 
with 06-methyl-G-transferase (MGMT), a suicidal DNA repair enzyme which removes the 
alkyl group from guanine residues methylated or ethylated on the 0 6-position, and attaches it 
irreversibly to one of its cysteine residues. 
A series of modified oligonucleotides have been synthesised containing 0 6-alkylguanine 
(Figure 18) and a similar base - a purine having a nitrogen instead of an oxygen atom in the 6-
position (N6-methyl-2,6-diaminopurine) (Figure 19). The 0 6-alkyl-G oligonucleotides are to 
be tested for the binding of a mutant MGMT containing an alanine residue instead of the 
cysteine in the reactive site, and the oligonucleotides containing N 6-methyl-2,6-diaminopurine 
(N6-DAP) are to be used in conjunction with the wild type enzyme. 
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Figure 18. 06-alkylguanine 
	
Figure 19. N6-methyl-2,6-diaminopurine 
The procedures followed for the synthesis of suitably modified deoxyguanosine derivatives 
and for their transformation into phosphoramidite monomers for automated solid support DNA 
synthesis are outlined below. Optimisation of the deprotection time, purification and analysis 
of the oligonucleotides synthesised are also discussed. Comparative UV melting (thermal 
denaturing) studies were carried out on some of the sequences containing the above modified 
nucleic acid bases. 
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2.1 Structure of a Phosphoramidite 
Phosphoramidites are chemically modified nucleosides which are used in DNA synthesis, and 
they are added one at a time to the support bound nucleotide chain. The reactive groups on 
these nucleosides are blocked or protected to prevent unwanted side reactions. The 
characteristics of cyanoethyl phosphoramidites (Figure 20) are: 
• a trivalent phosphorus moiety on the 3' end, which will form the phosphite 
internucleotide linkage with the 5' hydroxyl of the support bound oligonucleotide, 
• a diisopropylamino group on the 3' phosphorus moiety on which it confers 
stability; it also acts as a leaving group when protonated, 
• a 3-cyanoethyl protecting group on the 3' phosphorus moiety, which prevents side 
reactions and improves the solubility of the compound, 
• a DMTr protecting group on the 5' end, to prevent self-polymerisation, 
• protecting groups on the exocyclic amines of dA, dC and dG (dT does not have 
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Figure 20. Standard phosphoramidites of (a) dA, (b) dG, (c) dT and (d) dC 
2.2 Synthesis of N 2-Acetyl-06-alkyl-dG 
When synthesising a phosphoramidite with an alkyl group in the 0 6-position of deoxy-
guanosine, a few difficulties must be overcome. Methods involving direct alkylation are 
unsuitable, mainly due to the fact that alkylating agents give significant N-alkylation. 
Gaffney & Jones (1982) were the first to devise a practicable route for the synthesis of 
N2-isobutyryl-0 6-alkyl-dG that did not involve direct alkylation. This method exploited the 
findings of Bridson etal. (1977) and Daskalov etal. (198 1) that the 0 6-position of guanosine 
and deoxyguanosine is susceptible to acylation, sulphonylation and phosphorylation. The 
problem with this method is that the isobutyryl group used for protection of the 2-amino group 
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of the 06-substituted guanine requires prolonged exposure of the oligonucleotide to 
concentrated ammonia at high temperatures (65°C for 72 hours). Even so, the final product 
may be contaminated by incompletely deprotected material as well as by the formation of 
2,6-diaminopurine (DAP) (Figure 21) through displacement of the 0 6-alkyl function through 
nucleophilic attack by ammonia during the prolonged exposure at high temperature (Fowler et 












Figure 21. Formation of DAP by prolonged exposure of 06-alkyl-G to conc. NH 3 
The presence of a DAP residue in oligonucleotides has been shown to increase the stability of 
duplexes when it is paired with thymine, as it can form three hydrogen bonds with this DNA 
base (Howard etal., 1966; Scheit & Rackwitz, 1982). For this study, DAP is an undesirable 
side product, since it reduces the amount of 0 6-alkyl-G present in oligonucleotides and would 
affect their UV melting temperatures. 
The synthesis of N 2-acyl-06-alkyl-2'-deoxyguanosine employed here (Figure 22) generally 
follows the method of Li & Swann (1989), which was itself adapted from the method of 
Gaffney and Jones (1982), but the acyl group used for the protection of the 2-amino group of 
06-alkyl-G is acetyl (Gaffney etal., 1984), rather than phenylacetyl (Li & Swann, 1989; Smith 
etal., 1990), as this is more convenient. Deoxyguanosine triacetate is relatively easy to 
prepare, and the acetyl group is quite readily removed from the 2-amino group of the 
substituted guanine residues in the oligonucleotides. In addition, the number of steps in the 
synthesis is reduced when using acetyl as a protecting group rather than phenylacetyl, and the 
overall yields for 3',5'-acetyl-N 2-acyl-2'-deoxyguanosine are comparable for the two methods - 
78% for acetyl versus 83% for phenylacetyl. 
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Deoxyguanosine (1) is reacted with a large excess of acetic anhydride (Ac 20) at reflux in 
pyridine (Py). Various purification methods of the resulting deoxyguanosine triacetate (2) 
were tried. Recrystallisation from EtOH / H 20 (1:9) gave a deep pink solid in a fairly low 
yield (53%). Boiling with a small amount of charcoal did not improve the yield by very much, 
and not enough impurities were removed. Boiling with a larger amount of charcoal gave much 
clearer and purer crystals, but unfortunately the yield dropped dramatically, as the bulk of the 
compound crystallised within the charcoal layer during filtration. Flash column chromato-
graphy was considered, but the compound did not dissolve well in dichloromethane. However, 
upon filtration, a very small amount of product was isolated. Recrystallisation from acetone, 
followed by two more recrystallisations of the supernatant, gave off-white, well defined 
crystals, raising the yield to 70 - 80%. 
The deoxyguanosine triacetate (2) is first sulphonylated (3) with mesitylenesulphonyl chloride, 
then displaced by a sterically hindered tertiary amine - in this case N-methylpyrrolidine - to 
give the N-methylpyrrolidinium derivative (4), which is in turn displaced by the appropriate 
alcohol in the presence of DBU, to give 0 6-alkyl-deoxyguanosine triacetate (5) in a one-pot 
reaction. After work up of the reaction mixture, the product is purified by wet flash column 
chromatography. 
The next step is the removal of the acetyl groups from the 3' and 5' oxygen atoms of the sugar 
ring by adding NaOH to compound 5 dissolved in pyridine and methanol, to obtain N2-acetyl-
06-alkyldeoxyguanosine (6). The reaction time and NaOH concentration were optimised so 
that there was minimal deprotection of the N 2-acetyl. The methanol is required in order to 
obtain a homogenous reaction mixture, otherwise the NaOH solution and the compound 5 in 
pyridine solution do not mix. The mixture is then neutralised with pyridinium-Dowex. This 
procedure has the benefit of removing the sodium ions while generating pyridine, which can 
then be removed in vacuo. 
After protection of the 5'-OH group and subsequent transformation into a phosphoramidite, 
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Figure 22. Synthesis of N 2-acetyl-0 6-alkyldeoxyguanosine 
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2.3 Synthesis of 0 6-pentafluorophenyl-N 2-trifluoroacetyl-2'-deoxy-
guanosine 
In order to obtain oligonucleotides with a N-methyl group rather than the usual oxygen at the 
6-position of a guanine residue, the nucleoside to be incorporated during DNA synthesis has to 
be chosen carefully. As is the case for 0 6-substituted guanines, the N 2-acyl protecting group 
should be relatively labile, otherwise - as is the case for isobutyryl - deprotection is extremely 
slow and the end product may be contaminated with incompletely deprotected material. 
In addition, the 6-methylamino group can pose a few problems. If it is inserted in the 
phosphoramidite, it will undergo side reactions during DNA synthesis, notably during 
coupling, when it would be phosphitylated. It could be protected with an acyl group, but the 
presence of two N-acyl bonds in the purine moiety makes the glycosidic bond between 
deoxyribose and the nitrogen base very sensitive to acid. Protic acids lead to depurination 
within minutes, and even with Lewis acids such as ZnBr 2, depurination has been observed 
after about one hour (Gaffney et al., 1984). 
Postsynthetic modification of a functional group at the 6-position of a deoxyguanosine 
derivative incorporated in oligonucleotides appears to be the best option. The research group 
of Gaffney and Jones (The State University of New Jersey) found that 0 6-pentafluorophenyl-
N2-trifluoroacetyl-2'-deoxyguanosine (PFTFdG) was a useful synthon for the postsynthetic 
modification of oligonucleotides (Gao etal. 1992). Their method for its synthesis (Fathi etal., 
1990) was used here (Figure 23). 
Deoxyguanosine (1) in pyridine was treated with trifluoroacetic anhydride (TFA) and then 
with a pentafluorophenol (PFP) solution in pyridine to give 0 6-pentafluorophenyl-N 2-tri-
fluoroacetyl-2'-deoxyguanosine (9) in a one-pot reaction. The mechanism of the synthesis has 
not been completely elucidated, as the authors were not able to isolate any reaction 
intermediates. It is presumed, however, that the reaction leads first to exhaustive 
trifluoroacetylation of the starting material, giving compound 7, with the 0 6-trifluoroacetyl 
group being then displaced by pyridine, yielding the 6-pyridyl derivative 8, which is a 
fluorescent polar material (TLC) (Fathi etal., 1990). PFP then displaces the 6-pyridyl group, 
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Figure 23. Synthesis of 06-pentafluorophenyl-N 2-trifluoroacetyl-2-deoxyguanosjne 
2.4 Synthesis of Phosphoramidites from the Modified Deoxyguanosine 
Derivatives 
In order to incorporate the modified deoxyguanosine derivatives in oligonucleotides, they have 
to be first protected at the 5'-OH with a 4,4'-dimethoxytrityl (DMTr) group, and then 
phosphitylated to obtain the phosphoramidites (Figure 24). 
The standard methods of dimethoxytritylation (Jones, 1984) and phosphitylation (Sinha etal., 
1984) were used. The deoxyguanosine derivative (6, 9) is treated with DMTrCI in pyridine in 
the presence of triethylamine to give the 5'-dimethoxytrityl compound (10 a-c), which is then 
reacted with the phosphitylating agent 2-cyanoethyl-N,N-(diisopropylamino)chlorophosphite 
in anhydrous tetrahydrofuran (THF) in the presence of diisopropylethylamine (DIPEA), the 
end product being the desired phosphoramidite (11 a-c). 
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Figure 24. Synthesis of phosphoramidites from modified deoxyguanosine derivatives 
The phosphitylating agent was synthesised according to the following method (Sinha et al., 
1983) (Figure 25): Phosphorus trichioride is treated with 3-hydroxypropionitrile to give 
2-cyanoethyl-dichiorophosphite. This is then reacted with diisopropylamine to obtain 
2-cyanoethyl-N,N-(diisopropylamino)chlorophosphite. P(III) compounds are very sensitive to 
moisture and oxygen, therefore the synthesis of the phosphitylating agent as well as the 
phosphitylation of nucleosides must be carried out in anhydrous conditions under argon or 
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Figure 25. Synthesis of phosphitylating agent 
2.5 Oligonucleotide synthesis 
After suitably modified phosphoramidite monomers were obtained, the synthesis of the oligo-
nucleotides involves straightforward solid support automated DNA synthesis by the phosphor-
amidite method, which is the method of choice for most laboratories because of efficient and 
rapid coupling and the stability of the starting materials (Beaucage and Caruthers, 1981). 
2.5.1 Short History 
The first synthesis of a dinucleotide containing a 3'->5' phosphate internucleotide linkage 
identical to the one in natural DNA was reported in 1955 by Michelson and Todd. Khorana 
and co-workers developed the protection of the 5'-hydroxyl group with trityl derivatives and 
the protection of the exocyclic amino groups of adenine and guanine with benzoyl and 
isobutyryl groups, respectively, during their pioneering work carried out in the late nineteen-
fifties and in the nineteen-sixties (Beaucage and Iyer, 1992; Blackburn and Gait, 1990). 
The introduction of the 'phosphite triester' method (Letsinger et al., 1975) revolutionised the 
synthesis of oligonucleotides, which up to then was carried out mostly by the 'phosphotriester' 
method (Letsinger and Mahadevan, 1965 and 1966). However, the deoxynucleoside 
chlorophosphite intermediates were unstable to moisture and difficult to handle because of 
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their high reactivity. A new class of intermediates for oligonucleotide synthesis - the 
phosphoramidites (Figure 26) - was introduced by Beaucage and Caruthers (1981). These 
compounds could be isolated and stored as stable powders. 
DMTrO 	 B 
P — OCH 3 
CH3 
B is a suitably protected nucleic acid base 
Figure 26. Phosphoramidite (Beaucage and Caruthers, 1981) 
The concept of solid phase synthesis was developed by Merrifield (1963) for peptide synthesis. 
The use of organic - mainly polystyrene based (Letsinger and Mahadevan, 1965) - and 
inorganic - silica based (Köster, 1972) - solid supports for the synthesis of nucleic acids was 
then investigated. After the introduction of the phosphite triester method of oligonucleotide 
synthesis, the interest in suitable solid supports was revived (Matteucci and Caruthers, 1981). 
Currently, the most widely used solid support is silica based and is controlled pore glass (CPG) 
(Beaucage and Iyer, 1992). 
Reliable automation of DNA synthesis became possible after Beaucage and Caruthers (1981) 
introduced phosphoramidites as a new class of monomers for DNA synthesis, which were 
more stable under normal laboratory conditions than the nucleoside chlorophosphites or the 
corresponding tetrazolides commonly used at the time. A number of DNA synthesisers 
employing the phosphoramidite approach are currently available. 
The N,N-dimethylamino group was subsequently replaced with N,N-diisopropylamino 
(McBride and Caruthers, 1983; Adams etal., 1983), which facilitated the purification of the 
phosphoramidite monomers and increased their stability in solution. 
The removal of the methyl group on the phosphorus moiety required treatment with thiophenol 
at the end of the synthesis. The latter is an unpleasant reagent, so methyl protection on the 
phosphoramidites has been superseded by f3-cyanoethyl protection (Sinha et al., 1983 and 
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1984), since this group can be easily removed under the basic conditons required to cleave the 
oligonucleotides from the solid support, using the same reagent - concentrated ammonia - 
employed in base deprotection. 
2.5.2 Solid Support DNA Synthesis by the Phosphoramidite Method 
The synthesis is performed with the growing DNA chain attached to the solid support trapped 
on the synthesis column between two filters. The chemical reactions are driven to completion 
by the use of an excess of reagents relative to the support bound oligonucleotide, and the 
unreacted compounds, which are in the liquid phase, can easily be removed by washing with 
an appropriate solvent (Brown and Brown, 1991; Gait, 1984). Therefore, no purification steps 
are required between cycles. 
Each cycle of base addition consists of four steps (Figure 27): 
(1) Detritylation - occurs in the presence of a protic acid, usually trichloroacetic acid 
(TCA) in anhydrous dichloromethane (DCM). The removal of the acid-labile 
dimethoxytrityl (DMTr) protecting group on the 5'-end of the support-bound 
nucleoside enables the coupling of the 5'-hydroxyl group with a phosphoramidite 
during the following step. 
Coupling - the phosphoramidite is activated by tetrazole and then forms an 
internucleotide phosphite with the support-bound 5'-hydroxyl. 
Capping - the oligonucleotide chains that failed to undergo addition in the 
previous step are capped by acetylation with Ac 20 in the presence of 
1-methylimidazole, to prevent their propagation in subsequent cycles, which will make 
them easier to separate from the main product. 
Oxidation - the phosphite linkage, being susceptible to acid and base cleavage, is 
then oxidised by iodine in a solution of water, pyridine and THF, and the cycle can 
start again. 
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When the synthesis is complete, the DMTr protection on the last nucleoside can be left on or 
removed. For this study it was removed, as the oligonucleotides were quite short. It is mainly 
in case of long oligonucleotides that reverse phase HPLC purification with the DMTr on 
presents a distinct advantage, as this hydrophobic group makes the oligomer to which it is 
attached elute later from the column, thus enabling a better separation, after which the DMTr 
group is removed by treatment with 80% acetic acid. Short oligonucleotides are usually quite 
easy to separate, even without an attached DMTr group. In addition, 'trityl off' purification 
avoids the additional exposure of the modified oligomers to aqueous protic acid, which could 
lead to some depurination. 
2.6 Deprotection and Postsynthetic Modification of Oligonucleotides 
Cleavage from the solid support and deprotection of the phosphate groups are usually done 
automatically, in concentrated ammonia. The crude oligonucleotide synthesis mix is then 
placed at 55°C to remove the base protecting groups. The 0 6-alkylguanine oligonucleotides 
were cleaved and deprotected in this way. 
The 06-pentafluorophenyl-N2-trifluoroacetyl guanine (PFTFG) oligonucleotides were treated 
manually with a 40% aqueous solution of methylamine at 55°C during the final step, which is 
cleavage from the solid support and deprotection. If it were to be used on the DNA synthe-
siser, methylamine could attack the plastic tubing and the seals. At the same time the 
06-pentafluorophenyl group of the modified guanines is displaced by methylamine to give 
N6-methyldiaminopurine (N 6-MeDAP) (Figure 28). The deprotection time of these oligomers 
seemed to be a crucial factor in respect of the ease of their FIPLC purification and had to be 
optimized (see Section 2.7.4). 
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Figure 28. Postsynthetic modification and deprotection of PFTFG containing oligonucleotides 
The 06-methyl-G oligonucleotides could also have been obtained by postsynthetic 
modification. Treatment of the PFTFG containing oligomers with DBU in methanol leads to 
the replacement of the pentafluorophenyl group of the modified guanine to give 0 6-methyl-G. 
However, the reaction is much slower in case of the oligonucleotides compared to that of the 
monomer; Gao etal. (1992) reported that the reaction was less than two-thirds complete even 
after five days. Consequently, the synthesis of an 0 6-methyl-G phosphoramidite which would 
then be used in DNA synthesis was deemed a more suitable method for obtaining 
oligonucleotides containing this particular modified base. 
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2.7 Optimization of the Deprotection Time, Purification, Enzymatic 
Digestion and CZE Analysis of the Oligonucleotides 
The purification of the oligonucleotides consists of preparative reverse phase HPLC, desalting 
on Sephadex G- 10 and freeze-drying. 
2.7.1 Deprotection and HPLC Purification of the 0 6-Alkyl-G Oligonucleotides 
The unmodifed bases making up the oligonucleotides have standard protection on their amino 
groups (see Section 2.1) and the 0 6-alkyl-G bases are protected by an acetyl group. To 
determine the optimum deprotection time of the 0 6-alkyl-G oligonucleotides, one of these 
(CGC GM-AA TTC GCG) was treated with concentrated ammonia at 55°C for over five days, 
and analytical HPLC traces of the crude mixture were done after 4.5, 16, 19, 36 and 126 hours. 
The chromatogram obtained after 4.5 hours (Figure 28a) indicates a two main overlapping 
peaks, the one on the right being the bigger one. After 16 and 19 hours (Figure 28b and c, 
respectively) the peak on the left has increased significantly in size, the one on the right 
appearing as a shoulder to the former. After 36 hours (Figure 28d) there is just one main peak, 
and after 126 hours (Figure 28e) there appears to be no significant change. It was therefore 
assumed that deprotection was complete at 36 hours. Consequently, judging by the size of the 
shoulder to the main peak after 19 hours and trying to avoid unnecessary prolonged exposure 
to concentrated ammonia at 55'C, the 06-methyl-G and 0 6-ethyl-G oligonucleotides were 












Figure 29. Analytical HPLC traces of CGC GMeAA  TIC GCG after (a) 4.5, (b) 16, (c) 19, (d) 36 
and (e) 126 hrs deprotection in conc. NH3 at 55°C 
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Prior to purification by preparative HPLC, analytical HPLC of the oligonucleotides was 




Figure 30. Prep HPLC trace of (a) GCA GGMeG  AAC and (b) GCA GGGEt  AAC 
2.7.2 Enzymatic Digestion of the 0 6-Alkyl-G Oligonucleotides 
In order to make sure that 0 6-methyl-G and 06-ethyl-G, respectively, have been incorporated 
in oligonucleotides, these were submitted to enzymatic digestion with phosphodiesterase from 
snake venom and alkaline phosphatase from bovine intestinal mucosa. This generates a 
mixture of free nucleosides in the proportions that they were incorporated in the 
oligonucleotides. 
The enzyme digests were analysed by reverse HPLC on their own, as well as coinjected with 
an HPLC standard, i.e. the appropriate modified nucleoside. It was found that an extra peak 
due to the modified nucleoside appeared on the chromatograms of the enzyme digests. This 
had a longer retention time than the unmodified (standard) nucleosides. When coinjected with 
the HPLC standard, the size of the peak attributed to the modified nucleosides had increased 
significantly. This proves that the modified nucleosides were successfully incorporated in 








The order of elution of the peaks is dC, dG, dA and 0 6-alkyl-dG. No peaks corresponding to 
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(a) 	 (b) 
Figure 31. Enzyme digest of GCA GGGMe  AAC (a) on its own and (b) coinjected 
with 06-MedG 
(a) 	 (b) 
Figure 32. Enzyme digest of GCA GGEtG  AAC (a) on its own and (b) coinjected 
with 06-EtdG 
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2.7.3 CZE Analysis of the 06-Alkyl-G Oligonucleotides 
CZE was used to check the purity of the oligonucleotides after they had been purified, desalted 
and freeze dried, as it is a very sensitive method. The CZE traces of the 0 6-alkyl-G oligo-
nucleotides all showed one single sharp main peak. Examples of the obtained CZE traces are 
shown in the appropriate experimental section. 
2.7.4 Deprotection, HPLC Purification, Enzymatic Digestion and CZE Analysis of the 
PFPG I N6-Methyldiaminopurine Oligonucleotides 
To determine the optimum deprotection time of the PFPG / N 6-DAP containing 
oligonucleotides, one of these - GCA GGNHMeG  AAC - was treated with 40% aqueous 
methylamine at 55°C for 12 days. The crude oligonucleotide mixture was analysed by HPLC 









Figure 33. Analytical HPLC traces of GCA GGNHMeG  AAC after (a) 1, (b) 3, (c) 5, (d) 7 
and (e) 12 days treatment with methylamine at 55°C 
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The chromatogram obtained after 1 day (Figure 33a) indicates a main peak with a shoulder on 
the right. After 3 days (Figure 33b) the shoulder on the right has increased in size. After 5 and 
7 days (Figure 33c and d, respectively) there appear to be two main peaks running very close 
together and partially overlapping, the one on the left being the bigger one, and after 12 days 
(Figure 33e) the one on the right is bigger. At first it was assumed that the postsynthetic 
modification of PFPG oligonucleotides may be quite slow, especially when they contain three 
guanines in a row (one of them being modified), which generates an environment that is quite 
hydrophobic and may have the tendency to prevent the access of solvent (water) and of the 
deprotecting reagent. Based on that assumption, the peak on the left would be due to the as yet 
unmodified oligomers. 
When the oligonucleotides were submitted to preparative HIPLC purification, the chroma-
tograms showed either two overlapping main peaks in case of GCA GGNHMeG  AAC 
(Figure 34a) or a broad main peak with a few significant shoulders for GCA GGGNHMe  AAC 
(Figure 34b). This made purification very difficult. 




Figure 34. Prep HPLC of (a) GCA GGNHMeG  AAC and (b) GCA GGGNHMe  AAC 
The two main peaks of GCA GGNICG AAC were collected separately, submitted to 
enzymatic digestion and analysed by Capillary Zone Electrophoresis. HPLC analysis of the 
enzyme digests showed that, surprisingly, both peaks contained N 6-methyldiaminopurine 
nucleoside. CZE of the first HPLC peak showed one single main peak, sometimes with a 
broad base, whereas the second HPLC peak seemed to block the capillary. In most cases the 
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second HPLC peak showed nothing at all on CZE, but occasionally a distortion of the base line 
in the shape of a bulge, a small peak with a broad base or a great number of single narrow 
peaks would appear. It was concluded that the second HPLC peak was due to secondary 
structure of the oligonucleotides, which would explain why it might block the capillary. It 
may also be possible that this DNA secondary structure would sometimes get sheared in the 
capillary, which is consistent with a large number of peaks appearing occasionally during CZE 
analysis. 
The broad HPLC peak of GCA GGGNIe  AAC didn't block the capillary during CZE analysis, 
but appeared to be impure. 
No such problems were encountered with the oligonucleotide GCA GPFPGG  AAC, where the 
analytical HPLC traces after 2, 3 and 4 days treatment with methylamine were virtually 
identical, showing one sharp main peak (Figure 35). This indicated that the postsynthetic 




Figure 35. Analytical HPLC traces of GCA GNHMeGG  AAC after (a) 2 and (b) 4 days 
treatment with methylamine at 55°C 
The prep HPLC showed a single main peak (Figure 36), which appeared to contain no 
impurities when analysed by CZE. 
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Figure 36. Prep HPLC trace of GCA GNHMeGG  AAC 
Gao etal. (1992) had reported that postsynthetic modification of the PFPG residues with 
ammonia to 2,6-diaminopurine in oligonucleotides takes about 60 hours. Methylamine is more 
nucleophilic than ammonia, so it was considered reasonable to assume that its reaction with 
the PFPG oligomers would take less time. The oligonucleotides were resynthesised and their 
deprotection time shortened. Considering the analytical HPLC traces in Figure 33 and the fact 
that apparently the size of the shoulder/peak on the right of the main peak should be minimised 
to ease purifiation, newly synthesised PFPG oligonucleotides were treated with 40% aqueous 
methylamine for 10 - 12 hours and then purified by reverse phase HPLC. The prep J-IPLC 
traces obtained show only a small shoulder on the right of the main peak (Figure 37b). 
(a) 	 (b) 
Figure 37. (a) Analytical and (b) prep HPLC of GCA GGNHMeG  AAC after 12 hours treatment 
with methylamine at 55°C 
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After desalting and freeze drying, each N 6-methyl-DAP oligonucleotide was submitted to 
enzymatic digestion to check whether this modification was indeed present. An extra peak due 
to the modified nucleoside appeared on the chromatograms of the enzyme digests. This had a 
longer retention time than the unmodified (standard) nucleosides. When coinjected with 
N6-methyl-DAP nucleoside, the size of the peak attributed to the modified nucleoside had 
increased significantly. This proves that PFTFdG was successfully incorporated in DNA 
oligomers and then modified to N 6-methyl-DAP. Examples of the HPLC chromatograms 
obtained are shown below. The order of elution of the peaks is dC, dO, dA and 
N6-methyl-DAP nucleoside. 
Ka  of 
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Figure 38. Enzyme digest of GCA GGNHMeG  AAC (a) on its own and (b) coinjected 
with N6-MeDAP nucleoside 
CZE analysis of the oligonucleotides after 10 - 12 hours treatment with methylamine, reverse 
phase HPLC purification, desalting on Sephadex G-10 and freeze drying, showed one single 
sharp main peak. Examples of the CZE traces obtained are shown in the appropriate 
experimental section. 
2.8 UV Melting (Thermal Denaturing) 
UV melting studies were carried out on the duplexes formed from some of the modified 
oligonucleotides and a complementary strand with C and then with T opposite the modified 
base. The generic sequence of these duplexes is represented in Figure 39. The melting 
temperatures of the modified duplexes (Table 1) were compared with those of the duplex 
formed by the unmodified oligonucleotide, where each of the relevant guanines were paired in 
turn both with C and with T (Table 2). 
5' GCA G*iG*2G*3  AAC 3' 
3' CGT C C C TTG 5' 
(T) (T) (T) 
Figure 39. Generic sequence of the G-modified duplexes submitted to UV melting 
Table 1. Melting temperatures of the G-modified duplexes 
T. (°C) G 1 NHMe G2NHMe G3NHMe Me G2MC G3MC Et G2Et G3Et 
T 38.5 38.9 37.3 22.1 24.0 22.8 21.2 23.3 21.8 
C 25.7 29.3 29.1 27.9 30.4 28.1 27.0 30.8 27.3 
Table 2. Melting temperatures of the unmodified duplexes 
TM (00 G 1 G2 G3 
T 31.1 29.4 27.4 
C 43.8 
When paired with a C, there is hardly any difference between the melting temperatures of the 
modified duplexes, but they all are significantly destabilised compared to the natural, 
AN 
unmodified duplex. Those duplexes where the second in the row of three guanines (G 2) is 
substituted, appear to be somewhat more stable than their counterparts with G 1 or G3 modified, 
the difference in melting temperatures ranging from 0.2 - 3.5°C. The structures of the natural 
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Figure 40. Guanine - cytosine base pair 
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Figure 41. (a) 06-methylguanine - cytosine and (b) N 6-methyldiaminopurine - cytosine 
wobble base pairs with the methyl group in the distal orientation 
When paired with a T, the situation is changed. The melting temperatures of the 
N6-methyldiaminopurine duplexes are quite high, almost as high as the one of the natural 
duplex, and significantly higher than that of the unmodified mismatched duplexes (with each 
G paired in turn with a T). The 0 6-alkyl duplexes, however, are even more destabilised than 
they were in the previous case. These results indicate that there is favourable base pairing, i.e. 
there are three hydrogen bonds between GNJ%e  and T (Figure 43b) with the methyl group 
probably adopting the proximal orientation, but, as discussed in Section 1.5.2, at best only two 
hydrogen bonds between GMC  and T (Figure 43a) and two between G and T (Figure 42). 
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Figure 42. Guanine - thymine base mispair 
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Figure 43. (a) 06-methylguanine - thymine and (b) N 6-methyldiaminopurine - thymine base 
pairs with the methyl group in proximal orientation 
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3. Experimental 
3.1 Chemicals and Solvents 
All chemicals were obtained from Aldrich, Fluka, Sigma or Fisons. Silica gel 60 (80-430 
mesh) was obtained from Fluka. All solvents were of analytical or HPLC grade. Anhydrous 
acetonitrile was purchased from Applied Biosystems as DNA synthesis grade. 
Anhydrous pyridine was distilled over Call 2. Anhydrous tetrahydrofuran (THF) and diethyl 
ether (ether) were distilled over sodium and benzophenone. Triethylamine (TEA), 
diisopropylamine and diisopropylethylamine (DIPEA) were dried by storage over CaH 2 . 
Methanol and ethanol were dried by distillation from magnesium turnings and iodine. Toluene 
was dried by storage over sodium wire. Pyrogen-free, reverse osmosis purified water was used 
throughout. 
3.2 Thin Layer Chromatography (TLC) 
TLC was carried out on aluminium sheets coated with a 0.2mm layer silica gel 60 F 254 , 
supplied by Merck, using the following solvent systems (all v/v): 
dichioromethane : methanol (10: 1) 
dichioromethane : methanol (9.5 : 0.5) 
ethylacetate : acetonitrile (1: 1) 
ethylacetate : triethylamine (9.9 : 0.1) 
ethylacetate : methanol : concentrated ammonia (5 : 1 : 1) 
dichloromethane : methanol : acetic acid (10 : 2: 1) 
n-butanol : acetic acid : water (3 : 1: 1) 
Before carrying out TLC of dimethoxytritylated compounds, the plates were pretreated with 
triethylamine to prevent detritylation due to the acidic silica gel. 
The purity of all compounds synthesised was verified by one spot on TLC. 
70 
For prep TLC, 20cm x 20cm glass plates were coated in the lab with silica gel GF 254 obtained 
from Fluka, by the following procedure: A mixture of 130g silica gel and 225g deionised 
water - vigorously shaken for 30 seconds - was poured in the spreader set at a distance of 
1.0mm from the plates. The spreader was then pulled quickly in one single movement from 
one end to the other of the row of six glass plates clamped in a special holder. The plates were 
left to stand for 20 minutes and then placed in the drying oven overnight. 
Compounds were visualised under UV light at 254nm. To see the presence of sugar groups, 
the TLC plates were sprayed with an anisaldehyde solution of the composition anisaldehyde 
(para-methoxybenzaldehyde) : AcOH: conc. H2SO4 : EtOH (5: 1: 1: 100 v/v/v/v) and then 
heated on a hotplate. A positive test was indicated by a dark blue, green or brown coloration 
on heating. Dimethoxytrityl groups were visualised by fuming HCI as bright orange colours. 
3.3 Wet Flash Column Chromatography 
This was carried out under slight nitrogen or argon pressure (0.5 bar) using silica gel 60. For 
compounds containing the cyanoethyl-N,N-diisopropyl-phosphoramidite group the silica was 
dried overnight at 120°C and then cooled in a dessicator over P 205 prior to being used in order 
to remove any moisture present. For compounds containing the DMTr group, the silica was 
preequilibrated with solvent containing 1% TEA. 
3.4 Instrumentation 
'H-NMR spectra were recorded on a Brucker WP-200 (200.13 MJ-Iz) Fourier transform 
spectrometer. 13C-NMR spectra were recorded on a Brucker WP-200 (50.32 MHz) Fourier 
transform spectrometer. Tetramethylsi lane was used as internal reference and cited chemical 
shifts are given in ppm downfield of this standard. 31 P-NMR spectra were recorded on a Jeol 
FX90Q (90 MHz) Fourier transform spectrometer. H 3PO4 85% was used as external reference 
and cited chemical shifts are given in ppm downfield of this standard. UV spectra were 
recorded on a Perkin Elmer Lambda 2 ultraviolet-visible spectrophotometer. Positive ion fast 
atom bombardment (FAB) mass spectra were recorded on a Kratos MS 50 TC spectrometer 
using either a thioglycerol or a 3-nitrobenzyl alcohol (3-NOBA) matrix. C, H and N 
microanalysis was performed on a Perkin Elmer 240 elemental analyser. 
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3.5 Oligonucleotide Synthesis 
Oligonucleotide synthesis was performed using solid phase 2-cyanoethyl-N,N-diisopropyl-
phosphoramidite chemistry (Beaucage and Caruthers 1981; Beaucage and Iyer, 1992; Brown 
and Brown 1991) on an Applied Biosystems 394 automated DNA synthesiser equipped with 
on-line long wave detector (498nm). All DNA synthesis reagents and standard phosphor-
amidite monomers were supplied by Applied Biosystems. 
The modified phosphoramidites synthesised for this study were dried in vacuo, stored with 
P205 overnight and used as a 0.11 - 0.12M solution in anhydrous acetonitrile. Coupling 
efficiencies were in general > 98%. 'Trityl-off' syntheses were carried out. The 0 6-alkyl-G 
and the unmodified oligonucleotides were cleaved automatically from the solid support with 
concentrated ammonia. Deprotection of 0 6-alkyl-G and unmodified oligonucleotides was 
carried out by incubation in sealed vials with teflon caps at 55°C in concentrated ammonia for 
24 hours and 12 hours, respectively. The PFPG oligonucleotides were cleaved manually and 
deprotected in 40% aqueous methylamine at 55°C for 10-12 hours. 
The following DNA sequences were synthesised: 
GCA GPFPGG  AAC GCA GMeGG  AAC GCA GEtGG  AAC 
GCA GGPFPG  AAC GCA GGMeG  AAC GCA GGEtG  AAC 
GCA GGGPFP  AAC GCA GGGMe  AAC GCA GGGEt  AAC 
CGC GPFPAG  CTC GCG CGC GMeAA  TTC GCG GTT TCC TCG 
CGC GAG CTC GCG GCA GGG AAC GTT CTC TCG 
CGC GPFPAG  CTT GCG GTT CCC TCG GTT CCT TCG 
CGC GAG CTT GCG 
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3.6 HPLC Analysis and Purification of Oligonucleotides 
Oligonucleotide analysis and purification was carried out on a Gilson Model 306 equipped 
with UV detector, an Aquapore Octyl reverse phase column (10mm x 250mm) and an 
octadecyl pelicullar guard column, controlled by a computer running Gilson 712 software. 
The eluting buffers used were: 
buffer A - 0.1M NH40Ac 
buffer B - 0.1M NH40Ac plus 20% MeCN 
At a flow rate of 3ml/min, the following gradient was used: 
Time (mm) 	% Buffer 	B 
	
0.00 	 0.0 
3.00 	 0.0 
4.00 	 15.0 
milli]NMI  
061III 	 [IIIx1 
tIIx,1 
31II 
30.00 	 0.0 
Analytical runs were monitored at 260nm and 0.2 absorbance units full scale (AUFS). 
Preparative scale runs were monitored at 293-298nm and I AUFS. 
3.7 Enzymatic Digestion of Oligonucleotides 
Enzymatic digestion of oligonucleotides allows the identification of their nucleoside 
composition. The enzymes used in this procedure are phosphodiesterase I (type VII from 
Crotalus atrox venom) and alkaline phosphatase (type VII from bovine intestinal mucosa). 
The former enzyme cleaves the oligonucleotides into its constituent nucleoside-5'-phosphates 
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(nucleotides), and the latter one hydrolyses the phosphate groups from the nucleotides to give 
the corresponding nucleosides. 
One unit of phosphodiesterase I will hydrolyse 1.0 mM of bis(p-nitrophenyl)phosphate per 
minute at pH 8.8 and 37°C. One unit of alkaline phosphatase will hydrolyse 1 mM of 
p-nitrophenylphosphate at pH 10.4 and 37°C. 
Oligonucleotides (2 OD260 units) dissolved in 500tl enzyme digest buffer (1M sodium 
chloride and 50mM Tris at pH 8.8) were incubated with 0.10 units phosphodiesterase I and 
0.30 units alkaline phosphatase at 37°C for 24 hours. The digest was then analysed by reverse 
phase HPLC at 260nm and 0.2 AUFS using buffer A: 0.IM NH 4Ac and buffer B: 0.1M 
NI-I4Ac plus 20% MeCN, at a flow rate of 3ml/min. One of the following two gradients was 
used: 
Time (mm) % Buffer B Time (mm) % Buffer B 
0.00 0.0 0.00 0.0 
2.00 0.0 2.00 0.0 
3.00 15.0 3.00 15.0 
26.00 100.0 26.00 100.0 
29.00 100.0 29.00 0.0 
29.50 0.0 30.00 0.0 
30.00 0.0 
3.8 Sephadex Gel-Filtration (Desalting) of Oligonucleotides 
During the reverse phase HPLC purification step, the oligonucleotides were eluted with buffers 
containing salt and possibly other small molecules. In order to remove these small molecules, 
the oligonucleotides up to 10 bases in length were submitted to gel filtration on a Pharmacia 
Sephadex G-1 0 column (2.6cm x 40cm) connected to an UV detector, at a flow rate of 
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2m1/min. The eluent which passed through the UV detector, was monitored at 260nm. The 
DNA peak was collected and lyophilised to give a fluffy white powder. 
The sequences of more than 10 bases in length were desalted on Pharmacia NAP- 10 (nucleic 
acid purification) cartridges containing Sephadex G-25, according to the manufacturer's 
instructions. 
3.9 Capillary Zone Electrophoresis (CZE) 
The purity of all oligonucleotides synthesised was verified by one single sharp peak on CZE. 
This was carried out on an Applied Biosystems Model 270A Capillary Electrophoresis system 
with Microgel capillaries using 75mM Tris-phosphate with 10% methanol at pH 7.6 elution 
buffer. The on-line detector was set at 272nm with the loading voltage at -5kV, the running 
voltage at -15kV and the sample uptake time at Ito 5 seconds. Sample runs were recorded on 
a chart recorder set at chart speed 1cm/min, attenuation 16, offset 5 and peak threshold 10 000. 








Figure 45. CZE traces of (a) GCA GMeGG  AAC, (b) GCA GGGEt  MC, 
(c) GCA GGNHMeG  AAC and (d) GCA GGG MC 
3.10 UV Melting (Thermal Denaturing) Studies 
UV melting was carried out on a Lambda 15 UV-visible spectrophotometer conttolled by a 
computer running a PECSS (Perkin Elmer Computerised Spectroscopy Software) package. 
The temperature of the sample was controlled by a Perkin Elmer Peltier block with a heating 
rate of 1°C/mm. The absorbance of the sample at 260nm was measured at intervals often 
seconds to obtain absorbance versus time melting curves. The data was then converted to 
absorbance versus temperature curves and the melting temperature (which corresponds to the 
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point of inflection of the curves) was obtained by calculating the first derivative of the curve 
and determining its maximum point. The melting temperature of a nucleic acid is that where 
half of it is double stranded and half single stranded. All melting curves were determined in 
triplicate. 
The micromolar extinction coefficients of the single stranded oligonucleotides were calculated 
using the following formula taken from Brown and Brown (1991): 
6254 =[(8.8xnT)+(7.3xnC)+(11.7xnG)+(15.4xnT)]x0.9 
The factor of 0.9 is due to the fact that base stacking interactions in the single strand suppress 
the absorbance of DNA relative to the value calculated from the extinction coefficients of the 
individual nucleosides. 
The values for the micromolar extinction coefficients 6(0*)  of the modified nucleosides were 
determined experimentally from the UV spectra of the compounds. The following values were 
found: 
6254(dGMe) = 8.71 
6254(dGEt) = 3.49 
c254(dG'Me) = 6.75 
Single-stranded oligonucleotides were dissolved in UV melting buffer (0.1MNaCI, 0.01M 
NaH2PO4, 20mM cacodylic acid, 1mM EDTA, adjusted to pH 7.0 with NaOH). Solutions 
were then mixed to give 5.0jiM solutions of double-stranded DNA when made up to 2.7ml 
with UV melting buffer in a cuvette. Baseline corrections were carried out against a reference 
cell containing UVmelting buffer. Below 15°C, nitrogen was continuously flushed through the 
sample compartment to prevent condensate formation. 
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3.11 Synthetic Chemistry 
3', 5-Bis(O-acetyl)-N2-acetyl-2'-deoxyguanosine [Gaffney et al., 1984] 
0 
N NH 
H3CCO 	 N 	N NHCCH3
11 
0 b o 
H3 CCO 
0 
Deoxyguanosine monohydrate (5.03g. 17.5mmol) was dried by the evaporation of anhydrous 
pyridine (3 x 15m1), suspended in dry pyridine (100m!), and acetic anhydride (25m1, 
265mmol, l5eq. [d=1.082]) was added. The reaction mixture was stirred at reflux for 4.5 
hours, when TLC showed the absence of both starting material and 3', 5'-bisacetylated 
intermediate (Rf 0.0 and 0.15 , respectively in solvent system I). The solvents were then 
removed in vacuo. Small amounts of toluene were added to help remove the pyridine. The 
solid residue was dissolved in acetone at reflux and left to cool. Crystalline deoxyguanosine 
triacetate precipitated and was filtered. The supernatant was concentrated on the rotary 
evaporator until crystals started to form again and was then filtered. These operations were 
repeated with the new filtrate. A cream coloured crystalline solid was obtained. Yield 78% 
(5.36g). Rf 0.30 (system I); 0.15 (system II); 0.74 (system VI). [FAB] m/z (M+H): found 
394.13768, calculated 394.13627. 1H-NMR: 8H  (d6-DMSO) 2.02, 2.08, 2.17 (3s, 9, 3'- 5'-
N2-Ac: CH3), 2.49-2.58 (m, 1, H2'), 2.91-3.02 (m, 1, H2"), 4.16-4.27 (m, 3, H4'5'5"), 5.30-5.32 
(m, 1, H3'), 6.17-6.20 (t, 1, Hi'), 8.20 (s, 1, H8), 11.70, 12.03 (2s, 2, 1-NH, N 2-H). 13C-NMR: 
6 (d-DMS0) 20.70 CH3 , 20.96 CH3, 23.94 CH3 , 38.93 CH2, 63.71 CH2, 74.55 CH, 81.90 
CH, 83.13 CH, 120.49 CH, 137.54 C, 148.19 C, 148.71 C, 154.94 C, 170.21 C, 170.36 C, 
173.71 C. Anal. calcd. for C 16H 19N507 .3/4H20: C 47.23, H 5.08, N 17.21; found C 47.20, 
H 5.05, N 17.27. liv spectrum (MeOH): ?m=  202nm, A.m2=259nm, Xm3= 279nm. 
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H3 CCO 	 N NHCCH3 
H3 CCO 
0 
3', 5 '-Bis(O-acetyl)-N 2-acetyl-2'-deoxyguanosine (5 .07g, 1 2.9mmol) was suspended in dry 
dichloromethane (DCM)(8Oml). Triethylamine (TEA) (7.2m1, 51.6mmol, 4eq. [d=0.726]), 
mesitylenesuiphonyl chloride (MSCI) (5.64g. 25 .8mmol, 2eq.) and 4-(N, N-dimethylamino)-
pyridine (DMAP) (60mg, 0.5mmol) were added and the reaction was stirred at room 
temperature for 1.5 hrs, when TLC showed total conversion to the higher running 
06-sulphonylated compound (Rf 0.64 in system I). The reaction mixture was then cooled in 
an ice bath and N-methylpyrrolidine (13.4ml, 129mmol, lOeq. [d=0.819]) was added. After 
30 minutes, conversion to the 6-N-methylpyrrolidinium compound was complete (R f 0.0 in 
system I). After warming to room temperature, the mixture was stirred with MeOH (3.6m1, 
90.3mmol, 7eq. [d=0.791]) and DBU (5.8m1, 38.7mmol, 3eq. [d=1.018]) for 1.5 hrs, when a 
compound with a higher Rf was formed. The reaction was quenched with aqueous KH2PO4 
(1M, lOOmI, pH 6.5). The organic layer was drawn off, dried over Na 2S041  filtered and 
concentrated in vacuo. The residue was dissolved in a small amount of DCM and purified by 
wet flash column chromatography with a gradient of 0 - 3% MeOH in DCM. The appropriate 
fractions were combined and evaporated in vacuo obtaining the title compound as a pale 
yellow foam. Yield 62% (3.26g). Rf 0.48 (system I); 0.25 (system II); 0.82 (system VI). 
[FAB] m/z (M+H): found 408.1495 1, calculated 408.15192. 1H-NMIR: 6H  (d6-DMSO) 1.99, 
2.01, 2.09 (3s, 9, 3'- 5'- N2-Ac: CH3), 2.48-2.57 (m, 1, H2'), 3.16-3.30 (m, 1, H2"), 4.06 (s, 3, 
06-CH3), 4.21-4.34 (m, 3, H4'5'5"), 5.42-5.45 (m, 1, H3'), 6.32-6.38 (t, 1, Hi'), 8.40 (s, 1, H8), 
10.46 (s, 1, N2-H). 13 C-NIVIR: 6 (d6-DMSO) 20.70 CH3 , 20.99 CH3 , 24.90 CH3 , 35.18 CH2, 
54.27 CH3 , 63.84 CH2, 74;67 CH, 81.97 CH, 83.91 CH, 117.77 C, 141.65 CH, 152.25 C, 
152.51 C, 160.61 C, 169.16 C, 170.19 C, 170.31 C. Anal. calcd. for C 17H21 N507 : C 50.12, 
H 5.20, N 17.19; found C 50.47, H 4.70, N 16.39. UV spectrum (MeOH): X 1 202nm, 









The procedure above was followed up to the conversion of the 0 6-sulphonylated compound to 
the quaternary pyrrolidinium salt. After warming to room temperature, the mixture was stirred 
with EtOH (5.3ml, 90.3mmol, 7eq. [d=0.785]) and DBU (5.8m1, 38.7mmol, 3eq.) for 2.5 hrs, 
when a compound with a higher R f was formed. The reaction was quenched with aqueous 
KH2PO4 (1M, lOOml, pH 6.5). The organic layer was drawn off, dried over Na 2 SO4, filtered 
and concentrated in vacuo. The residue was dissolved in a small amount of DCM and purified 
by wet flash column chromatography with a gradient of 0 - 3% MeOH in DCM. The 
appropriate fractions were combined and evaporated in vacuo to a pale yellow foam. Yield 
52% (2.82g). Rf 0.50 (system I); 0.26 (system II); 0.83 (system VI). [FAB] m/z (M+H): 
found 422.16765, calculated 422.16757. 1H-NMR: 6H  (CDC13) 1.42-1.47 (t, 3, 0 6-Et: CH3), 
2.04, 2.10 (2s, 6, 3'- 5'-Ac: CH 3), 2.50 (s, 3, N2-Ac: CH3), 2.52-2.60 (m, 1, 112'), 2.89-2.98 (m, 
1, H2") 4.27-4.42 (m, 3, H4'5'5"), 4.50-4.59 (q, 2, 06-CH2), 5.37-5.41 (m, 1, H3'), 6.29-6.32 
(m, 1, Hi'), 7.93 (s, 1, H8), 8.14 (s, 1, N 2-H). 13C-NMR: 8C (CDCI3) 14.19 CH3 , 20.58 CH3 , 
20.74 CH35  24.98 CH3 , 37.00 CH2, 63.45 CH2, 74.16 CH, 82.27 CH, 84.42 CH, 118.30 C, 
135.96 C, 139.32 CH, 151.99 C, 160.84 C, 170.09 C, 170.31 C, 170.56 C. Anal. calcd. for 
C 181123N507 .1/2H20: C 50.23, H 5.62, N 16.27; found C 50.54, H 5.68, N 16.05. UV 






HO—\0 	N NHCCH3 11 
HO 
3', 5 '-Bis(O-acetyl)-N 2-acetyl-06-methyl-2'-deoxyguanosine (2.05g, 5mmol) was dissolved in 
pyridine (30m1) and methanol (25m1). NaOH solution (0.5M, 21m1, 2.leq.) was added and the 
reaction mixture was vigorously shaken for 20 seconds, then it was poured over Dowex 50-X8 
pyridinium form. The mixture was then filtered, and the filtrate was concentrated in vacuo to a 
pale yellow solid. Yield 96% (1.55g). The product was not soluble in solvent system I, and 
was therefore not purified by flash column chromatography. R f 0.09 (system I); 0.22 (system 
VI); 0.64 (system VII). [FAB] m/z (M+H): found 324.13084, calculated 324.13079. 
1 H-NMIR: 8H(d6-DMSO)  2.26 (s, 3, N2-Ac: CH3), 2.28-2.36 (m, 1, H2'),2.68-2.78 (m, 1, 
H2"), 3.50-3.75 (m, 3, H5'5", 5'-OH), 3.82-3.89 (m, 1, H4'), 4.08 (s, 3, 0 6-CH3 ), 4.43-4.48 (m, 
1, H3'), 5.33 (bs, 1, 3'-OH), 6.31-6.37 (t, 1, Hi'), 8.45 (s, 1, H8), 10.44 (N2-H). 13C-NMR: 6 
(d6-DMSO) 24.89 CH33  39.38 CH2, 54.21 CH3 , 61.73 CH2, 70.76 CH, 88.00 CH, 117.51 C, 
137.90 C, 141.27 CH, 152.23 C, 152.58 C, 160.48 C, 169.35 C. Anal. calcd. for 
C 13H 17N505 .H20: C 45.75, H 5.61, N 20.52; found C 45.89, H 5.51, N 20.65. UV spectrum 
(MeOH): A. 1 =202nm, ?.2=219nm, ? 3=270nm. 




HO__\ 74 N NHCCH3 11 
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3', 5'-Bis(O-acetyl)-N 2-acetyl-06-ethyl-2'-deoxyguanosine (2.1 Og, Smmol) was dissolved in 
pyridine (30m1) and methanol (25m1). A 0.5M NaOH solution (21ml, 2.leq.) was added and 
the reaction mixture was vigorously shaken for 20 seconds, then it was poured over Dowex 50-
X8 pyridinium form. The mixture was then filtered, and the filtrate was concentrated in vacuo 
to a pale yellow solid. Yield 97% (1.63g). R f 0.17 (system I); 0.25 (system VI); 0.66 (system 
VII). [FAB] m/z (M+H): found 338.14694, calculated 338.14644. 1 H-NMR: oH  (d6-DMSO) 
1.36-1.42 (t, 3, 0 6-Et: Cl-I3), 2.23 (s, 3, N2-Ac: CH3), 2.27-2.32 (m, 1,112'), 2.66-2.77 (m, 1, 
H2"), 3.48-3.72 (m, 3, H5'5", 5'-OH), 3.83-3.88 (m, 1, H4'), 4.4 1-4.45 (m, 1, H3'), 4.51-4.59 (q, 
2, 06-CH2-), 5.05 (bs, 1, 3'-OH), 6.29-6.3 5 (t, 1, Hi'), 8.42 (s, 1, 148), 10.36 (N 2-H). 
13C-NMR: 8C (d6-DMSO) 14.53 CH3, 24.84 CH3 , 39.42 CH2, 61.76 CH2, 62.83 CH2, 70.80 
CH, 83.42 CH, 87.98 CH, 117.49 C, 141.12 CH, 152.21 C, 152.63 C, 160.11 C, 169.29 C. 
Anal. caled. for C 14H 19N505 .H20: C 47.32, H 5.96, N 19.71; found C 47.46, H 5.79, N 19.98. 
UV spectrum (MeOH): X 1 =20Inm, ? 2=220nm, ? 3 270nm. 




N HO__\ o / 	N NH2 
HO 
3', 5'-Bis(O-acetyl)-N 2-acetyl-0 6-methyl-2'-deoxyguanosine (203mg, 0.5mmol) was dissolved 
in pyridine (3m1) and methanol (3m1). NaOH solution (2M, 0.6m1, 2.4eq.) was added and the 
reaction was stirred overnight. The mixture was then poured over pyridinium-Dowex for 
neutralisation, filtrated, and the filtrate was concentrated in vacuo to a pale yellow solid. Yield 
98% (136mg). Rf 0.14 (system I); 0.24 (system VI); 0.64 (system VII). [FAB] m/z (M+H): 
found 282.12000, calculated 282.12023. 1H-NMR: 8H  (d6-DMSO) 2.17-2.26 (m, 1, H2'), 
2.5 1-2.63 (m, 1, H2"), 3.45-3.61 (m, 3, H5'5", 5'-OH), 3.81-3.85 (m, 1, H4'), 3.95 (s, 3, 
06-CH3 ), 4.34-4.37 (m, 1, H3'), 5.15 (bs, 1, 3'-OH), 6.21-6.25 (t, 1, Hi'), 6.44 (s, 2, NIL-I2), 8.08 
(s, 1, H8). 13C-NMR: O  (d6-DMSO) 39.29 CH2, 53.29 CH3 , 61.88 CH2, 70.92 CH, 82.94 
CH, 87.75 CH, 114.11 C, 137.87 CH, 153.87 C, 159.91 C, 160.80 C. Anal. calcd. for 
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C 1 1 H 15N504 : C 46.97, H 5.38, N 24.90; found C 46.73, H 5.79, N 24.39. UV spectrum 
(MeOH) : X 1 =21 mm, ?=248nm, X3=282nm. 
06-ethyl-2'-deoxyguanosine [HPLC standard] 
0 CH-.,CH 
N 
NLL HO— \ o / 	N NH2 
HO 
3', 5'-Bis(0-acetyl)-N 2-acetyl-0 6-ethyl-2'-deoxyguanosine (210mg, 0. Smmol) was dissolved in 
pyridine (3m1) and methanol (3m1). A 2M NaOH solution (0.6ml, 2.4eq.) was added and the 
reaction was stirred overnight. The mixture was then poured over pyridinium-Dowex for 
neutralisation, filtrated, and the filtrate was concentrated in vacuo to a pale yellow solid. Yield 
97% (143mg). Rf 0.22 (system I); 0.28 (system VI); 0.66 (system VII). [FAB] m/z (M+H): 
found 296.13705, calculated 296.13588. 1 H-NMR: oH  (d6-DMSO) 1.37-1.42 (t, 3, 0 6-Et: 
Cl3 ), 2.17-2.25 (m, 1, H2'), 2.53-2.65 (m, 1, 142"), 3.47-3.63 (m, 3, H5'5", 5'-OH), 3.82-3.86 
(m, 1, H4'), 4.35-4.39 (m, 1, H3'), 4.48-4.56 (q, 2, 0 6-CH2-), 5.22 (bs, 1, 3'-OH), 6.25-6.31 (t, 
1, HI'), 6.42 (s, 2, NH 2), 8.10 (s, 1, H8). 13C-NMR: O (d 6-DMSO) 13.56 CH3 , 39.27 CH2 , 
57.63 CH3 , 61.82 CH23  70.87 CH, 83.06 CH, 87.83 CH, 115.29 C, 138.17CH, 153.44 C, 
159.12 C, 161.40 C. Anal. calcd. for C 1211 17N504 .I/4H20: C 48.08, H 5.88, N 23.36; found 
C 48.35, H 5.89, N 23.44. UV spectrum (MeOH): X 1 =201, ? 2=247nm, ? 3=281nm. 
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N2-acetyl-06-methyl-2'-deoxyguanosine (2.00g. 6.2mmol) was coevaporated from anhydrous 
pyridine (3 x 7m1) and dissolved in anhydrous pyridine (20m1) and TEA (950p1, 6.8mmol, 
1.leq. [d=0.726]). 4,4'-Dimethoxytrityl chloride (DMTrCI)(2.3g, 6.8mmol, 1.leq.) and 
DMAP (150mg, 1.2mmol, 0.2eq.) were added and the mixture was stirred at room temperature 
for 2 hours. Methanol (20m1) was added to quench the reaction, and the solvents were 
removed in vacuo. The residue was dissolved in ethyl acetate (EtOAc) (200m1) and was 
washed three times with a saturated KCI solution (lOOmI). The organic layer was dried over 
Na2SO4, filtered and concentrated in vacuo to give the product as a gum, which was then 
purified by wet flash column chromatography, eluting with a gradient of 0 - 2.5% MeOH in 
DCM on a column with the silica preequilibrated with 1%TEA in DCM. The appropriate 
fractions were combined, and the solvents were removed in vacuo. A cream-yellow foam was 
obtained. Yield 64% (2.48g). R f 0.41 (system I); 0.27 (system IV). [FAB] m/z (M+H): 
found 626.25918, calculated 626.26147. 1H-NMR: 6  (CDCl) 2.46-2.58 (m, 1, H2'), 2.62-
2.73 (m, 1, 1­12"), 3.25-3.44 (m, 2, H5'5"), 3.72 (s, 6, Ar-OCH 3), 4.08 (s, 3, 06-CH3), 4.17-4.21 
(m, 1, 114'), 4.65-4.68 (m, 1, H3'), 5.37 (bs, 1, 3'-OH), 6.41-6.47 (t, 1, Hi'), 6.73-7.38 (m, 13, 
Ar), 7.96 (s, I, 1­18), 8.29 (s, 1, N2-H). 13C-NMR: & (CDCI3) 25.00 CH3 , 40.37 CH2, 54.32 
CH3 , 55.01 CH3 , 63.88 CH2, 72.21 CH, 84.16 CH, 86.31 CH, 112.96 CH, 118.09 C, 126.72 
CH, 127.68 CH, 127.89 CH, 129.81 CH, 135.47 C, 139.95 CH, 144.33 C, 151.75 C, 152.07 C, 
15 8.3 0 C, 160.97 C, 171.03 C. Anal. calcd. for C 34H35N507 : C 65.27, H 5.64, N 11.19; found 
C 64.44, H 5.62, N 11.12. UV spectrum (MeOH): X 1 =203nm, A.2=236nm, ) 3 271nm. 
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5'-O-(4,4 '-DimethoxytrityI)-N 2-acetyI-O6-ethyI-2'.deoxyguanosine 
H3 CO 	 I 
CH2CH3 
N:: 	





N2-acetyl-06-ethyl-2'-deoxyguanosine (1.38g. 4.1mmol), coevaporated from anhydrous 
pyridine (3 x6ml) and dissolved in anhydrous pyridine (lSml) and TEA (630pi, 4.5mmol, 
1.1eq.) was stirred with DMTrC1 (1.5g. 4.5mmol, 1.1eq.) and DMAP (110mg, 0.9mmol, 
0.2eq.) at room temperature for 2.5 hours. Methanol (15ml) was added to quench the reaction, 
and the solvents were removed in vacuo. The residue was dissolved in EtOAc (150m1) and 
was washed with a saturated KC1 solution (3 x 75m1). The organic layer was dried over 
Na2 SO4, filtered and concentrated in vacuo. The resulting gum was then purified by wet flash 
column chromatography, eluting with a gradient of 0-2.5% MeOH in DCM on a column with 
the silica preequilibrated with 1%TEA in DCM. The appropriate fractions were combined, 
and the solvents were removed in vacuo, obtaining a cream-yellow foam. Yield 58% (1 .52g). 
Rf 0.43 (system I); 0.31 (system IV). [FAB] m/z (M+H): found 640.27696, calculated 
640.27712. 'H-NMR: oH  (CDC13) 1.42-1.49 (t, 3, 06-Et: CH3), 2.46-2.78 (m, 5, H2'2", 
N2-Ac: CH3 ), 3.24-3.51 (m, 2, H5'5"), 3.73 (s, 6, Ar-OCH 3), 4.09-4.19 (m, 1, H4'), 4.49-4.60 
(q, 2, 06-CH2-), 4.65 (m, 1, 1­13'), 5.41 (bs, 1, 3'-OH), 6.40-6.47 (t, 1, Hi'), 6.73-7.44 (m, 13, 
Ar), 7.90 (s, 1, 1 ­18), 8.18 (s, 1, N2-H). 13C-NMR: O  (CDCl) 14.25 CH3 , 24.98 CH3, 40.40 
CH2 , 55.03 CH3 , 63.37 CH2, 63.90 CH2, 72.19 CH, 84.11 CH, 86.32 CH, 112.97 CH, 118.09 
C, 126.73 CH, 127.70 CH, 127.91 CH, 129.83 CH, 135.48 C, 139.79 CH, 144.36 C, 151.78 C, 
152.13 C, 158.32 C, 160.72 C, 170.96 C. Anal. calcd. for C 35H37N507 : C 65.72, H 5.83, 
N 10.95; found C 65.52, H 5.76, N 11.02. UV spectrum (MeOH): ? 1 =202nm, A.2=235nm, 
2 3-271nm. 
85 
2-Cyanoethyl-N,N-(diisopropylamino)chlorophosphite [Sinha et al., 1983] 
\f--- 	- 
3-Hydroxypropionitrile (3.4m1, SOmmol, 0.14eq.) dissolved in anhydrous acetonitrile (20ml) 
under argon, was added dropwise, via a double ended needle, to a stirring solution of PCI3 
(30.6ml, 350mmol, leq.) in anhydrous acetonitrile (20m1) under argon. A further addition of 
solvent (5m1) was made to rinse the delivery flask and needle. After stirring for 15 minutes at 
room temperature the reaction mixture went cloudy, and the solvent was removed in vacuo to 
leave an oil which was distilled under reduced pressure (0.5mm Hg, 125-130°C) in a 
Kugelrohr to give 2-cyanoethyiphosphodichlorite. This was dissolved in anhydrous ether 
(40ml) stirring, under argon, at 0°C (in an ice bath), and a solution ofN,N-diisopropylamine 
(10.5m1, 74.9mmol, 2eq.) dissolved in anhydrous ether (40ml) was added dropwise via a 
double ended needle. A further addition of solvent (5m1) was made to rinse the delivery flask 
and needle. A white salt precipitated. After 5 minutes, the reaction mixture was filtered under 
argon and concentrated in vacuo to give an oil which was purified by Kugelrohr distillation 
(0.5mm Hg, 160°C). A clear oil was collected. Yield (calculated in respect of 3-hydroxy-
propionitrile) 37% (4.38g). 31 P-NMR: ö (CDCI 3) 180.25. 













5'-(4,4'-Dimethoxytrityl)-N 2-acetyl-0 6-methyl-2'-deoxyguanosine (1.0g, 1 .6mmol) was dried 
by the evaporation of anhydrous pyridine (2 x 6m1) and of anhydrous THF (2 x 7m1), and 
dissolved in dry THF (lOmI). Diisopropylethylamine (DIPEA) (11 13j.il, 6.4mmol, 4eq. 
[d=0.742]) and then 2-cyano-ethyl-N,N-(diisopropylamino)chlorophosphite (393 pi, 1. 76mmol, 
1.leq. [d=1.061]) was added dropwise with a syringe. A solid was seen to precipitate. After 
stirring the reaction mixture for 20 minutes, EtOAc (50m1, stored over Na2SO4) was added and 
the organic layer was extracted once with saturated KC1, then quickly dried over Na 2SO4, 
filtered and the solvents removed in vacuo. The product was purified by wet flash column 
chromatography (silica preequilibrated with 1% TEA in EtOAc), eluting with EtOAc. The 
appropriate fractions were combined, and the solvents were removed in vacuo. The high 
vacuum pump was used as well in order to remove any remaining traces of TEA, which, if 
present, reduces the coupling efficiency of the phosphoramidite. A cream coloured foam was 
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5 '-(4,4'-Dimethoxytrityl)-N 2-acetyl-06-ethyl-2'-deoxyguanosjne (702mg, 1.1 mmol) was dried 
by the evaporation of anhydrous pyridine (2 x 5m1) and of anhydrous TI-IF (2 x 6m1), and 
dissolved in dry TI-IF (lOmi). DIPEA (765pi, 4.4mmol, 4eq.) and then 2-cyanoethyl-
N,N-(diisopropylamino)chlorophosphite (268 RI, I .2mmol, 1.1 eq.) was added dropwise with a 
syringe. A solid was seen to preciptate. After 20 minutes' stirring , EtOAc (40ml, stored over 
Na2 SO4) was added to reaction mixture, and the organic layer was extracted once with 
saturated KCI, then quickly dried over Na 2 SO4, filtered and the solvents removed in vacuo. 
The product was purified by wet flash column chromatography (silica preequilibrated with 1% 
TEA in EtOAc), eluting with EtOAc. The appropriate fractions were combined, and the 
solvents were removed in vacuo. A cream coloured foam was obtained. Yield 80% (73 8mg). 
Rf 0.63 (system I); 0.52 (system IV). 31 P-NMR: ö, (CDCI 3 ) 149.02 (d). 
06-pentafIuorophenyI-N2-trifluoroacetyI-2deoxyguanosine [Fathi et aL, 1990] 
0 * F 
N F 
HO_ \\O7N  N NHCCF3 
11 
HO 
Deoxyguanosine monohydrate (1.14g, 4mmol) was coevaporated from anhydrous pyridine 
(3 x 5m1), suspended in dry pyridine (60m1), and trifluoroacetic anhydride (3.4m1, 24mmol, 
6eq.) was added dropwise with a syringe, while cooling the reaction mixture in an ice bath. 
After 15 minutes, TLC showed the formation of a fluorescent compound with R f 0. A solution 
of pentafluorophenol (9.6g, 52mmol) in dry pyridine (200m1) was added via a double ended 
needle. After a further 24 hours, the reaction mixture was concentrated in vacuo and poured 
into 500m1 of water and extracted with EtOAc (4 x 200m1). The combined organic layers were 
washed with water (3 x 50m1), dried with Na2SO4, filtered and concentrated on the rotary 
evaporator. The resulting gum was redissolved in EtOAc (lOml) and added dropwise under 
rapid stirring to petrol ether 40-60 (700m1). A brown precipitate was formed and filtered. The 
precipitate was submitted to wet flash column chromatography elutig with 10% MeCN in 
EtOAc. The appropriate fractions were combined and dried in vacuo to a cream yellow foam. 
Yield 83% (1.75g). Rf 0.22 (system I); 0.47 (system III); 0.62 (system V); 0.70 (system VI). 
[FAB] m/z (M+H): found 530.07349, calculated 530.07 107. 1H-NMR: oH  (d6-DMSO) 2.33-
2.39 (m, 1, 112'), 2.75-2.82 (m, 1, H2"), 3.50-3.64 (m, 3, H5'5", 5'-OH), 3.87-3.91 (m, 1, H4'), 
4.44-4.48 (m, 1, H3'), 5.31 (bs, 1, 3'-OH), 6.39-6.43 (t, 1, HI'), 8.79 (s, 1, H8), 12.08 (s, 1, 
N2-H). 13C-NMIR: O (d 6-DMSO) 39.38 CH2, 61.52 CH2, 70.55 CH, 84.08 CH, 88.23 CH, 
112.53 C, 118.00 CH, 135.12 C, 139.11 C, 140.15 C, 144.06 C, 144.84 C, 149.60 C, 153.74 C, 
154.34C, 156.58 C, 159.50 C, 183.47 C. Anal. calcd. for C 18H 1 1N505 F8 : C 40.85, H 2.09, 
N 13.23; found C 40.54, H 1.86, N 12.81. UV spectrum (MeOH) : ? 1 202nm, ? 2 222nm, 
X3-269nm. 
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5-('4,4 -DimethoxytrityI)-O 6-pentafluorophenyI-N2-trifluoroacetyI-2deoxyguanosine 
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06-pentafluorophenyl-N2-trifluoroacetyl-2'-deoxyguanosine (1.70g, 3.2mmol) was dried by 
evaporation of anhydrous pyridine (3 x 6m1) and dissolved in dry pyridine (30m1). TEA 
(490j.il, 3.5mmol, i.ieq.) and DMTrCI (1.3g, 3.8mmol) were added. After 4 hours, methanol 
(1 OmI) was added to quench the reaction. The reaction mixture was then concentrated in 
vacuo, dissolved in ether (90m1) and washed with water (3 x 60m1). The organic layer was 
dried over Na2 SO4, filtered and the solvent removed on the rotary evaporator. The residue was 
dissolved in a small amount of EtOAc and submitted to wet flash column chromatography 
(silica gel preequilibrated with 1% TEA in DCM), eluting with 0 - 2.5% MeOH in DCM. The 
appropriate fractions were combined and dried in vacuo, to give the title compound as a 
cream-yellow foam. Yield 65% (1.73g). Rf 0.58 (system I); 0.71 (system III); 0.46 (system 
IV). [FAB] m/z (M+11): found 832.20796, calculated 832.20175. 1H-NMR: oH  (CDCI 3) 
2.41-2.48 (m, 1, 1 ­12'), 2.77-2.83 (m, 1, 1­12"), 3.36-3.38 (m, 2, H5'5"), 3.75 (s, 6, Ar-OCH 3), 
4.13-4.15 (m, 1, 114'), 4.64-4.67 (m, 1,113'), 5.28 (bs, 1, 3'-OH), 6.28-6.33 (t, 1, Hi'), 6.77-7.41 
(m, 13, Ar), 7.83 (s, 1, H8),12.10 (s, 1, N 2-H). 13C-NMR: O (CDCI 3 ) 39.53 CH, 55.05 CH3 , 
63.58 CH2, 72.31 CH, 84.03 CH, 85.98 CH, 113.03 CH, 114.91 C, 126.81 CH, 127.75 CH, 
127.92 CH, 129.89 CH, 135.39 C, 135.51 C, 137.20 C, 139.43 CH, 139.66 C, 141.20 C, 
143.60C, 144.34C, 155.01C, 157.81 C, 158.41 C, 158.49 C. Anal. calcd. for 
C39H29N507F8 .1/2C 5H5N: C 57.15, H 3.76, N 8.83; found C 56.91, H 4.03, N 8.97. 
UV spectrum (MeOH): ? 1 =202nm, ? 2=236nm, ?3=285nm. 
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5'-(4,4'-Dimethoxytrityl)-0 6-pentafluorophenyl-N 2-trifluoroacetyl-2'-deoxyguanosine (900mg, 
I .O8mmol) was coevaporated from dry pyridine (2 x 6m1) and dry THF (2 x 4m1), and 
dissolved in dry THF (lOmI). DIPEA (750pi, 4.32mmol, 4eq.) and then 2-cyanoethyl-
N,N-(diisopropylamino)chlorophosphite (265 j.tI, 1.2mmol, 1.leq.) was added dropwise with a 
syringe. A solid was seen to precipitate. After stirring the reaction for 20 minutes, EtOAc 
(50m1) was added, and the organic layer extracted once with saturated KCI, before being 
quickly dried over Na2 SO4, filtered and the solvents removed on the rotary evaporator. The 
product was purified by wet flash column chromatography (silica preequilibrated with 1% 
TEA in EtOAc), eluting with EtOAc. The appropriate fractions were combined, and the 
solvents were removed in vacuo to obtain a cream coloured foam. Yield 94% (1045mg). 
Rf 0.80 (system I); 0.71 (system IV). 31 P-NMR: 6 (CDCI 3) 149.02 (d). 
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N6-methyl-2, 6-diaminopurine-2 'deoxynuc!eoside [HPLC standard] 
I-IN 	.:) 
NN 
HO_-\O ,74 N NH2 
HO 
06-pentafluorophenyl-N 2-trifluoroacetyl-2'-deoxyguanosine (48mg, 0.09mmol) was dissolved 
in a small amount of methanol (0.5m1) and reacted with aqueous methylamine 40% (3m1) in a 
sealed vial for 24 hours at 60°C. The mixture was then concentrated in vacuo. The residue 
was dissolved in methanol, loaded onto prep TLC plates and eluted with 10% MeOH in DCM. 
The band corresponding to the title compound was scraped of the plates, extracted with 
methanol and filtered. Rf 0.08 (system I); 0.03 (system III); 0.35 (system V). [FAB] m/z 
(M+H): found 281.13559, calculated 281.13621. 1 H-NMR: 8H (d6-DMSO) 2.28-2.36 (m, 1, 
H2'), 2.49-2.64 (m, 1, H2"), 3.02 (s, 3, N 2-CH3), 3.38-3.53 (m, 3, I-15'5", 5'-OH), 3.84-3.89 (m, 
1, H4'), 4.32-4.35 (m, 1, H3'), 5.28 (bs, 1, 3'-OH), 6.16-6.20 (t, 1, 111'), 6.41 (s, 2, NH 2), 7.86 
(s, 1, N6-H), 8.15 (s, 1, H8). UV spectrum (MeOH): X 1 =201nm, ? 2=225nm, X3=249nm. 
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4. Conclusions 
Oligonucleotides containing the required chemical modifications were obtained in high purity, 
as shown by enzyme digestion studies and Capillary Zone Electrophoresis analyses. UV 
duplex melting (thermal denaturing) experiments have been carried out on duplexes containing 
the modified bases both paired with cytosine and thymine. 
Currently the above oligonucleotides are being tested for the binding of wild type and mutant 
06-methyltransferase. Preliminary experiments suggest that they are recognised by the 
enzyme, which indicates that this approach to study the protein may be the right one. If the 
oligonucleotides will be bound by the enzyme, attempts will be made to obtain crystals of the 
enzyme-DNA complexes. The free oligonucleotides are also being crystallised on their own. 
N6-methyldiaminopurine may turn out to be a DNA base that mimics 0 6-methylguanine, 
which would make it a useful tool in the study of 0 6-methyltransferase, and which may help to 
elucidate the mechanism of DNA repair by this particular enzyme. 
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Part 2. Studies on DNA Triplexes 
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1. Introduction 
1.1 Nucleic Acid Triple Helices: History and Structure 
1.1.1 Discovery 
The first observation of the formation of a nucleic acid triplex was made nearly four decades 
ago between two poly(rU) strands and one poly(rA) strand (Felsenfeld etal., 1957). Later it 
was shown that triple helical structures could be formed by two poly(rC) strands with guanine 
mononucleotides (Howard etal., 1964) and oligoribonucleotides (Lipsett, 1963 and 1964; 
Howard et al., 1964) when the pH was lowered, and it was postulated that the second poly(rC) 
strand was protonated. Morgan and Wells (1968) then reported the formation of an alternating 
sequence triplex between the DNA duplex d(CT)d(GA) and an r(CU) RNA third strand. 
On the basis of an anti conformation for the bases, it was suggested that the third strand of a 
nucleic acid triplex is bound in the major groove parallel to the purine strand of the duplex by 
Hoogsteen (Hoogsteen, 1963) hydrogen bonds (Morgan and Wells, 1968). This hypothesis 
was supported by the X-ray fibre-diffraction work carried out by Arnott and co-workers (1974 
and 1976), who were the first to propose a model for the molecular structure of the DNA triple 
helix d(T)d(A)*d(T), where "S" indicates Watson-Crick (W/C) and "*" Hoogsteen (HS) 
base pairing. A representation of a triplex is illustrated in Figure 1. 
.4 
Figure 1. Representation of a triplex 
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1.1.2 Evidence for Triple Helix Formation 
Moser and Dervan (1987) targeted duplex DNA with homopyrimidine oligonucleotides with 
an EDTA-Fe(II) moiety attached which could in principle bind the probe strand in parallel or 
antiparallel orientation. EDTA-Fe(II) cleaves the DNA backbone by oxidation of the deoxy-
ribose with a short-lived diffusible hydroxyl radical, and is a nonspecific cleaving species. 
The resulting cleavage pattern proved that the homopyrimidine oligonucleotide (third or 
Hoogsteen strand) binds antiparallel to the pyrimidine Watson-Crick (first) strand and parallel 
to the purine (second) strand, confirming the binding model proposed earlier (see Section 
1.1.1). 
Rajagopal and Feigon (1989a,b) provided the first NMR data on the formation of a DNA triple 
helix, from d(GA)4 and d(TC)4 oligonucleotides, and observed the imino protons from proto-
nated cytosines directly, proving their involvement in Hoogsteen hydrogen bonds. Thymine 
N3 imino protons were shown to be implicated in both Watson-Crick and Hoogsteen base 
pairing in a TA*T type triplex (Pilch etal., 1990b). 
Direct evidence for the I-Ioogsten hydrogen bonding to the N 7 atoms of the purines came from 
NMR studies with oligodeoxynucleotides containing adenine and guanine labeled with 15N at 
these positions (Gaffney etal., 1995). 
1.1.3 Types of Nucleic Acid Triplexes 
For all triplexes, a third strand associates with a duplex tract that is purine-rich in one strand 
and therefore pyrimidine-rich in its complement. The pyrimidine strand of the Watson-Crick 
duplex is referred to as the first strand and the purine strand as the second strand. The third or 
1-loogsteen strand may be either pyrimidine-rich (the pyrimidine motif) or purine-rich (the 
purine motif). 
Triplexes can be formed both by DNA and RNA as well as by their combinations. However, it 
has been suggested that RNA does not participate in triplexes of the purine motif (Maher, 
1992b). Different research groups have obtained different results regarding the stability of 
mixed DNA-RNA triple helices made of the various possible combinations of strands. This is 
probably due to the fact that sequence and experimental conditions are likely to have an 
influence on relative stabilities (Sun and Hélène, 1993). However, these studies consistently 
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indicate that the triplexes are more stable when DNA represents the central homopurine strand 
than when RNA does (Frank-Kamenetskii and Mirkin, 1995). 
Two major types of DNA triple helices have been described - intermolecular and intramole-
cular. In an intermolecular triplex, a separate third strand associates with a target duplex 
DNA. In an intramolecular triplex, the third strand is a portion of one of the strands of the 
duplex that has folded back to combine with the purinepyrimidine tract. Intramolecular 
triplexes can be found either in supercoiled plasmids containing mirror repeats of 
purinepyrimidine tracts or in single DNA strands that can fold back on themselves (Gee and 
Miller, 1992). 
Sklenár and Feigon (1990) demonstrated the formation of an intramolecular foldback triplex 
containing both TA*T and C-G*C 1 base triplets where the strands were held together by loops 
consisting of pyrimidine nucleotides. Miner and Dervan (1990) also synthesised intramolecu-
lar foldback triplexes of the pyrimidine motif, but of opposite polarities, and showed that the 
triplex with the purine tract at the 5' end was more stable than the equivalent triplex with the 
purines located at the 3' end. Durand and co-workers (1992) used hexaethyleneglycol to link 
the triplex strands, and the use of other linkers, e.g. based on a terephtalamide derivative 
(Salunkhe etal., 1992), has also been reported. 
It has been suggested that some intramolecular triplexes can form dimers (Borisova et al., 
1995), but structures for such intermolecular associates have not been proposed yet. 
1.1.4 Triplexes of the Pyrimidine Motif 
In the pyrimidine motif, thymine residues in the third strand recognise adenines in the second 
strand, i.e. TA base pairs, and cytosine recognises guanines, i.e. CG base pairs. The latter 
requires cytosine protonation to enable the formation of two hydrogen bonds, and as a result 
the stability of the resulting base triplet increases as the pH decreases. 
Some studies have suggested that the cytosine residues in the third strand of DNA triple 
helices are protonated at pH 7, far above their intrinsic pKa  (Lavelle and Fresco, 1995), but 
most others, including the present study, indicated that triplexes containing CG*C are 
significantly destabilised at neutral pH. 
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The TA*T and C-G*CI base triplets or triads can form in either the Hoogsteen (HS) or reverse 
Hoogsteen (rHS) configuration (Figure 2a and b, respectively). They are isomorphous in the 
Hoogsteen configuration, therefore the third strand of the triplex binds parallel to the purine 
strand and antiparallel to its chemically homologous pyrimidine strand. e and 0 indicate 
the relative orientations of the nucleic acid strands. 
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Figure 2. TA*T and C-G*CI base triplets in the (a) Hoogsteen and 
(b) reverse Hoogsteen configuration 
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1.1.5 Triplexes of the Purine Motif 
Triplex formation in the purine motif was first suggested by Hogan and co-workers (Cooney et 
al., 1988), whose experiments showed that in the presence of Mg2+ a guanine-rich DNA 
oligonucleotide bound to a d&dC rich sequence upstream of the human c-myc gene without 
the requirement of an acidic pH. Subsequent studies demonstrated that the third strand is 
antiparallel to the purine strand of the duplex DNA target (Beal and Dervan, 1991). This type 
of triplex is based on CG*G and TA*A base triplets in the reverse Hoogsteen configuration 
(Figure 3). The CG*G and TA*A triads within a triple helix are not isomorphous; therefore, 
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Figure 3. CG*G and TA*A in the reverse Hoogsteen configuration 
Triplexes of the purine motif are more versatile than the ones of the pyrimidine motif. It is 
possible to incorporate thymine residues in the purine-rich third strand which would then form 
TA*T base triplets (Figure 4) in an otherwise pyrpur*pur triple helix. In addition, in acidic 
conditions an adenine residue in the third strand may also oppose a guanine in the duplex, 
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Figure 4. Structure of (a) TA*T and (b) CG*A in the purine motif 
Both CG*G and TA*T base triplets can adopt either HS or rHS configurations. In both cases, 
the two triplets are not isomorphous and the HS configuration is energetically preferred, but 
the distortion of the third strand backbone would be more pronounced and the associated 
energy penalty greater for HS than for rHS configuration (Sun and Hélène, 1993). 
A combined NMIR-molecular dynamics study (Radhakrishnan and Patel, 1993) defined the 
solution structure of an intramolecular pyrpur*pur triplex and identified the structural 
transitions necessary for accomodating thymines in a guanine rich third strand: an increase in 
axial rise and a decrease in axial twist at T-G steps. 
In vitro experiments have produced evidence for the existence of a parallel pyrpur*pur triplex 
structure - with the third purine-rich strand parallel to the purine strand involved in the 
Watson-Crick duplex, but it was found to be much less stable than its antiparallel counterpart 
(Shchyolkina et al., 1995). 
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1.1.6 Fine Structure of Triple Helices. A-DNA versus B-DNA Conformation 
Right-handed double helical DNA can adopt two distict types of conformation: A-DNA is 
favoured at low humidity and B-DNA at high humidity. In both A-DNA and B-DNA the 
glycosidic bond is in the anti conformation. 
A-DNA is characterised by a deep and narrow major groove and a shallow and wide minor 
groove, and it has 11 base pairs per turn with a vertical rise of 2.56A per base pair. The bases 
are displaced by 4.5A from the helix axis, creating a hollow core down the axis, and have a 
positive tilt angle of 20°C. The sugar rings have C3 -endo, also called N-type, puckers. 
B-DNA has 10 base pairs per turn with a vertical rise of 3.3 - 3.4A per base pair. The major 
and minor grooves are of similar depth. The displacement of the bases from the helix axis is 
much smaller than, and in the opposite direction to, that of A-DNA (-0.2 to -1 .8A), and as a 
result the bases straddle the helix axis. The base tilt is also smaller than that of A-DNA and is 
negative (-6°). The sugars have C2 -endo or S-type puckers. 
The first model of a DNA triplex structure was proposed by Arnott and co-workers (1974 and 
1976), based on an A-DNA like conformation of all three strands with C3 '-endo sugar puckers, 
despite some short contacts which are generally known to be outside the allowed range. Some 
NMR studies appeared to support the A-DNA model (Umemoto etal., 1990). 
IR data (Howard et al., 1992) and molecular modelling studies (Raghunathan et al., 1993), 
however, suggested a B-DNA conformation with C2'-endo sugar puckers, which had the 
advantage of no disallowed nonbonded distances present in the earlier A-DNA type model. 
NMR studies of intramolecular DNA triplexes selectively enriched with 13C in position C' on 
the third strand also suggest that the triple helix adopts a B-type conformation rather than an 
A-type one (Bornet and Lancelot, 1995). Other NMR studies of a DNA triplex containing a 
modified base in the third strand lend support to this conclusion by indicating that the duplex 
portion of the triple helix has a structure more similar to B-DNA than A-DNA (Wang etal., 
1996). 
It appears, however, that the situation is not as clear cut, and it is likely that the sequence of 
the triplex as well as the experimental conditions play a role. As a result, various studies can 
lead to somewhat different conclusions, but most of them conclude that DNA triplexes have a 
conformation that is neither completely A-form nor 13-form. 
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While the structure of d(T.A*T) triple helices is thought to be very close to the B-form, 
having C2 -endo sugar puckers and an axial rise per residue of -3.3A, a model for d(CG*C) 
triplexes based on the results of IR and Raman spectroscopy experiments proposed that only 
the guanine strand has C2 -endo sugar puckers, the cytosine strands having puckers in the 
C3 -endo region, with an axial rise per residue of -3.9A due to electrostatic repulsion between 
neighbouring positively charged base triplets (Ouali etal., 1993). For mixed sequence 
triplexes, these parameters will vary depending on the sequence. 
Substitution of cytosine with 5-methylcytosine in either strand of a pyrimidine motif triplex 
does not change the conformation of the helix; JR studies with the cytosines partly or totally 
replaced by 5-methylcytosine have shown a relative proportion of two S-type sugars to one 
N-type (Fang et al., 1995a). Similar experiments have shown that the loop length of 
intramolecular foldback triplexes does not significantly influence their conformation (Fang et 
al., 1995b). 
Computer modelling with a d(CG*G) 7 and a d(TA*T) 7 triplex suggested that the backbone 
geometry of the B-DNA target duplex has to be adjusted into an A-DNA like form with a deep 
major groove in order to accomodate the third strand in triplex formation; the sugar pucker, 
however, displayed a more rich variation (Cheng and Pettitt, 1995). Molecular dynamics 
simulations on a d(CG*G) 7 triplex indicated that the the conformation of strands I and III is 
strictly neither A-form nor B-form, whereas the conformation of strand II is near the A-form 
(Weerasinghe et al., 1995). 
The formation of a pyrimidine motif triple helix between a DNA duplex and an RNA third 
strand appears to be associated with a conversion of the sugars of the polypurine strand from 
S-type to N-type (Dagneaux etal., 1995). Within mixed DNA-RNA triplexes, the RNA 
strands maintain their A-type structure, as they have less conformational freedom than DNA. 
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1.2 Types of DNA Triplex Structures Found in Vivo and Their Potential 
Biological Role 
Triplex DNA is formed through the binding with high sequence specificity of a third DNA 
strand in the major groove of a DNA duplex. They have been discovered in segments with 
predominantly purines in one strand (purpyr sequences). These sequences are overrepresented 
in eukaryotic DNA and have been mapped near genes and recombination hot spots (Wells et 
al., 1988). Several types of so-called 'unorthodox' structures can be adopted by this type of 
sequence, such as Z-DNA, cruciforms and triplexes (van bide and Zlatanova, 1994). The 
formation of sequence specific triple helices can block DNA replication and transcription by 
inhibiting DNA binding proteins directed at overlapping sites in vitro. However, the 
biological role of the triplexes is as yet unclear, but it is presumed that they may be involved in 
DNA replication, transcription and recombination. 
1.2.1 H-DNA 
Sequences biased in favour of strings of contiguous purine or pyrimidine residues were found 
in a variety of eukaryotic organisms. They occur several times more often than would be 
expected from a statistical point of view, and they have some unusual properties, such as 
nuclease Si hypersensitivity. 
A substantial number of these sequences contain mirror-repeats; this is consistent with a 
proposed intramolecular triplex model for such tracts, called H-DNA (Mirkin etal., 1987). 
Interruptions in the regular purpyr sequences can occur only at the apex of the triplex without 
disturbing the conformation of the rest of the tract. The term 'H form' was used because the 
structural transition from B-DNA to this novel conformation occured at acidic pH under low 
torsional tension and was clearly a protonated structure. A model for H-DNA is represented in 
Figure 5. 
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Figure 5. Model of H-DNA (from Wells et al., 1988) 
The H-DNA form consists of an intramolecular triple helix formed by the pyrimidine strand 
and half of the purine strand, leaving the other half of the purine strand - usually the 5' half-
single-stranded (Frank-Kamenetskii and Mirkin, 1995). 
Intramolecular triplexes in the purine motif can adopt a similar structure, called *H.DNA  (or 
H'-DNA), where half of the pyrimidine strand remains single-stranded. As is the case for other 
triplexes of the purine motif, adenine residues can be replaced with thymine, and at low pH 
guanine can be replaced with adenine. Consequently, sequences adopting the *H  form are not 
necessarily mirror-repeated, and they need not be homopurinehomopyrimidine either. This 
structure is stabilised by bivalent cations. However, different sequences have different cation 
requirements, and this is not well understood (Frank-Kamenetskii and Mirkin, 1995). 
1.2.2 R-DNA 
.4 
It was proposed that the triple-helical intermediate during RecA mediated homologous 
recombination is a novel form of structure designated as R-form or recombination form of 
DNA (Hsieh et al., 1990). The fundamental differences between R-DNA and the 'classical' 
triplexes are the facts that the chemically homologous strands are parallel rather than 
antiparallel and that any sequence can adopt an R-DNA structure. In addition, the proposed 
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base pairing schemes (Figure 6), arrived at through energy minimisation studies, suggest that 
the bases in the third strand are hydrogen-bonded to both bases of the Watson-Crick pair 
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Figure 6. Base pairing schemes for base triplets in R-DNA 
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Evidence to support the existence of R-DNA comes from in vitro experiments involving 
mainly chemical probing, but also other methods, such as enzymatic degradation, UV melting 
and binding of fluorescent dyes, on foldback triplexes (Shchyolkina etal., 1994 and 1995) as 
well as on plasmid DNA (Kim etal., 1995). However, the structure of the recombination 
intermediate is far from being understood. 
1.2.3 Detection of Triplex DNA Structures in Vivo 
Direct detection of H-DNA in vivo is difficult because of the complexity of genomic DNA, 
and as a consequence most studies used E.co!i cells with recombinant plasmids containing 
triplex-forming inserts as a convenient model system. Certain chemicals give characteristic 
patterns of H- or *H.DNA  modification, and as a result treatment of cultured cells with these 
chemicals followed by plasmid isolation and localisation of the modified bases proved to be a 
useful approach for the detection of these structures in vivo (Frank-Kamenetskii and Mirkin, 
1995). 
The presence of triplexes in vivo was probed with monoclonal antibodies raised against triple 
helical DNA. The antibodies were found to bind to eukaryotic chromosomes (Lee et al., 
1987). 
1.2.4 Implication of Triplexes in Biological Processes 
Transcription 
It was reported that triple helix formation significantly reduced transcription rates by RNA 
polymerases in vitro (Morgan and Wells, 1968). One study found that a purinepyrimidine 
tract acted virtually like a transcriptional diode, i.e. transcription was effectively blocked in the 
direction that produces a purine-rich RNA due to triple helix formation which trapped the 
RNA polymerase, while transcription in the other direction was unrestricted (Grabczyk and 
Fishman, 1995). 
In vitro experiments indicate that triple-helical complexes at homopurinehomopyrimidine 
sequences can block transcription initiation more efficiently than transcription elongation 
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(Maher, 1992a). This suggests that oligonucleotide-directed triple helix formation can conceal 
the recognition sequences of DNA-binding proteins, and that helicase activities associated with 
elongating RNA polymerases can unwind the third strand of a triplex from the underlying 
duplex (Maher, 1996). 
The idea that helicases may be able to disrupt triple helices is supported by experiments with 
Simian virus 40 (SV40) large T-antigen (T-ag) helicase. These have shown at first that DNA 
unwinding was significantly inhibited in regions susceptible to triple helix formation (Peleg et 
al., 1995). However, further studies indicated that this enzyme can unwind the third strand of 
DNA triplexes formed by the addition of a TFO to duplex DNA, but only if the enzyme binds 
to a single-stranded 3' flanking tract of the oligonucleotide first and then migrates in a 3'—>5' 
direction, causing the release of the third strand in a process driven by ATP hydrolysis (Kopel 
et al., 1996). Unwinding of DNA triplexes may be required for processes such as DNA 
replication, transcription, recombination and repair. 
The in vivo expression of genes was shown to be repressed when a poly(dG)poly(dC) 
sequence capable of adopting a triplex structure under superhelical torsion in vitro, was placed 
5' to a promoter, and this effect was dependent on the length of the insert (Kohwi and Kohwi-
Shigematsu, 1991). These findings support the existence of triple helices in vivo. 
It has been suggested that the mechanism of transcription repression by triple helix formation 
involves both interference with the binding of transcription factors to their specific recognition 
sequences and by blocking promoter assembly into initiation complexes (van Holde and 
Zlatanova, 1994). It has also been proposed that nucleic acid triplexes may play a role in 
regulating transcription elongation through a feedback mechanism: The transcription process 
generates levels of negative supercoiling high enough to drive the formation of unusual 
structures, such as triple helices, in the wake of elongating polymerases. If transcriptional 
activity in a given gene becomes very high, then the buildup of negative supercoils behind the 
polymerase could drive the formation of triplex structures within the gene, and these in turn 
would cause polymerases to pause until the supercoils have been relaxed by topoisomerases 
(van Holde and Zlatanova, 1994). 
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Replication 
Triplexes have been suggested to play a role in DNA replication as well. This was based on 
the observation that DNA synthesis is prevented in vitro by the formation of triple helical 
structures. Supercoiled templates containing *H.DNA  lead to the premature termination of 
DNA synthesis at locations that correlate with the triplex border precisely (Dayn etal., 1992). 
Triple helical structures can form during DNA polymerisation and efficiently block it. It was 
suggested that this may occur either through folding back of the template strand which will 
then form a triplex with the newly synthesised DNA, or through folding back of the displaced 
nontemplate strand to form a triplex downstream of the replication fork at an appropriate 
sequence (Frank-Kamenetskii and Mirkin, 1995). 
Studies on the ability of DNA polymerases to extend an oligo(dA) primer through a poly(dT) 
tract showed that the polymerases terminate in the centre of the latter. However, replication 
arrest was abrogated by the addition of a single-stranded DNA binding protein or by 
substitution of 7-deaza-dATP for dATP (Mikhailov and Bogenhagen, 1996). These findings 
are consistent with the formation of a TA*T DNA triplex between the primer stem and the 
folded template tract, and suggest that single-stranded DNA binding proteins may enable 
polymerases to replicate successfully through sequences which may be prone to intramolecular 
triplex formation. 
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1.3 Applications of DNA Triplexes 
It has been suggested that there is potential for therapeutic applications in which gene expres-
sion is repressed by triplex formation - the so-called 'antigene' strategy - and that triplexes can 
be used as a tool in molecular biology (Gee and Miller, 1992). The formation of such 
sequence specific triple helices can block DNA replication and transcription by inhibiting 
DNA binding proteins directed at overlapping sites. As a consequence, oligonucleotide-
directed triple helix formation could lead to the development of novel therapeutic agents to be 
used in the treatment of cancer, viral infections including AIDS and immunological diseases 
such as arthritis (Chubb and Hogan, 1992). 
1.3.1 Specificity of Triple Helix Formation 
The recognition of a purine base from the major groove forms the basis for sequence-
specificity. As a consequence, base recognition of this type is limited to purine-rich tracts 
(Maher, 1992b). 
It is possible, however, to target double helical DNA built of clusters of pyrimidines and 
purines by alternate strand triplex formation. The third strand may consist of adjacent homo-
pyrirnidine and homopurine blocks connected by natural 3'—*5' phosphodiester linkages, 
forming HS and rHS hydrogen bonds, respectively, with purines on alternate strands of the 
target duplex (Beal and Dervan, 1992). This will result in two neighbouring triplexes, one in 
the pyrimidine motif and the other in the purine motif. Strand switching involving the 
formation of triplexes in a single structural motif would require a 3'-3' or a 5'-5' linkage 
between the two parts of the TFO, depending on the sequence requirements (Sun and Hélène, 
1993). 
The use of a polymeric linker to join two oligonucleotides which form triple helices at distant 
sites on a long duplex tract has also been reported (Kessler etal., 1993). 
The majorlimitation in the use of TFOs is matching high sequence selectivity with binding 
that is sufficiently strong to interfere with genetic processes. Under physiological conditions, 
TFOs bind relatively weakly to their targets, which fact by itself favours a high sequence 
selectivity. However, in order to significantly influence genetic processes, the TFOs must be 
rather long, which limits the number of potential targets, as such long 
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homopurinehomopyrimidine stretches are likely to be infrequent within a particular target 
gene (Frank-Kamenetskii and Mirkin, .1995). As a consequence, ways are being sought to 
lower the stringency of triple helix formation, if possible without compromising selectivity. 
Triplexes can accomodate a few types of mismatched base triplets, but they are invariably 
destabilised, especially if the mismatches are in the centre of the helix rather than at its ends. 
Increasing the number of mismatches abrogates triple helix formation altogether. 
Interruptions in the purine strand of the Watson-Crick duplex, i.e. AT and GC base pairs 
rather than the usual TA and CG within a pyrimidine motif triplex, can be recognised by G 
and T respectively, to form AT*G and GC*T base triplets (Yoon etal., 1992). Because the 
pyrimidine base in strand II can only provide one site for Hoogsteen hydrogen bonding, 
destabilisation of the triplex occurs. 
Studies on the relative stabilities of individual mismatched base triads can give somewhat 
different results, probably as a consequence of different sequence contexts being studied, since 
stacking interactions within a triple helix are crucial for its stability. For example, the AT*G 
triplet was shown to be destabilised when its flanking TA*T triplet on the 5' side of guanine 
was replaced with CG*C (Kiessling etal., 1992). 
The formation of triplexes is roughly two orders of magnitude slower than duplex formation 
(Maher, 1992b), and it is an all-or-none process (Pilch etal., 1990a), as is duplex formation. 
Kinetic experiments indicate that triple helices are formed according to a nucleation-zipping 
model, where three to five base triplets are involved in the nucleation step, the latter being the 
rate-limiting step (Rougee etal., 1992). A base triplet mismatch in the centre of the target 
sequence disrupts the cooperativity of interactions between neighbouring base triplets, thereby 
destabilising the triplex structure (Mergny etal., 1991). 
1.3.2 The Stabilisation of DNA Triple Helices 
The presence of Mg 2 and Nat and lowering of the pH promote triple helix formation. Three-
stranded complexes are stabilised relative to their double-stranded counterparts by increasing 
Na or Mg2 concentration as a result of increased electrostatic work needed to bring together 
three negatively charged phosphodiester chains (Riley etal., 1966). 
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Since pyrimidine motif triplexes require the protonation of the cytosine residues in the third 
(Hoogsteen) strand, they are not favoured at physiological pH, and triplexes of the purine 
motif are destabilised by physiological concentrations of K. However, polyamines - which 
are present in the cell and in greater concentrations in its nucleus - have been shown to 
facilitate triple helix formation at physiological pH (Hampel et al., 1991). Therefore the 
stability of triple helices in vivo probably depends on the interplay of a variety of factors, such 
as the ones mentioned above, in addition to the sequence and length of the triplexes. 
The relatively low stability of the nucleic acid triplexes creates difficulties for their study, 
which makes the use of a high concentration of oligonucleotide and/or salt, polyamine, etc. 
necessary. Several approaches to stabilise the triple helices have been described, especially for 
the pyrpur*pyr ones. These include the use of intercalating ligands covalently attached to one 
end of the Hoogsteen strand, covalent cross-linking of the triplex and incorporation in the third 
strand of modified bases that bind either by intercalating into the Watson-Crick duplex or by 
hydrogen bonding, mimicking other bases. Backbone modifications have also been investi-
gated, especially with regard to improving oligonucleotide resistance to nucleases present in 
the cell. Combinations of these approaches have also been used. 
However, increased stability of the triplexes entails decreased selectivity, as the TFOs, if they 
have very strong affinity for their target, could also bind to another site containing a mismatch 
(Frank-Kamenetskii and Mirkin, 1995). 
Cross-linking 
Cross-linking between a TFO and its duplex DNA target blocks the action of RNA 
polymerases during transcription in vitro. Light-sensitive cross-linking agents, such as 
psoralene, when attached to one end of a TFO, lead to photoadduct formation with the target 
duplex at the triplex-duplex junction, therefore crosslinking the third DNA strand to the 
underlying duplex (Bates et al., 1995). 
The photoadduct is repaired in vivo, which limits the usefulnes of this approach for therapeutic 
purposes. However, the persistence of both the psoralen cross-link and of the corresponding 
purine-motif triple helix for at least 72 hours was demonstrated in vivo (Musso etal., 1996). 
Unrepaired cross-links may cause chromosome-specific rather than gene-specific toxicity due 
to inhibition of DNA replication (Maher, 1996). 
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Cross-linking can also be achieved through alkylation, especially of guanine residues in the 
target duplex, by a TFO joined to an electrophilic moiety (Povsic et al., 1990; Shaw et al., 
1991). The formation of disulfide cross-links between the strands of a DNA triplex has also 
been reported (Goodwin etal., 1994). 
The Use of Ligands 
Minor groove binding ligands such as netropsin (Park and Breslauer, 1992) and Hoechst 33258 
(Durand etal., 1994) bind to (dT).(dA)*(dT) type triplexes, but they destabilise the triplex 
while stabilising the duplex. 
A series of heterocyclic compounds with several fused aromatic rings, some of them drugs 
used mainly in chemotherapy, have been shown to bind to DNA triplexes by intercalation due 
to strong stacking interactions. For example, coralyne and related compounds have a clear 
preference for triplexes over duplexes. Coralyne has four fused aromatic rings and binds 
triplexes much better than ethidium which has only three (Lee etal., 1993). The positive 
charge of these compounds helps them overcome the high charge density due to the three 
negatively charged phosphodiester chains. 
Lee etal. (1993) reported that coralyne does not have a sequence preference, but experiments 
carried out for the present study seem to indicate otherwise. Derivatives of coralyne have been 
shown to intercalate preferentially in (dT)(dA)*(dT) rather than in d(TC)d(GA)*d(CT) 
triplexes (Latimer etal., 1995), which is probably due to the repulsion between the positive 
charges of the intercalating drug and of the CG*C base triads. Consequently, coralyne could 
be expected to behave in a similar fashion. 
Two benzopyridoindole derivatives, also with four fused aromatic rings, have been shown to 
bind triplexes more tightly than duplexes (Mergny et al., 1992; Pilch et al., 1993). The 
stabilising effect of these ligands is stronger on triplexes containing TA*T stretches. 
A series of intercalators consisting of unfused aromatic cations have also been investigated and 
found to stabilise DNA triplexes (Wilson et al., 1993). The reasoning behind their design was 
that torsional flexibility within the ligands could be well accomodated within the triple helix, 
as there is a propeller twist between the bases within a triad. 
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DNase I footprinting studies have indicated that triplex-binding ligands promote the formation 
of triplexes even if the latter contain central triplet mismatches (Chandler etal., 1995). The 
triplex-duplex junction is favoured as an intercalation site for various ligands, which is 
probably due to special structural and conformational features of this particular site. 
Modified Bases 
The substitution of cytosine with 5-methylcytosine extends slightly the pH range over which a 
pyrimidine motif triplex is stable. Additional stabilisation is brought about by hydrophobic 
interactions between the methyl groups of thymine and those of 5-methylcytosine in the major 
groove (Sun and Hélène, 1993). 
The stability of triplexes of the pyrimidine motif under physiological conditions would be 
strengthened if cytosines could be replaced by heterocycles that do not require protonation to 
form two hydrogen bonds with guanine residues in the Watson-Crick purine strand. Two such 
examples are pseudoisocytosine (Ono etal., 1991) and 8-oxo-adenine derivatives (Miller et 
al., 1992). The latter adopt a syn conformation about the glycosidic bond. 
Interruptions in polypurine tracts have been targeted with TFOs containing non-natural bases 
that can span the major groove and form hydrogen bonds with both W/C strands (Miller, 
1996), and the resulting triplexes are stable. 
A non-natural base that binds preferentially at purpyr base pairs within a pyrimidine motif 
triplex, by intercalating on the 3' side with respect to the purine strand rather than by hydrogen 
bonding, has also been synthesised (Griffin et al., 1992). However, it does not discriminate 
between AT and GC base pairs, and the stability of the triplets it forms depends on nearest 
neighbour interactions. 
Third strands containing an abasic site were tested over various interruptions in a 
polypurinepolypyrimidine tract, and it was found that they had significantly lower affinities 
for the duplex than some of those containing standard bases at the interruption sites (Home 
and Dervan, 1991). This was attributed to the loss of base stacking interactions. 
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Backbone modifications 
Modifications to the backbone of oligonucleotides have been used to increase nuclease resis-
tance. Two such modificatons, phosphorothioate (Kim etal., 1992) and methyiphosphonate 
linkages (Callahan etal., 1991), appear to destabilise the triple helices. 
Oligonucleotides of the (dT)m  type containing cc-nucleosides have been shown to form triple 
helices only slightly less stable than their naturally occuring p-counterparts with (dA) (dT) 
duplexes (Le Doan etal., 1987). The orientation of the oligonucleotide third strand was found 
to be parallel to the purine strand of the W/C duplex, thus forming reverse Hoogsteen 
hydrogen bonds. If the TFO contained cytosine as well, it formed Hoogsteen hydrogen bonds, 
the chain orientation being antiparallel to the purine strand. This is due to the isomorphism of 
the TA*T and CG*C base triplets formed by a-nucleosides in the HS configuration, 
although the rHS configuration is energetically more stable for individual TA*T and CG*C 
base triads (Sun and Hélène, 1993). 
a-Olgonucleotides with a cross-linking agent attached at one end and an intercalating agent at 
the other end have also been used. These formed very stable triplexes, as affinity cleavage 
reactions showed (Praseuth etal., 1988). 
Polypyrimidine oligonucleotides with peptide backbones (PNA), instead of forming triplexes 
with a DNA duplex, have been shown to open the duplex and displace their chemically 
equivalent strand. Two PNA oligonucleotides then form a remarkably stable triplex with the 
complementary homopurine strand (Demidov etal., 1993). This type of structure is called 
P-loop. 
1.3.3 Therapeutic Applications 
Currently, most active drugs are inhibitors of proteins. It has been proposed that TFOs could 
form the basis for gene-targeted (antigene) drugs that might repress transcription from 
undesired genes in living cells. A number of studies employed TFOs to selectively modulate 
gene expression by altering DNA-protein interactions, both in vitro and in cultured cells. 
Transcription of individual genes in cell culture was inhibited by sequence-specific triplex 
formation in regulatory enhancer sequences, which are crucial for binding of nuclear factors 
that regulate transcription (Lavrovsky et al., 1996). Oligonucleotide-dependent inhibition of 
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RNA polymerase II transcription initiation from the c-myc gene was observed at first in a cell-
free transcription system (Cooney etal., 1988). After exposure to the oligomer, a reduction of 
the c-myc mRNA level resulted in cultured cells (Postel etal., 1991). TFOs with an attached 
DNA intercalator (acridine) or cross-linking moiety (psoralen) have also been shown to act as 
transcriptional repressors (Grigoriev etal., 1992 and 1993). 
The action of HIIV integrase was inhibited in vitro by targeting the binding sites of this enzyme 
in the viral genome, which consist of a purine tract adjacent to a pyrimidine tract, with an 
oligonucleotide capable of forming a continuous alternate strand triple helix; this prevented the 
insertion of the viral genome into its target DNA (Bouziane etal., 1996). It is clear, therefore, 
that blocking the recognition sites of DNA-binding proteins represents a useful approach to 
therapy, with a wider scope than just the repression of transcription. 
However, currently the use of TFOs in therapy suffers from important constraints regarding 
requirements for stabilising binding conditions, restrictions on permitted target sequences, and 
inefficient delivery of oligonucleotides to the cell nucleus (Maher, 1996). In addition, it has 
been suggested that triplex formation cannot be targeted at DNA that is tightly associated with 
nucleosome cores (Brown and Fox, 1996). If solutions to these problems are found, 
oligonucleotide-directed triplex formation could become a viable approach to cancer therapy. 
1.3.4 DNA Triplexes as a Tool in Molecular Biology 
The formation of DNA triplexes can also be used as a tool in molecular biology. Site-specific 
cleavage of large DNA fragments has been achieved by targeting homopyrimidine 
oligonucleotides with an attached EDTA-Fe(II) moiety to a region of duplex DNA with a 
contiguous run of purines in one strand (Moser and Dervan, 1987). In case of large DNA 
fragments, the selectivity of restriction endonucleases may not be sufficient, as their target 
sites are usually of 4-8 base pairs in size, but the TFOs are longer than that and therefore more 
specific. However, the cleavage efficiency of this procedure was quite low (15-25%) and 
needed refining in order to increase the yield. 
Two approaches to solve this problem have been reported. One approach involves the 
attachment of DNA cleaving enzymes to oligonucleotides. An oligonucleotide-staphylococcal 
nuclease adduct cleaved plasmid DNA in 75% yield (Pei et al., 1990), but multiple cleavage 
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patterns were observed at the binding site, probably due to the conformational flexibility of the 
attached enzyme (Dervan, 1992). 
The second approach is termed 'Achilles' heel cleavage' and involves transient site-specific 
protection by triple helix formation, from enzymatic methylation, followed by disruption of 
the triplex and consequent cleavage by a restriction enzyme (Strobel and Dervan, 1991). A 
340 kilobase yeast chromosome was cleaved in this way at a unique site in near quantitative 
yield (Strobel and Dervan, 1991), and a 200 megabase human chromosome was cleaved in 80-
90% yield (Strobel etal., 1991). 
Sequence-specific double-strand alkylation mediated by triple helix formation can also lead to 
site-specific cleavage of DNA (Povsic etal., 1992). Attachment of an alkylating agent to the 
5' end of a liomopyrimidine oligonucleotide gave alkylation of a guanine to the 5' side of the 
local triple helix. Two such oligonucleotide-electrophile conjugates bound adjacent inverted 
purine tracts on duplex DNA by triple helix formation and alkylated single guanine residues on 
opposite strands of the duplex. Depurination at the alkylated sites gave a double-strand break 
with specific overhangs, suitable for ligation by restriction enzymes. 
One limitation of triplex-mediated cleavage of DNA is that it can only be applied to mostly-
purine tracts or to tracts containing consecutive runs of purines and pyrimidines (Dervan, 
1992). 
Formation of DNA triplexes at sequences that overlap protein binding sites, inhibits DNA 
binding by these proteins. By determining the 3' and 5' triplex interference boundaries, the 
core DNA-binding sequence for topoisomerase II has been determined (Spitzner et al., 1995). 
This approach may be useful for the characterisation of DNA-binding sites of other proteins as 
well. 
Another application is the purification of double-stranded DNA by triplex-mediated affinity 
capture (Ji and Smith, 1993). The target DNA from bacterial cell lysates formed triple helices 
with biotinylated oligonucleotides immobilised on magnetic beads. Elution from the beads 
gave the desired DNA plasmids in high purity. This procedure can speed up DNA purification 
significantly and, in addition, it could be automated, which would be extremely useful, 




The main problem when studying DNA triplexes is their low stability. In order to overcome it, 
high concentrations of oligonucleotide and salt are usually required. The aim of this study was 
to synthesise oligonucleotides capable of folding back on themselves twice and thus form 
intramolecular triplexes, which are much more stable than triplexes made from single strands. 
The conformations of such intramolecular triple helices have been shown to be identical to the 
conformations of triplexes made up of separate (unlinked) strands, provided that the sequences 
of the two types of triplexes are identical (Durand et al., 1992). 
The triplexes were to be investigated by UV melting to determine how various factors, such as 
their sequence and length, the nature of the linkers, pH (where appropriate), cation concentra-
tion and the addition of a triplex binding drug, affect their stability. 
Another aim was to carry out NMR studies and crystallisation experiments with the triplexes. 
DNA triple helices made of separate strands tend to give fiber-type rather than normal X-ray 
diffraction patterns, even if single crystals are obtained (Liu etal., 1996). It was hoped that 
the crystallisation of intramolecular triplexes would provide a solution to this problem. The 
usefulness of the triple helix binding drug coralyne in crystallisation was assessed in these 
experiments as well, because drugs are often helpful in obtaining DNA crystals. 
124 
2. Results and Discussion 
Triplex-forming oligonucleotides with appropriate sequences were synthesised, linked by 
hexaethyleneglycol (HEG) or hydrocarbon chains. Such oligonucleotides are capable of 
folding back on themselves to give triplexes which have identical conformations to those of 
the unlinked ones, but with significantly increased stabilities; they are called foldback triplex 
forming oligonucleotides (FTFOs). The strands of the triple helical structures are linked with 
hexaethyleneglycol (I-lEG) or two 1,8-octanediol (Ocd) moieties. HEG and Ocd were 
chemically modified so that they could be incorporated in oligonucleotides by the 
phosphoramidite method. 
These oligonucleotides were synthesised in larger quantities for crystallisation experiments 
and they were to be studied by UV melting. For comparison purposes, the duplexes 
corresponding to the intramolecular triplexes were synthesised as well and included in the UV 
melting studies; the duplex strands were also linked by hexaethyleneglycol or octanediol 
chains. 
In addition, CD and NMR studies were conducted in collaboration with Dr. A. Lane from the 
National Institute of Medical Research, London. 
Durand etal. (1990) were the first to report the use of HEG to link the strands of a DNA 
duplex and then of a triplex (1992) to be studied thermodynamically and by circular dichroism 
(CD). I-lEG was chosen because it allows a large mobility of the oligonucleotide parts of the 
molecule and because the presence of the oxygen atoms allows a good solubility of the 
compounds. 
For the purpose of crystallisation the HEG linker might make the oligonucleotides too soluble, 
so a linker of similar length was chosen but with a different structure (Figure 7); it is made of 
two 1,8-Octanediol molecules linked by a phosphodiester bond which is formed during 
automated DNA synthesis. 
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Figure 7. HEG (a) and Ocd (b) linkers 
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The Ocd linker is only slightly longer than the HEG linker - 22 bonds compared to 20, and has 
fewer oxygen atoms and should therefore be more hydrophobic and help the triplexes come 
out of solution more easily during the crystallisation process. 
2.1 Synthesis of Fo!dback Triplex Forming Oligonucleotides 
The triplex sequences chosen for study were of the pyrimidinepurine*pyrimidine type: TA*T 
on the one hand, and a mixed sequence alternating TA*T and CG*C base triplets on the 
other hand. 
The two linkers used were hexaethyleneglycol (HEG) and a linker made of two I ,8-Octanediol 
(Ocd) units respectively, connected with the DNA bases via phosphodiester bonds. 
2.1.1 Synthesis of the Linker Phosphoramidite Monomers 
The synthesis of the linker phosphoramidite monomers suitable for incorporation into DNA 
was based on the method described by Durand et al. (1990) for HEG, and comprises two steps 
(Figure 8): dimethoxytritylation followed by phosphitylation. 
Since both KEG and Ocd have two identical -OH groups in their molecules which can be 
dimethoxytritylated, an excess of HO-X-OH to DMTr-Cl of 5: 1 was used. The mono-
dimethoxytritylated compounds can then be separated from the reaction mixture by wet flash 
column chromatography on silica gel. 
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Figure 8. Synthesis of Linker Phosphoramidite Monomers 
2.1.2 Oligonucleotide Synthesis 
After the transformation of I-lEG and Ocd in suitable phosphoramidite monomers, the 
synthesis of the oligonucleotides involves straightforward solid support automated DNA 
synthesis by the phosphoramidite method. 
The order of the individual DNA strands in the FTFOs is important, as this determines whether 
a triplex would form or not. There are two possible orientations for the third (pyrimidine) 
strand within the triple helix: parallel or antiparallel to the purine strand, corresponding 
respectively to Hoogsteen and reverse Hoogsteen binding of the bases as discussed in Section 
1.1.4. 
As both TA*T and CG*C base triplets favour the Hoogsteen configuration, the third DNA 
(pyrimidine) strand must be parallel to the purine strand and antiparallel to the other 
pyrimidine strand involved in duplex formation, in order for the triplex to be able to form. As 






Note: In the above, n is 6, 8 or 10 and x is HEG or (Ocd) 2 . 
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Figure 10. (a) GA.TC .CT and (b) TC.CT.AG triplexes 
In addition, sequences with the purine strand in the middle of the oligonucleotide were 
synthesised for comparison in the UV melting studies. 
The oligonucleotides were deprotected in concentrated ammonia, purified by reverse phase 
1-IPLC, desalted on NAP columns containing Sephadex G-25 and freeze-dried. As CZE 
analyses showed, the oligonucleotides were obtained in high purity. Examples of the CZE 
traces obtained are shown in the appropriate experimental section. 
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2.2 UV melting 
2.2.1 Preliminary Experiments 
It is well known that the presence of Na and/or Mg 2l favours DNA triplex formation because 
the electrostatic repulsion between three negatively charged phosphodiester chains is greater 
than that between the two chains in a duplex and would prevent triple helix formation in the 
absence of cations. Polyvalent cations are more effective than monovalent ones at promoting 
triplex formation. 
Preliminary UV melting experiments were carried out on the sequence A8-T8-T8  (HEG) 
[dA8-HEG-dT8-HEG-dT8] in order to determine the optimal conditions for triplex formation 
and observation. The results are shown in Table 1. 







?(nm) Tm (°C) 
50 MgCl2 0.01 6.0 - 260 57.6 
50 MgCl2 0.01 6.0 - 284 52.5 
50 MgCl2 0.002 6.0 - 260 51.7 
10 MgCl2 0.001 7.0 - 260 52.6 
50 NaCl 0.1 6.0 0.2 260 39.8 	51.6 
50 NaCl 0.1 6.0 0.2 284 35.1 
10 NaCl 0.1 7.0 0.2 260 36.5 	49.5 
10 NaCl 0.05 7.0 0.2 260 29.7 	47.2 
10 NaCl 0.02 7.0 0.2 260 20.9 	41.2 
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The UV melting buffers containing NaCl allowed the observation of both the triplex-to-duplex 
and duplex-to-coil transitions when the Na cacodylate (ccod) concentration was kept relatively .  
low (10mM as opposed to 50mM), whereas the ones with MgCl2  did not, even at low salt and 
Na ccod concentrations. This is probably due to the fact that Mg 2l ions bind much more 
strongly to DNA than Na'. The addition of EDTA to the NaCl buffers is necessary to cancel 
out the action of any Mg 2l that may be present. The UV melting curves of A 8 .T8 .T8 (1-lEG) at 
three different NaCl concentrations in 10mM Na ccod buffer are shown in Figure 11. 
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Figure 11. UV melting profiles of A 87878 (HEG) in 0.02, 0.05 and 0.1M NaCl 
UV melting buffers 
The variation of the melting temperatures Tmi  (triplex-to-duplex) and T (duprex-to-coil) of 
the FTFO with varying NaCI concentration is represented in Figure 12. 
130 
50 





0 	 0.05 	 0.1 
NaCI conc (M) 
Figure 12. Variation of the UV melting temperatures of A 83838 (HEG) with increasing NaCl 
concentration 
As the graph shows, Tmi  increases more rapidly than Tm2  when the NaCl concentration rises, 
which proves that, as expected, the stability of the triplex is influenced by salt concentration to 
a greater extent than that of the duplex. 
For further experiments the following buffer was chosen: 10mM Na ccod I 0.05M NaCI / 
0.2mM EDTA. This permits the observation of both transitions, which are, in addition, well 
spaced. 
Previous studies on triple-helix formation of the TA*T type (Riley etal., 1966; Cassani and 
Bollum, 1969) showed that the melting of the third strand from the underlying duplex - the 
Hoogsteen (HS) transition - is accompanied by an increase in absorbance at 284nm as well as 
at 260nm. The melting of the duplex - the Watson-Crick (WC) transition - is accompanied by 
an absorbance increase at 260nm, but not at 284nm. However, as can be seen from Table I, 
the melting temperatures obtained for the HS transition at 284nm appear to be significantly 
lower than the ones obtained at 260nm. Also, the amplitude of the absorbance change for the 
HS transition at 284nm was much smaller. Consequently, all observations were carried out at 
260nm. 
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Durand etal. (1992) have shown that for this type of FTFO the melting temperature is 
independent of the DNA concentration, thus proving the formation of intramolecular triplexes 
and ruling out the possible existence of intermolecular ones. 
2.2.2 UV Melting of the (T.A*T)8  Triplexes in the Presence of NaCl 
The UV melting behaviour of the (T.A*T) 8 type oligonucleotides is detailed in Table 2. The 
buffer used was: 10mM Na ccod / 0.05M NaCl / 0.2mM EDTA (pH 7.0). 
Table 2. UV melting temperatures of (TA-T)8 triplexes 
HIEG (Ocd)2 
Sequence Tm1 (°C) Tm2 (°C) Tm1 (°C) Tm2(°C) 
A8 .T8.T8 	(dA8-x-dT8-x-dT8) 28.2 45.3 30.3 44.2 
T8.A8 .T8 	(dT8-x-dA8-x-dT8) - 48.0 - 46.3 
T8-T8-A8 	(dT8-x-dT8-x-dA8) 19.1 48.0 26.0 46.2 
As expected, the sequence with the purine strand in the middle does not form a triplex; it just 
shows a duplex-to-coil transition. 
Surprisingly, the A8 .T8 .T8 and T8 .T8 .A8 sequences do not have identical melting temperatures. 
The triplex-to-duplex transition of A 8 .T8 .T8 occurs at a higher temperature whereas the 
duplex-to-coil transition at a lower temperature than the ones of T8-T8-A8,  for both linkers. 
This may be due to the sterical influence of the linkers themselves. 
However, the duplex-to-coil transition of the FTFOs occurs at a temperature close to the one of 
the T8 .A8 .T8, which only forms a double-stranded structure with a dangling end x-T 8 or T8-x. 
In case of the triplex-to-duplex transition, the linker seems to make a greater difference. 
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2.2.3 UV Melting of the Mixed Sequence Triplexes in the Presence of NaCl 
The mixed sequence triplexes consist of alternating TA*T and CG*C base triplets. Since 
the CG*C triplet requires a protonated cytosine, the stability of a triplex containing such base 
triplets is pH dependent. The UV melting profiles change significantly as the pH changes, 
which is illustrated for the oligonucleotide GA.TC .CT (BEG) in Figure 13. 
The UV melting temperatures of the mixed sequence triplexes as a function of pH, are detailed 
in Table 3. The buffer used was: 10mM Na ccod I 0.05M NaCl / 0.2mM EDTA. 
Table 3. UV melting temperatures of mixed sequence triplexes as a function of pH 
HEG (Ocd)2 
Sequence pH Tm1 (°C) 	Tm2(°C) Tm1 (°C) 	Tm2(°C) 
GA.TC.CT [d(GA)3-x-d(TC)3-x-d(CT)3 ] 7.5 9.6 56.9 11.9 53.8 
7.0 18.8 57.1 22.9 54.0 
6.5 23.8 57.6 31.7 53.6 
6.0 38.0 55.9 45.0 
5.5 50.8 52.8 
5.0 56.8 58.2 
TC.GA.TC [d(TC)3-x-d(GA)3-x-d(TC)3 ] 6.0 13.7 59.3 16.5 56.4 
5.0 19.0 59.6 - 52.7 
TC.CT.AG [d(TC)3-x-d(CT)3-x-d(AG)3 ] 7.5 - - 9.9 58.5 
7.0 10.1 63.1 17.5 59.5 
6.5 18.1 62.4 27.3 58.7 
6.0 32.4 62.1 42.83 55.1 
5.5 46.5 58.6 53.9 
5.0 57.4 60.0 
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Figure 13. UV melting curves of GA.TC .CT (HEG) at pH (a) 7.5, (b) 7.0, (c) 6.5, (d) 6.0, (e) 5.5 
and (f) 5.0 
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As expected, the stability of the triplexes increases significantly as the pH decreases. The 
melting temperature of the duplex-to-coil transition decreases slightly at lower pHs, as the 
more extensive protonation of the cytosines starts to affect the Watson-Crick hydrogen bonds 
as well. 
In case of the Ocd linked oligonucleotides, the triplex-to-duplex transitions occur consistently 
at higher temperatures, and the duplex-to-coil transitions at lower temperatures, than the 
equivalent transitions of the HEG linked ones. For all mixed sequence FTFOs, as the pH is 
lowered, the two melting temperatures are getting closer, i.e. the temperature difference 
between the two transitions decreases. At low pH (5.0, 5.5 and even 6.0 in one case) only one 
transition was observed. At pH 5.5 the observed transition was broader than that at pH 5.0, 
which suggests that the triplex-to-duplex and the duplex-to-coil transitions occur close 
together and are unresolved. 
The dependence of the melting temperatures Tmi  and  Tm2  of GA.TC .CT (HEG) on pH is 
illustrated in Figure 14. 
Figure 14. Variation of the melting temperatures of GA.TC .CT (HEG) with pH 
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The apparently lower Tm  of the duplex at pH 5.5 is probably an artefact due to the fact that the 
two transitions are close together but unresolved. 
The sequence GA.TC .CT and its reverse - TC.CT.AG  - behave differently. For both linkers 
the triplex formed by GA.TC .CT seems to be more stable, whereas the duplex is less stable 
than that of TC.CT.AG . As the pH is lowered, the difference in triplex melting temperatures 
decreases, and at low pH values (5.5 and 5.0), where the two melting transitions are 
unresolved, TC.CT.AG appears to be more stable. However, the latter observation could arise 
as a consequence of the fact that the determined single melting temperature has a value 
inbetween the ones of the HS and the W/C transitions, and for TC.CT.AG  the latter occurs at a 
higher temperature. 
Surprisingly, the sequence with the purine strand in the middle does appear to form a triplex at 
acidic pH, but the corresponding melting temperatures are quite low; this may due to the 
formation of intermolecular triplexes, or to intramolecular triplexes with antiparallel reverse 
Hoogsteen binding of one pyrimidine to the purine strand, which are less stable. 
2.2.4 UV Melting Behaviour of TA-T Triplexes Compared to That of Their Corresponding 
Duplexes in the Presence of MgCl2 
This set of experiments was intended to compare the UV melting behaviour of the TA*T 
FTFOs with that of their corresponding foldback duplex forming oligonucleotides, the strands 
of which are being held together by the same linkers. 
When carrying out experiments on the sequence A 6.T6.T6 (Ocd), it became apparent that the 
two transitions for this FTFO could not be resolved, even at low salt concentrations. This is 
probably due to the fact that the sequence is quite short. The UV melting temperatures 
obtained for this FTFO under different conditions, are detailed in Table 4. The melting 
temperature of the duplex A 6.T6 (Ocd) at one of the salt concentrations used is shown for 
comparison purposes. All UV melting buffers used for the study of TA*T triplexes had 
pH 7.0. 
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Table 4. UV melting of A6 .T6.T6(Ocd) at various salt concentrations 
Na ccod EDTA Salt Salt conc Tm (°C) Tm(°C) 
conc (MM) conc (MM) (M) duplex 
10 0.2 NaCl 0.05 32.8 40.8 
10 0.2 NaCl 0.02 27.6 - 
10 0.1 - - 18.9 - 
It was then tried to increase the salt concentration in such a way as to make the HS and W/C 
transitions of the TA*T triplexes occur simultaneously, thus obtaining monophasic melting 
curves, and then to determine whether the triplexes would be more stable than their respective 
duplex oligonucleotides. 
A couple of triplex sequences and their corresponding duplexes have been used in order to 
establish optimal conditions for the proposed experiments. The results are shown in Table 5. 
Table 5. UV melting temperatures of some TA*T triplexes under different conditions 







A8 .T8.T8 (Ocd) 10 NaCl 0.25 1 53.3 
A8-T8 (Ocd) 10 NaCl 0.25 1 58.2 
A8 .T8 .T8 (Ocd) 10 NaCl 0.5 1 58.8 
A8.T8 (Ocd) 10 NaCl 0.5 1 61.7 
A6.T6.T6 (Ocd) 10 NaCl 0.5 1 48.9 
A6.T6 (Ocd) 10 NaCl 0.5 1 50.3 
A6.T6.T6 (Ocd) 10 MgCl2 0.005 - 48.0 
A6.T6 (Ocd) 10 MgCl2 0.005 - 47.4 
A6.T6.T6 (Ocd) 10 MgCl2 0.01 - 49.5 
A6.T6 (Ocd) 10 MgCl2 0.01 - 48.5 
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A buffer containing 10mM Na ccod / 10mM MgCl 2 (pH 7.0) was chosen for the subsequent 
experiments. MgCl 2 has a much stronger effect on the melting temperatures of DNA triplexes 
than NaCl, and much smaller quantities of salt are required. At the concentrations used, 
saturation of the triplexes with Mg 2 seems to have been achieved, as only a small rise in 
melting temperature has occurred after doubling the MgCl 2 concentration from 5mM to 
10mM. In addition, the melting of the FTFOs occurred at approximately the same or even at a 
slightly higher temperature than that of their respective duplex oligonucleotides. 
The UV melting temperatures of all TA*T FTFOs and of their corresponding duplex 
oligonucleotides in the 10mM MgC12 buffer are detailed in Table 6. 
Table 6. UV melting temperatures of TA*T triplexes and of their corresponding duplexes 
HEG (Ocd)2 
Sequence Tm (°C) Tm(°C) 
A63636 	(dA6-x-dT6-x-dT6) 49.7 49.5 
A6-T6 	(dA6-x-dT6) 49.7 48.5 
T6-T6-A6 	(dT6-x-dT6-x-dA6) 49.4 52.8 
(dT6-x-dA6) 49.1 48.7 
A8-T8-T8 	(dA8-x-dT8-x-dT8 ) 59.5 59.7 
A8-T8 	(dA8-x-dT8) 59.5 59.3 
T8-T8-A8 	(dT8-x-dT8-x-dA8 ) 60.0 61.1 
T8-A8 	(dT8-x-dA 8) 60.0 59.7 
A10310310* 	(dA 10-x-dT 10-x-dT 10) 65.0 65.1 
T10.T10.A10* 	(dT 10-x-dT 10-x-dA 10) 64.9 66.0 
A4.T434 	(dA4-x-dT4-x-dT4) - 28.9 
A4-T4 	(dA4-x-dT4) 
- ** 
Notes: * No duplexes were available for comparison. 
** Melting did not occur in the temperature range studied 
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As can be seen from the table above, the melting of the entire set of FTFOs occurred at the 
same or at slightly higher temperatures than that of the respective duplexes. The temperature 
difference between the melting of the triplex and that of the corresponding duplex is generally 
extremely small and could arise as a consequence of the calculations carried out to obtain the 
melting temperatures. There is, however, the possibility that the triplexes are slightly more 
stable than the duplexes. The nature of the linker seems to make relatively little difference to 
the thermal stability of the triplexes or of the duplexes. 
The oligonucleotides A 4.T4.T4 (Ocd) and A4.T4 (Ocd) were included in the study to see what 
impact the presence of the linker has on a very short sequence. Unlinked strands of dA 4 and 
dT4  cannot form a stable duplex or a triplex. Because of their shortness (end effects) and the 
fact that only two W/C hydrogen bonds can form between dA and dT, the strands would come 
apart as soon as they had bound. The presence of the linker in the A 4.T4 (Ocd) duplex 
oligonucleotide is not enough to stabilise the double helix, and as a consequence no melting 
was observed. However, the triplex A 4.T4 .T4 (Ocd) is quite stable, as its melting temperature 
of 28.9 °C shows. This clearly shows the stabilising effect the presence of the linkers in the 
molecule brings about. 
The dependence of the melting temperatures of the (A.T.T) FTFOs on their Iengh, i.e., on the 
number of base triplets 'n' in the sequence, is shown in Figure 15. The melting profiles of 
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Figure 15. Variation of the UV melting temperature of (A.T.T) triplexes with their length 
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Figure 16. UV melting curves of (A.T.T) triplexes 
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It is clear that the longer the triplex, the higher its UV melting temperature is. However, the 
increase in melting temperature gets smaller as the number of base triplets in the 
oligonucleotides 'n' increases. 
2.2.5 UV Melting Behaviour of the Mixed Sequence Triplexes Compared to That of Their 
Corresponding Duplexes in the Presence of MgCl2 
As was the case for the TA*T triplexes, the UV melting temperatures of the mixed sequence 
triplexes were compared to those of their corresponding foldback duplex forming 
oligonucleotides, the strands of which are being held together by the same linkers (Table 7). 
Buffers of the same salt concentration were used - 10mM Na ccod / 10mM MgCl 2 - at a pH 
of 5.5 and then at 7.0. 
Table 7. UV melting temperatures of mixed sequence triplexes and of their corresponding 
duplexes 
Tm(°C) / pH=5.5 Tm (°C) / pH=7.0 
Sequence HEG (Ocd)2 HEG (Ocd)2 
GA.TC.CT [d(GA)3-x-d(TC)3 -x-d(CT)3 } 57.5 57.8 14.2 	63.5 14.4 	63.2 
GA.TC 	[d(GA)3-x-d(TC)3 ] 61.6 60.1 61.9 61.4 
TC.CT.AG [d(TC)3-x-d(CT) 3-x-d(AG)3 ] 52.8 	65.1 59.2 12.8 	66.6 13.2 	65.7 
CT.AG 	[d(CT)3-x-d(AG)3 ] 66.0 63.8 66.6 64.7 
As expected, at pH 7.0 the triplex-to-duplex transition takes place at relatively low 
temperatures. In addition, the duplex-to-coil transition occurs at temperatures up to 2°C higher 
than that of the corresponding duplex oligonucleotide. 
At pH 5.5, the melting of the duplex oligonucleotides takes place at higher temperatures than 
the equivalent transitions of the FTFOs. This probably means that the two transitions for the 
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FTFOs under these conditions do not occur simultaneously and are unresolved; only one 
transition can be seen, the melting temperature of which has a value in-between those of the 
HS and W/C transitions. In case of TC.CT.AG  (HEG), two distinct transitions are visible. 
The latter FTFO was then submitted to UV melting at pH 5.5 at higher MgCl 2 concentrations 
(the concentration of Na ccod was kept constant at 10mM), to see if the gap between the 
temperatures of the two transitions could be narrowed. The results are detailed in Table 8. For 
comparison purposes, some results at identical salt concentrations but at pH 7.0 were included. 
Table 8. UV melting temperatures of TC.CT.AG (HEG) at increasing MgCl 2 concentrations 
Tm(°C) / M9Cl2 COIIC 
PH 10mM 20mM 50mM 
5.5 52:8 	65.1 48.2 	65.8 47.4 	65.6 
7.0 12.8 	66.6 - 13.6 	67.5 
At pH 5.5 the temperature of the HS transition decreases as the MgCl 2 concentration increases. 
This destabilisation of the triplex structure may be due to electrostatic repulsion between Mg 2 
and the positively charged CG*C base triplets. 
2.2.6 UV Melting Temperatures of DNA Triplex-Coralyne Complexes 
Coralyne (Figure 1) is a DNA binding drug that possesses significant antitumor activity 
(Zee-Cheng et al., 1974). It has been shown to intercalate into both triplex (Lee et al., 1993) 
and duplex DNA, and it also stacks outside the helix, particularly at low ionic strengths 
(Wilson et al., 1976). However, its affinity for triplexes seems to be greater than that for 
duplexes due to improved stacking interactions, and in its presence the UV melting 
temperature of the triplex has been shown to be higher than that of the duplex (Lee etal., 
1993). It may well be that the drug's antitumor activity is due to its binding to triplex rather 
than to duplex DNA, as the former structure has been found in vivo, and it is assumed to fulfil 
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a potentially important biological role. According to the work carried out by Lee etal. (1993), 
coralyne intercalates at every other base triplet in TA*T type triplexes, and at every base 
triplet in triplexes where CG*C and TA*T alternate, and it shows little sequence preference. 
However, in view of the fact that it is positively charged, coralyne could be expected to favour 
consecutive TA*T base triplets rather than intercalate at alternating TA*T - CG*C steps, 






Figure 17. Coralyne chloride 
UV melting experiments have been carried out to assess the effect of coralyne on the melting 
temperatures of the TA*T triplex hexamers (Table 9) and of the mixed sequence triplexes 
(Table 10), compared to the effects of the drug on the melting temperatures of their 
corresponding duplex oligonucleotides. These experiments were carried out in a 10mM Na 
ccod / 10mM MgCl2  buffer, at pH 7.0 for the (TA*T) 6 triplexes and at pH 5.5 for the mixed 
sequence ones. In case of the GA.TC .CT triplexes, the experiments were carried out at pH 7.0 
as well. The amount of coralyne added was calculated so that one aliquot should provide 
3 coralyne molecules per DNA molecule, i.e. one drug molecule for every other base triplet, 
with the exception of A 4 .T4 .T4 (Ocd) and its respective duplex, where it should provide one 
drug molecule per DNA molecule. The latter triplex was included in the study for comparison 
purposes. The DNA quantity was 10 nmoles in all samples. 
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Table 9. UV melting temperatures of the (TA-T)6 and A43434 (Ocd) triplex-coralyne 
complexes 
Tm (°C) I Coralyne Quantity*  (Drug to DNA Ratio) 
Sequence - 1 aliquot 2 aliquots 3 aliquots 4 aliquots 
(3 :1) (6 :1) (9 :1) (12 :1) 
A6.T6.T6 (I-lEG) 49.7 52.8 53.6 55.1 
A6.T6 (HEG) 49.7 49.2 - - 
T6.T6.A6 (HEG) 49.4 53.8 55.7 56.6 
T6 .A6 (HEG) 49.1 51.0 - - 
A6.T6.T6 (Ocd) 49.5 55.2 57.3 58.7 58.8 
A6.T6 (Ocd) 48.5 49.0 49.2 - 
T6.T6 .A6 (Ocd) 52.8 59.3 61.2 62.4 
T6-A6 (Ocd) 48.7 48.8 47.3 - 
T6 .A6 .T6 (Ocd) 14.0 	51.7 34.4 	51.6 38.0 	51.8 - 
- 1 aliquot 2 aliquots 3 aliquots 4 aliquots 
(1 : 1)** (2: 1)** (3: 1)** (4: 1)** 
A4.T4 .T4 (Ocd) 28.9 32.3 34.4 35.5 36.5 
A4.T4 (Ocd) - - - 
Notes: * 1 aliquot coralyne = 30 nmoles 
** I aliquot coralyne = 10 nmoles 
Spectrum gave an erratic curve and could not be used. 
Melting did not occur in the temperature range studied. 
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Table 10. UV melting temperatures of the mixed sequence triplex-coralyne complexes 
Tm(°C) / Coralyne Quantity*  (Drug to DNA Ratio) 
Sequence pH - 1 aliquot 2 aliquots 3 aliquots 
(3:1) (6:1) (9:1) 
GA.TC.CT(Ocd) 5.5 57.8 58.9 60.3 ** 
GA.TC(Ocd) 5.5 60.1 61.6 61.9 ** 
TC.CT.AG (Ocd) 5.5 59.2 59.1 60.1 ** 
CT.AG (Ocd) 5.5 63.8 64.1 64.2 ** 
GA.TC.CT(HIEG) 5.5 57.5 50.7 	58.3 48.2 	59.9 48.3 	59.6 
GA.TC(HEG) 5.5 61.6 62.7 62.3 ** 
TC.CT.AG (I-lEG) 5.5 52.8 	65.1 48.5 	65.8 50.4 	66.3 43.0 	67.2 
CT.AG (HEG) 5.5 66.0 66.2 66.5 ** 
GA.TC.CT(Ocd) 7.0 14.4 	63.2 14.9 	64.0 12.2 	64.0 ** 
GA.TC.CT(HEG) 7.0 14.2 	63.5 13.5 	63.0 ** - 
Notes: * 1 aliquot coralyne = 30 nmoles 
** Spectrum gave an erratic curve and could not be used. 
As can be seen from Table 9, coralyne increases the melting temperatures of the TA*T 
triplexes, and has a minimal effect on the melting of their respective duplexes. The effect on 
the Ocd linked oligonucleotides is greater than that on the HEG ones. 
Upon addition of the first coralyne aliquot, the melting temperature rises by up to 6.5°C for 
the Ocd and 4.4°C for the HEG FTFOs. AT M  is greater in case of T 6 .T6 .A6 for both linkers. 
When the second addition of coralyne is made, another increase in melting temperatures of 
around 2°C occurs. A third aliquot brings about a further rise of 0.8 - 1.5°C. If a fourth 
aliquot of coralyne is added, the spectra become erratic curves which cannot be used for the 
calculation of the melting temperature, with the exception of A 6.T6 .T6 (Ocd), where Tm 
increases by a further 0.1°C. The latter increase is, however, negligible compared to the 
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previous ones. Therefore it can be assumed that any further increase in drug concentration will 
not lead to a rise of the triplex melting temperature. A 4 .T4 .T4 (Ocd) is stabilised by coralyne 
as well. 
The melting temperatures of the duplex oligonucleotides show mainly variations of less than 
1°C, some positive and some negative. Their spectra become erratic after the addition of three 
or even two drug aliquots. A 4 .T4 (Ocd) does not appear to form a duplex with or without 
coralyne. 
The sequence T6 .A6 .T6 (Ocd) appears to form a fairly weak triplex in the absence of coralyne. 
This is due either to the formation of an intermolecular triplex, or of an intramolecular one 
with parallel pyrimidine strands, the third strand of which binds to the purine strand by reverse 
Hoogsteen hydrogen bonds. Upon the addition of one coralyne aliquot, the temperature of the 
triplex-to-duplex transition increases significantly by 20.4°C. A second addition raises the 
melting temperature further by 3.6°C. The temperature of the duplex-to-coil transition 
remains virtually unchanged. 
In contrast with the TA*T triplexes, the Ocd linked mixed sequence triplexes (Table 10) are 
stabilised very little by coralyne: their melting temperatures at pH 5.5 are increased only by 
2.5°C and 0.9°C after the addition of two drug aliquots. If more drug is added, the spectra 
become erratic. 
The HEG linked mixed sequence triplexes are destabilised by coralyne at pH 5.5. As 
described in section 2.2.4, the two melting transitions of the mixed sequence FTFOs probably 
do not occur simultaneously and are unresolved under the same conditions as the UV melting 
experiments carried out with coralyne. Upon addition of the drug, the temperature of the 
triplex-to-duplex transition decreases, while that of the duplex-to-coil transition rises very 
slightly. The latter could be an apparent increase only; as the gap between the two transitions 
widens, it may be that the temperature of the W/C transition can be calculated more accurately. 
The melting temperatures of the duplex oligonucleotides show very slight increases, the largest 
of which - 1.8°C after the addition of two coralyne aliquots - occurs for the GA.TC  (Ocd) 
duplex. 
At pH 7, the effect of coralyne on the melting temperatures of the mixed sequence triplexes is 
relatively insignificant. 
146 
These results suggest that under the conditions investigated coralyne has a sequence 
preference, in contrast to the findings of Lee etal. (1993). It binds to the TA*T triplexes and 
stabilises them, the Ocd more so than the HEG linked ones, while the effect it has on the 
mixed sequence triplexes is much smaller: a slightly stabilising one in case of the Ocd linked 
ones and a destabilising one in case of the HIEG linked FTFOs. This is consistent with the idea 
that there is electrostatic repulsion between the positively charged coralyne and the CG*C 
base triplets in the mixed sequence triplexes, which may result in incomplete intercalation. 
The stability of the duplexes seems to be virtually unaffected by the presence of the drug. 
It may be that coralyne would stabilise these types of triplexes and maybe even the duplexes to 
a greater extent, but this was not apparent because of the great stabilising effect of the linkers. 
2.3 Attempts to Crystallise DNA Foldback Triplexes 
The most powerful technique for determining the three-dimensional structure of biological 
macromolecules is single-crystal X-ray crystallography. Single-crystal analysis of DNA and 
RNA oligonucleotides and their complexes with drugs has provided a great deal of information 
about the structure and function of these molecules. However, the crystallisation of nucleic 
acids is currently still carried out in a trial-and-error manner, and the obtaining of diffraction 
quality crystals does not have a reliable success rate (Wang and Gao, 1990). 
No normal X-ray diffraction pattern from crystals of a DNA triplex has yet been reported. 
Attempts to obtain crystals of triplexes from mixtures of single strands yield fibre patterns, 
even from well-formed single crystals (Liu et al., 1996). It was suggested that this diffraction 
behaviour may be an intrinsic property of triple helices, reflecting the lack of lateral ordering, 
as there is no strong interaction between the cylindrical triplex molecules in the lateral 
direction; this may arise because triple helices are much more rigid than Watson-Crick 
duplexes (Liu etal., 1996). Crystallography of DNA duplexes shows deviations from 
canonical structures, such as distortions which enable the double helices to interact laterally; 
for example, a portion of one duplex can interact with the major groove of another. In a triplex 
the major groove is filled with the third strand, preventing this kind of lateral interaction (Liu 
etal., 1996). In addition, the higher charge density of a triplex may also disfavour such 
interactions. 
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Amott and co-workers (Arnott and Selsing, 1974; Arnott etal., 1976) were the first to propose 
a three-dimensional structure for a poly(dT)poly(dA)*poly(dT) triplex on the basis of X-ray 
fiber diffraction data. 
Van Meervelt etal. (1995) have described the structure of the CG*G base triplet as part of an 
extended DNA crystal structure to a resolution of 2.05A. The formation of this base triplet 
occurs as a result of interaction between adjacent overlapping duplexes. The same research 
group then obtained both parallel and antiparallel (C.G*G) 2 fragments in a crystal structure of 
a DNA duplex with staggered ends (Vlieghe et al., 1996). Other triplet structures 
characterised by X-ray diffraction were in protein-DNA complexes studied at about 3A (Luisi 
etal., 1991). 
Most DNA duplex sequences that have been crystallised successfully are 4 to 15 nucleotides 
long; these molecules are nearly globular, which enables them to pack more effectively against 
other molecules of this shape (Wang and Gao, 1990). It was reasoned that the triplexes would 
have a good chance of crystallising if they were relatively short, 6 - 8 nucleotides in length. 
DNA triple helices of this length are stable at very low temperatures only. However, the 
foldback DNA triplexes studied are very stable at room temperature, so they were synthesised 
in multi-milligram quantities, which were then used in crystallisation experiments. The 
quantities of DNA synthesised for this purpose are listed in Table 11. 
Table 11. Quantities of oligonucleotides synthesised for crystallisation 
Quantity (mg) 
Sequence (Ocd)2 IIEG 
A6.T6.T6 32.1 17.3 
T6 .T6 .A6 15.6 5.9 
A8-T8-T8 20.5 11.0 
T8-T8-A8 6.5 3.7 
GA.TC.CT 34.2 9.8 
TC.CT.AG 8.5 11.0 
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The purity of the oligonucleotides needs to be very high to increase the chance of obtaining 
good quality crystals. The synthesised FTFO-s were purified until CZE analyses showed one 
single peak in each case. Examples of the CZE traces are illustrated in the appropriate 
experimental section. 
Crystal lisations of the triplexes by the vapour diffusion and by the slow evaporation method 
have been tried. However, so far the experiments have been unsuccessful. For details of the 
procedures and solutions used, see the appropriate experimental section. 
It may be that the linkers used to stabilise the DNA triplexes are too long and therefore have 
too many degrees of freedom, which reduces the ability of the molecules containing them to 
pack effectively in a lattice. 
Coralyne was used in some of the crystallisation experiments, but this lead to the formation of 
a microcrystalline precipitate, which control experiments (without DNA) showed to be the 
drug on its own. It was concluded that coralyne does not represent a useful reagent in the 
crystallisation of nucleic acids, as it has a very poor solubility in the buffers and solutions 
normally used for this purpose. 
2.4 Results from CD and NMR Studies Carried out in Collaboration 
Circular dichroism and NMR studies were carried out on the A 6 .T6 .T6 and GA.TC .CT triplexes 
with and without coralyne. The nature of the linker - HEG or Ocd - did not make any 
difference to the CD and NMR spectra. 
The CD spectrum of A 6.T6.T6 at 15°C did change significantly when coralyne was added 
(Figure 18), while the spectrum of GA.TC .CT showed a very small change (Figure 19). These 
results indicate that under the conditions used (8tM triplex and 4p.M coralyne) A6-T6-T6  binds 
coralyne tightly, probably intercalatively, whereas GA.TC .CT does not. It seems therefore that 
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Figure 19. CD spectrum of GA.TC .CT with and without coralyne 
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'H-NMR spectra in H 20 at 10°C of both triplexes showed large changes consistent with 
intercalation upon addition of coralyne. At the high DNA and drug concentrations (1.5mM 
and 0.5mM, respectively) used for the recording of the NMR spectra coralyne binds well not 
only to A6.T6 .T6, but also to GA.TC .CT, as the changes in the spectra (Figures 20 and 21) 
indicate. 
15.0 	14.5 	 14.0 	 13.5 	 13.0 	 12.5 	 12.0 	 11.5 	ppm 
(a) 
15.0 	 14.5 	 14.0 	 13.5 	 13.0 	 12.5 	 12.0 	 11.5 	npm 
(b) 
Figure 20. 1 H-NMR spectrum of A6 .T636 (a) without and (b) with coralyne 
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(b) 
Figure 21. 1 H-NMR spectrum of GA.TC .CT (a) without and (b) with coralyne 
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3. Experimental 
3.1 Chemicals and Solvents 
All chemicals were obtained from Aldrich, Fluka or Fisons. Silica gel 60 (80 - 430 mesh) was 
obtained from Fluka. All solvents were of analytical or HPLC grade. Anhydrous acetonitrile 
was purchased from Applied Biosystems as DNA synthesis grade. 
Anhydrous pyridine was distilled over CaH 2 . Anhydrous TI-IF and diethyl ether were distilled 
over sodium and benzophenone. TEA and DIPEA were dried by storage over CaH 2 . Pyrogen-
free, reverse osmosis purified water was used throughout. 
3.2 Thin Layer Chromatography (TLC) 
TLC was carried out on aluminium sheets coated with a 0.2mm layer silica gel 60 F 254 , 
supplied by Merck, using the following solvent systems (all v/v): 
dichioromethane: methanol (10: 1) 
ethylacetate : triethylamine (99: 1) 
Before carrying out TLC of dimethoxytritylated compounds, the plates were pretreated with 
triethylamine, to prevent detritylation due to the acidic silica gel. For compounds with.R f 
values close to that of pyridine, the R f value was distorted. The Rf values given below (section 
3.11) correspond to that of the purified compounds. 
Compounds were visualised under UV light at 254nm. Dimethoxytrityl groups were 
visualised by fuming HCI as bright orange colours. The purity of all compounds synthesised 
was verified by one spot on TLC. 
3.3 Wet Flash Column Chromatography 
This was carried out under slight nitrogen or argon pressure (0.5 bar) using silica gel 60. For 
compounds containing the cyanoethyl-N,N-diisopropyl-phosphoramidite group, in order to 
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remove any moisture present in the silica, this was dried overnight at 120°C and then cooled in 
a dessicator over P 205 prior to being used. 
3.4 Instrumentation 
'H-NMR spectra were recorded on a Brucker WP-200 (200.13 MHz) Fourier transform 
spectrometer. 13C-NMR spectra were recorded on a Brucker WP-200 (62.90 MHz) Fourier 
transform spectrometer. Tetramethylsi lane was used as internal reference and cited chemical 
shifts are given in ppm downfield of this standard. 31 P-NMR spectra were recorded on a Jeol 
FX90Q (90 MHz) Fourier transform spectrometer. H 3PO4 85% was used as external reference 
and cited chemical shifts are given in ppm downfield of this standard. FAB mass spectra were 
recorded on a Kratos MS 50 TC spectrometer using a 3-nitrobenzyl alcohol (3-NOBA) matrix. 
C, H and N microanalysis was performed on a Perkin Elmer 240 elemental analyser. 
3.5 Oligonucleotide Synthesis 
Oligonucleotide synthesis was performed using solid phase cyanoethyl-N,N-diisopropyl-
phosphoramidite chemistry (Beaucage and Caruthers, 1981; Brown and Brown, 199 1) on an 
Applied Biosystems 394 automated DNA synthesiser equipped with on-line long wave 
detector (498nm). All DNA synthesis reagents and standard phosphoramidite monomers were 
supplied by Applied Biosystems. 
The modified phosphoramidites synthesised for this study were dried in vacuo, stored with 
'25 overnight and used as a 0.11 - 0.12M solution in anhydrous acetonitrile. Coupling 
efficiencies were in general >98%. 'Trityl-off' syntheses were carried out. The oligonucleo-
tides were cleaved from the solid support with concentrated ammonia and deprotected by 
incubation in sealed vials with teflon caps at 55°C in concentrated ammonia for 8 - 10 hours. 
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3.6 HPLC Analysis and Purification of Oligonucleotides 
Oligonucleotide analysis and purification was carried out on a Gilson Model 306 equipped 
with an UV detector, an Aquapore Octyl reverse phase column (10mm x 250mm) and an 
octadecyl pelicullar guard column, controlled by a computer running Gilson 712 software. 
The eluting buffers used were: 
buffer A - 0.1M NH4OAc 
buffer B - (a) 0.1M NH40Ac plus 20% MeCN - for the HEG oligonucleotides 
(b) 0.1M NH40Ac plus 35% MeCN - for the Ocd oligonucleotides, as the 
octanediol linker makes them more hydrophobic. 
At a flow rate of 3m1/min, the following gradient was used: 
Time (mm) 	% Buffer B 
	
0.00 	 0.0 
3.00 	 0.0 
4.00 	 15.0 
24.00 	 70.0 
26.00 	 100.0 
28.00 	 100.0 
29.00 	 0.0 
30.00 	 0.0 
Analytical runs were monitored at 260nm and 0.2 AUFS. Preparative scale runs were 
monitored at 293-295nm and 1 AUFS. Examples of the chromatograms obtained are given in 









Figure 23. Prep HPLC chromatograms of (a) GA.TC .CT (HEG) and (b) GA.TC .CT (Ocd) 
3.7 Sephadex Gel-Filtration (Desalting) of Oligonucleotides 
In order to remove the salt accumulated in the sample during the reverse phase HPLC 
purification step, the oligonucleotides were submitted to gel filtration on Pharmacia NAP-b 
(Sephadex G-25) cartridges. The DNA was lyophilised to give a fluffy white powder. 
iE.1 
3.8 Capillary Zone Electrophoresis (CZE) 
The purity of all oligonucleotides synthesised was verified by one single sharp peak on CZE. 
This was carried out on an Applied Biosystems Model 270A Capillary Electrophoresis system 
with Microgel capillaries using 75mM Tris-phosphate with 10% methanol at pH 7.6 elution 
buffer. The on-line detector was set at 272nm with the loading voltage at -5kV, the running 
voltage at -15kV and the sample uptake time between I and 5 seconds. Sample runs were 
recorded on a chart recorder set at chart speed 1cm/rn in, attenuation 16, offset 5 and peak 








Figure 24. CZE traces of (a) A636.T6 (HEG), (b) TC.CT.AG (HEG), 
(c) T636.A6 (Ocd) and (d) GA.TC .CT (Ocd) 
3.9 Crystallisation Experiments 
Glass spot plates (Corning 7220) were used for the crystallisation of the foldback DNA triplex 
forming oligonucleotides. The plates were extensively cleaned and treated with silanising 
agent (5% chlorotrimethyl silane in DCM) to produce a water-repelling surface. This supports 
the crystallising solution in a round beaded shape, which allows the concentratidhs "of all 
components in solution to increase uniformly as the droplet becomes smaller; otherwise it 
would collapse into a flat pool with an increased surface area, causing it to dry rapidly during 
equilibration, which could lead to the precipitation of the oligonucleotide (Wang and Gao, 
1990). 
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The following aqueous solutions were used: 
Na cacodylate buffer (100mM), pH6.8 for TA*T type triplexes or pH=5.5 for 
mixed sequence triplexes 




Each FTFO (I mg) was dissolved in the Na ccod buffer A (35pi in case of the vapour diffusion 
method, or 50p1 in case of slow evaporation), and 51.11  of this solution were placed in the top 
three and the bottom three wells of a nine wells crystallising plate in case of the vapour 
diffusion method, or in each well in case of slow evaporation. Then water was added to the 
wells, if needed, in such quantities to ensure that the volumes of the droplets on any one plate 
were identical after all solutions were added. 
Specific quantities of the following combinations of solutions were then added sequentially (in 
the order indicated below), ensuring that the oligonucleotide did not precipitate: 
• 	B - GA.TC .CT (HEG) and (Ocd) 2 
• 	B and C - A 6.T6 .T6 (Ocd)2 
• 	B and D - GA.TC .CT and TC.CT.AG, (HEG) and (Ocd) 2 
• 	B and E - TC.CT.AG (HEG) 
• 	B, C and D - A6 .T636 and GA.TC .CT, (BEG) and (Ocd) 2 
• 	B, D and E - all sequences 
This protocol was then applied to each of the remaining wells containing DNA, the amount of 
solutions B,C,D and E being varied slightly in each well, to give a wide range of conditions. 
In case of the vapour diffusion method, 200.tl or 1001.11 solution D was added to the three 
middle wells of the crystallising plate. The wells were then covered with glass microscope 
slides with vacuum grease applied to ensure an efficient seal. The majority of the plates were 
kept at room temperature, the remainder were kept at 9°C. They were examined daily under a 
microscope to follow the process of crystallisation. 
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3.10 UV Melting (Thermal Denaturing) Studies 
UV melting was carried out on a Lambda 2 UV-visible spectrophotometer controlled by a 
computer running a PECSS (Perkin Elmer Computerised Spectroscopy Software) package. 
The temperature of the sample was controlled by a PTP-1 Peltier block with a heating rate of 
1°C/mm. The absorbance of the sample at 260nm was measured at intervals often seconds to 
obtain absorbance versus time melting curves. The data was then converted to absorbance 
versus temperature curves, and the melting temperatures (which correspond to the points of 
inflection of the curves) were obtained by calculating the first derivative of the curve and 
determining its maximum points. For the buffers used, see section 2.2. 
The melting of the FTFOs synthesised for this study was either biphasic, in which case the 
melting curves had two inflection points, or monophasic, when the melting curve had just one 
inflection point. In case of the biphasic melting, the first inflection point, corresponding to a 
lower temperature, represents the triplex-to-duplex transition; the second one, corresponding 
to a higher melting temperature, represents the duplex-to-coil transition. In case of the 
monophasic melting, the transitions occur directly from triplex to single stranded DNA. All 
melting curves were determined in triplicate. 
3.11 Synthetic Chemistry 
1-0-(4,4'-Dimethoxytrityl)-hexaethyleneglycol [Durand et al., 19901 
H3 CO 
H3 CO 	—C -- O —(CH2 - CH2 - 0)5 - CH2 - CH2 - OH 
6 
KEG (12.50g, 45mmol, I lml, 5eq.) and DMAP (215mg, 1.8mmol, 0.2eq.) were coevaporated 
from anhydrous pyridine (3 x 7ml) and dissolved in anhydrous pyridine (50m1). DMTrCI (3g, 
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9mmol, leq.) was added portionwise over 30 minutes, and the reaction was stirred at room 
temperature for 5 hours. EtOAc (250m1) was added, and the mixture was washed with a 0.5M 
NaHCO3 solution (125m1) and then with water (125m1). The organic layer was dried over 
Na2 SO4, filtered and evaporated down, to give the product as an oil. This was dissolved in a 
small amount of EtOAc and purified by wet flash column chromatography, eluting with a 
gradient of 0- 2% MeOH in DCM on a column with the silica preequilibrated with 1%TEA in 
DCM. The appropriate fractions were combined, and the solvents were removed in vacuo. An 
orange coloured oil was obtained. Yield (calculated in respect to DMTrCI) 79% (4.15g). 
Rf 0.55 (system I); 0.35 (system II). [FAB] m/z M: found 5 84.29856, calculated 584.29853. 
1 H-NMR: oH  (CDC13) 3.18-3.23 (t, 2, CH 2-014), 3.54-3.69 (m, 23, CH 2, OH), 3.75 (s, 6, 
Ar-OCH3) 6.78-7.46 (m, 13, Ar). 13C-NMR: O- (CDCI 3 ) 45.85 CR2, 54.97 CH3 , 61.46 CH2 , 
62.92 CH2, 70.06 Cl2, 70.31 CH2, 70.36 CH2, 70.46 CH2, 70.51 CH2, 72.36 CH2, 85.68 C, 
112.81 CH, 126.41 CH, 127.51 CH, 127.98 CH, 129.84 CH, 136.12 C, 144.87 C, 158.14 C. 
Anal. calcd. for C 33H4409 : C 67.79, H 7.58; found C 67.21, H 7.18. 
1-O-(4,4 '-Dimethoxytrityl)-hexaethyleneg!ycol-(2-cyanoethyl-N,N-diisopropyl)-
phosphoramidite (Durand et al., 1990) 
H3 CO 
H3 CO C-0—(CH2 CH2 0)5 CH2 CH2 —0 — P 
6 	A 
1 -O-(4,4'-Dimethoxytrityl)-hexaethyleneglycol (993mg, 1 .7mmol) was dried by the 
evaporation of anhydrous pyridine (2 x 5m1) and of anhydrous THF (5m1), and dissolved in 
dry TI-IF (lSml). DIPEA(1.18m1, 6.8mmol, 4eq.) and then 2-cyanoethyl-N,N-(diisopropyl-
amino)chlorophosphite (417tl, 1.9mmol, 1.1eq.) was added dropwise with a syringe. A white 
solid precipitated. After stirring the reaction for 20 minutes, EtOAc (50m1, stored over 
Na2SO4) was added to reaction mixture, and the organic layer was extracted once with 
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saturated KCI, then quickly dried over Na 2SO41  filtered and the solvents removed in vacuo. 
The product was purified by wet flash column chromatography (silica preequilibrated with 1% 
TEA in EtOAc), eluting with EtOAc. The appropriate fractions were combined, and the 
solvents were removed in vacuo to obtain an orange coloured oil. Yield 76% (1013mg). 
Rf O.84 (system I); 0.65 (system II). 31 P-NMR: 8p (CDCI 3 ) 149.18 
1-0-(4,4 -DimethoxytrityI)-1,8-octanedioI 
H3 CO 
H3 CO 	 C_O - (CH2)8 - OH 
1,8-Octanediol (6.75g, 45mmol, 5eq.) and DMAP (2 15mg, 1.8mmol, 0.2eq.) were dried by the 
evaporation of anhydrous pyridine (3 x 7m1) and dissolved in dry pyridine (50m1). DMTrCI 
(3g, 9mmol, leq.) was added portionwise over 30 minutes, and the reaction was stirred at 
room temperature for 5 hours. EtOAc (250m1) was added, and the mixture was washed with a 
0.5M NaHCO3 solution (125m1) and then with water (125m1). The organic layer was dried 
over Na2SO4, filtered and evaporated down. At this stage unreacted starting material 
precipitated. EtOAc was added and the mixture was filtered, then the solvent was removed in 
vacuo. The residue was dissolved in a small amount of EtOAc and submitted to wet flash 
column chromatography, eluting with a gradient of 0 - 2% MeOH in DCM on a column with 
the silica preequilibrated with 1%TEA in DCM. The appropriate fractions were combined, 
and the solvents were removed in vacuo, to give an orange coloured oil. Yield 70% (2.81 g). 
Rf 0.65 (system I); 0.54 (system II). [FAB] m/z M: found 448.25941, calculated 448.26136. 
1 H-NMR: oH  (CDCI 3) 1.29-1.45 (m, 8, CH2), 1.49-1.64 (m, 5, CH2, OH), 3.01-3.06 (m, 2, 
CH2-OH), 3.59-3.64 (t, 2, CH 2-OAr), 3.78 (s, 6, CH 3), 6.79-7.47 (m, 13, Ar). 13C-NMIR: O 
(CDCI 3) 25.53 CH2, 26.06 CH2, 29.19 CH2, 29.88 CH2, 32.60 CH2 , 55.02 CH3 , 62.81 CH2 , 
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63.25 CH2, 85.44 C, 112.77 CH, 126.36 CH, 127.51 CH, 128.02 CH, 129.85 CH, 136.58 C, 




o /' CN 
H3 CO 	C — 0 — (CH) - 0—P 
6 A N
1 -O-(4,4'-Dimethoxytrityl)- 1 ,8-octanediol (985mg, 2 .2mmo!) was coevaporated from 
anhydrous pyridine (2 x 5m1) and of anhydrous THF (5m!), and dissolved in dry THF (10m!). 
DIPEA (1 .53m1, 8.8mmol, 4eq.) and then 2-cyanoethyl-N,N-(diisopropylamino)chloro-
phosphite (537p1, 2.4mmol, l.leq.) was added dropwise with a syringe. A solid was seen to 
precipitate. After stirring the reaction for 20 minutes, EtOAc (40m1) was added to reaction 
mixture, and the organic layer was extracted once with saturated KCI, then quickly dried over 
Na2 SO4, filtered and the solvents removed in vacuo. The product was purified by wet flash 
column chromatography (silica preequilibrated with 1% TEA in EtOAc), eluting with EtOAc. 
The appropriate fractions were combined, and the solvents were removed in vacuo. An orange 
coloured oil was obtained. Yield 84% (1198mg). R f 0.84 (system I); 0.69 (system II). 
31 P-NMIR: 8p (CDCI 3 ) 147.54. 
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4. Conclusions 
TA*T and mixed sequence foldback DNA triplexes were obtained in multi-milligram 
quantities in a high purity state, as CZE analyses showed. Their thermal stabilities were 
investigated by UV melting in a variety of conditions, in the presence and in the absence of the 
triplex binding drug coralyne. Attempts to crystallise the FTFOs have been unsuccessful. 
From these studies it can be concluded that: 
The two linkers used - HEG and (Ocd) 2 - stabilise the FTFOs to a similar extent. 
Very short triplexes, which under normal circumstances would not form (A 4 .T4 .T4), are 
stabilised by the presence in their molecules of flexible linkers which hold the three strands 
together, while the equivalent duplex is not sufficiently stabilised and does not form. 
FTFOs of a given sequence have UV melting temperatures different from those of the ones 
of reversed sequence, even though they form triplexes of identical sequences. 
As expected, the stability of the mixed sequence triplexes increases with the lowering of 
the pF-l", while the temperatures of the duplex-to-coil transition is much less affected. 
Coralyne stabilises the TA*T type triplexes, while its effect on the mixed sequence ones is 
significantly smaller. This seems to indicate that the drug intercalates preferentially between 
consecutive TA*T rather than between alternating TA*T and C-G*Cl base triplets, in 
contrast to the results of Lee etal. (1993), which indicated that coralyne has little sequence 
preference. This conclusion is consistent with the assumption that there is repulsion between 
the positively charged coralyne and the CG*C base triplets, which may result in incomplete 
intercalation of the drug. 
The effect of coralyne on the duplex-to-coil transitions of all DNA sequences studied was 
minimal, therefore confirming that coralyne binds preferentially to triplex rather than to 
duplex DNA. 
The addition of coralyne to the triplexes to be crystallised led to the formation of a 
microcrystalline precipitate which in control experiments turned out to be the drug on its own, 
and therefore does not represent a useful reagent for crystallisation experiments. 
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ABSTRACT 
Intercalating ligands may improve both the stability 
and sequence specificity of triple helices. Numerous 
intercalating drugs have been described, including 
oralyne, which preferentially binds triple helices, 
though its sequence specificity has been reported to 
e low [Lee,J.S., Latimer,L.J.P. and Hampel,K.J. (1993) 
Biochemistry, 32, 5591-5597]. In order to analyse the 
sequence preferences of coralyne we have used a 
combination of DNase I footprinting, UV melting, 
LJV-visible spectrophotometry, circular dichroism and 
IMR spectroscopy to examine defined intermolecular 
riplexes and intramolecular triplexes linked either by 
iexaethylene glycol chains or by octandiol chains. 
DNase I footprinting demonstrated that coralyne has a 
'noderate preference for triplexes over duplexes, but a 
substantial preference for TAT triplets compared with 
triplets. The drug was found to have essentially no 
ffect on the melting temperatures of duplexes of the 
cind d(A)d(T) or d(GA) 0 d(TC). In contrast, it in-
reased the Tm for triplexes of the kind d(T)d(A)dT, 
)ut had little effect on the stability of d(TC)d(GA)' 
J(CT)0 at either low or high pH. On binding to DNA 
riplexes, there is a large change in the absorption 
pectrum of coralyne and also a substantial fluor-
scence quenching that can be attributed to intercala-
ion. The changes in the optical spectra have been 
ised for direct titration with DNA. For triplexes 
1(T)6d(A)6d(T)6, the Kd at 298 K was 0.5-0.8 tiM. In 
:ontrast, the affinity for d(TC)d(GA) d(CT) triplexes 
vas 6- to 10-fold lower and was characterized by 
maller changes in the absorption and CD spectra. 
his indicates a preference for intercalation between 
AT triples over CGCITAT triples. NMR studies 
onfirmed interaction by intercalation. However, a 
dngle, secondary binding was observed at high 
oncentrations of ligand to the triplex d(AGAAGA-
.-TCTTCT-L-TCTTCT), presumably owing to the rela-
ively low difference in affinity between the TAT site 
nd the competing, neighbouring sites. 
INTRODUCTION 
External regulation of specific gene expression can in principle be 
achieved by several different means, including the use of 
substrate analogues to inhibit a gene product, DNA or RNA 
complementary to a particular mRNA sequence (antisense 
strategy and nhozymes), a small molecule that binds to particular 
DNA sequences or an oligonucleotide that binds to a specific 
DNA duplex sequence (antigene strategy). The last methods are 
to be preferred, as there is only one target (or a small number of 
similar genes) per cell, compared with the amplification achieved 
by both transcription and translation. However, small molecules, 
despite recent successes at achieving high affinity for DNA (I), 
generally do not have sufficient sequence selectivity to turn off a 
single gene in a large genetic background (2). Antigene 
oligonucleotides may offer much greater sequence selectivity, 
despite the requirement for runs of purines on one strand of the 
target in order to form the triple helix.. One of the main difficulties 
with antigene methods is the relatively low thermodynamic 
stability of triple helices. compounded for some sequences by the 
need for protonation of cytosines (2). An alternative is to use a 
binary system of a triplex-forming oligonucleotide in conjunction 
with a small ligand that preferentially binds the triplex helix. Such 
a ligand will automatically improve triplex stability and also 
provide additional sequence selectivity, either by the sequence 
preferences of the ligand itself or by permitting the formation of 
specific mismatches (decreasing the stringency of the triple helix). 
Intercalating ligands that preferentially hind triplexes have 
been described and include the acridines, anthracene-9, I 0-diones, 
BePI, the naphthoquinolines and coralyne (3—li). Other aromatic 
systems that intercalate well into DNA duplexes may destabilize 
triple helices (e.g. ethidium: 2.7). One ligand that has been studied 
extensively is coralyne (7,12). This ligand is yellow and has 
convenient absorption bands at 330 and 450 nm, well removed 
from DNA absorption in the 260-280 nm range. It is also 
fluorescent and, as a planar ligand. has very little intrinsic circular 
dichroism. It can also be used to stabilize intermolecular triple 
helices, which then inhibit the action of DNase I (footprinting). 
We have used DNase I footprinting, optical spectroscopy and 
NMR to characterize the binding of coralyne to defined triplexes 
and determine the dissociation constants. Previous work with 
To whom correspondence should be addressed. Tel: +44 181 959 3666: Fax: +44 181 9064477: Email: a-lane@nimr.mrc.ac.uk  
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coralyne binding to polymeric DNA was reported to show that 
coralyne has no sequence specificity and that it also interacts with 
duplex DNA (7). We find significantly different behaviour, with 
both intra- and intermolecular triple helices. 
MATERIALS AND METHODS 
Strands of DNA were made using phosphoramidite chemistry 
and purified by HPLC as previously described (13). Covalently 
linked DNA oligorners were prepared using hexaethylene glycol 
as previously described (14). Such intramolecular triplexes are 
written as, for example, d(AAA AAA -L-Tfl'TTT-L-TTflTF), 
where L denotes the linker and the underlining shows the Watson—
Crick duplex. 
Plasmid pAG 1, which contains the sequence d( AAAAAAGG-
GGGG)d(CCCCCCTTVITF) cloned into the BamHI site of 
pUCI9, was prepared as previously described (3.5,15). A 
fragment containing this region was prepared by cutting the 
plasmid first with Hindlll, labelling at the 3'-end with reverse 
transcriptase and [- 32PjdATP and cutting again with EceRl. 
This procedure labels the purine strand of the target triplex site. 
The fragment was resolved and separated from the remainder of 
the plasmid by electrophoresis on a native 5C/ polyactylamide gel. 
The fragment was eluted from the gel slice, precipitated with ethanol 
and redissolved in 10 in  Tris—HCI. 0.1 mM EDTA. pH 7.5. 
Coralyne was purchased from Sigma (Poole, UK). According 
to TLC. NMR and mass spectrometry. the compound was ~!98 
pure and was used without further purification. 
DNase I footprinting 
DNase I tbotprinting was carried out as previously described 
(3,5,15). Aliquots of 1.5 il labelled DNA (—Jo nM) were mixed 
with 1.5 Ill third strand oligonucleotide and, where present. 1.5 .tl 
coralyne in a huller containing 50 mM sodium acetate, 5 mM 
MgCl-), 2 mM MnCJ7. pH 5.5, for the parallel YRY triplexes. or 
10 m Tris—HCI, 5 mM MgCl,, pH 7.5, for the antiparallel RRY 
triplexes. The mixture was allowed to equilibrate at room 
temperature for at least I h before adding 2 il DNase I solution 
(0.1 U/mI in 20 mM NaCI, 2 mM MgCl). The reaction was 
stopped after 1 min by adding 4 tl formamide containing tO niM 
EDTA and 0.1% (w/v) bromophenol blue. Samples were boiled 
for 3 mm, rapidly cooled on ice and loaded onto 11% 
polyacrylamide gels containing S M urea. The 40 cm gels were 
run at 1500 V for 2 h, fixed in 10% (v/v) acetic acid, transferred 
to Whatman 3 MM paper and dried at 80°C. The dried gels were 
autoradiographed at —70°C using an intensifying screen. Bands 
were assigned by comparison with Maxani—Gilbert marker lanes 
specific for G+A. 
Optical spectroscop 
UV melting studies were carried out as previously described (16). 
Optical spectra were recorded on a Hitachi U-3210spectrophoto-
meter with I ml cuvettes thermostatted at 25°C. Difference 
spectra were recorded using tandem quartz cuvettes (d= 4.4 mm). 
Titrations and optical studies were carried out either in Tris—NaC1. 
pH 8.0, or in sodium acetate. 5 mM MgCli. pH 5.0. Stock 
solutions of coralyne (-2 mM) were made up in water, as the 
ligand is less soluble in buffer, and kept in the dark. The stock 
solution was diluted with buffer for subsequent work. For 
titrations, small aliquots of a buffered solution of DNA were 
added serially to a solution of coralyne at 2-10 l.tM and the change 
in absorption measured at 334 nm. There is no absorbance for 
DNA at this wavelength. Titration curves were analysed using the 
program Kaleidagraph (Synergy Software, Reading, PA). Circular 
dichroism (CD) spectra were recorded on a JASCO speciropolari-
meter as previously described (17). 
NMR spectra were recorded at 14.1 Ton a Varian Unity NMR 
spectrometer. For spectra in H20. the Watergate method (18) was 
used for solvent suppression. The NMR spectra of the free 
triplexes d(AGAAGA-L-TCTFCT-L-TCTFcfl, where L is hexa-
ethyleneglycol, were assigned by standard methods. The chemical 
shifts of the exchangeable protons were monitored as a function 
of the concentration of coralyne. The amino groups of the 
cytosine bases in the Hoogsteen strand have highly characteristic 
chemical shifts (19) and are good indicators of the presence of a 
triple helix. 
RESULTS 
DNase I footprinting 
The interaction of coralyne with intermolecular DNA triplexes 
has been examined by its effect on the formation of a triple helix 
between d( l'l'l]' FCCCCC) and a DNA duplex fragment contain-
ing the sequence d(AAAAAAGGGGGG).d(CCCCCcymn) 
(see Materials and Methods). This triplex is not stable, presumably 
because of its short length and the presence of five contiguous 
C.GC base triplets. However, the triple helix can be stabilized 
either by attaching an intercalating acridine molecule at one end (15) 
or by adding a triplex binding ligand such as a naphthylquinoline (3). 
Figure 1A shows a DNase I_footprint of the duplex d(AAAAA-
AGGGGGG).d(CCCCCC ll'l'l' IT) with increasing concentrations 
of coralyne in the absence of the third strand. As the concentration 
of coralyne was increased, the intensity of the bands in general 
decreased and the enzyme was strongly inhibited above 10 .tM 
drug. It is not clear whether this was due to a direct inhibition of 
the enzyme or to intercalation of coralyne into the duplex. In the 
absence of coralyne. the third strand produced essentially no 
footprint even up to 50 j.tM (Fig. I B). At 10 J.IM third strand, the 
DNase I pattern was altered in the presence of 10 tM coralyne 
and higher (Fig . I B). Although there was a general attenuation of 
the band intensities in the presence of both ligand and oligonucleo-
tide, the pattern was different from that produced by either 
molecule alone,suggesting that coralyne stabilizes the DNA 
triplex helix. In particular, there was a region of enhanced cleavage 
at the 3'-end of the target site at the positions AAAAAAGGGGG/ 
G/GATC. corresponding to the triplex junction. This enhanced 
cleavage has previously been shown to be characteristic of parallel 
triplex formation (15). The enhancement was not observed with 
ligand alone (Fig. IA). Furthermore, the doublet at the upper, 
5'-edge of the target site was more efficiently protected in the 
presence ofoligonucleotide than with ligand alone. This indicates 
that coralyne significantly stabilizes this parallel DNA triplex. 
The changes in the intensity of other bands above and below the 
target site reflect the interaction of coralyne with the DNA duplex 
and are consistent with the generalized decrease in band intensity 
shown in Figure IA. 
Because it has been reported that coralyne, unlike other triplex-
binding ligands, has no preference for TA-T or GC-C triplets (7), 
we have compared the ability of coralyne to stabilize triplexes 
formed from the same target site with either d( l]TI'lTCC) or 
d(1TCCCCCC), which consist primarily of TA-T and CGC 
triplets respectively. Neither triplex was stable in the absence of 
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Figure 1. Effect of coralyne on DNase I digetiOil 01 d)AA.AAAAGGGGGG)d(CCCCCCTTTI'T'fl in the absence and presence of third strand oligonucleotides. 
A) Effect of coralyne on DNase I digestion ol the duplex. The concentration of coralyne (lIM) is shown at the top of each lane. (B) Effect of coralyne on the interaction 
with d(Il1TFCCCCC). The left hand lanes show cleavage in the presence of oligonucleotides at the given concentrations and the right hand lanes show digestion 
in the presence of 10 tM d)Y1TFTCCCCC) in the presence of different coralyne concentrations (.IM). (C) Effect of different concentrations of coralyne (riM) on 
the binding of d(1TIITfCC). The filled box denotes the position of the target site for d(IThflTICC). (0) Effect of increasing concentrations of coralyne on the 
interaction with 50 pM d(GGGGGT1TIT). Experiments )A)—(C) were carried out in 50 m sodium acetate. 5 m MgCl,. pH 5.5. while (D) was carried out in 10 mM 
Tris—HCI. MgCl , , pH 7.5. as described in Materials and Methods, con, control digestion: GA. Maxam—Gilbert G+A specific marker lanes: square brackets, position 
and length of the d(AAAAAAGGGG(jG) target site. 
added ligand (5), but 10 l.tM coralyne clearly stabilized the triplex 
with d(TTTITFCC) (Fig. IC), as shown by the enhanced 
cleavage at the 3' triplex/duplex junction and loss of the doublet 
at the upper edge of the target site. The enhancements observed 
with d(T]11TICC) were located at AAAAAAGG/G/GGGGATC. 
three bases higher in the gel than with dCFIT[TFCCCCCC). 
consistent with their location at the triplex/duplex boundary. In 
contrast, no triplex was visible with dCVTCCCCCC) in the 
presence of coralyne. This clearly indicates a significant binding 
preference for TAT triples over CG-C' triples, even at pH 5.5. 
We have also studied the effect of coralyne on the antiparallel 
R'RY triplex formed by d(GGGGG il'l'l' 1) at the same target 
site (Fig. ID). In the absence of ligand this oligonucleotide did not 
produce a significant footprint (5). However, a footprint was 
observed with 50 pM oligonucleotide in the presence of 30 jiM 
coralyne at pH 7.5, indicating that the antiparallel motif can also 
be stabilized by this ligand. The differences between the 
footprints produced by the TC and OT oligonucleotides in the 
presence of coralyne may reflect the different pH values in the 
experiments and the different conformations adopted by parallel 
and antiparallel triplexes. 
UV melting 
UV melting curves were recorded in the absence and presence of 
different concentrations of coralyne (not shown). In the absence 
of coralyne. d(AAAAAA-L-TL- lTlTl'l) showed a 
single, sharp transition with a Tm  of 49.5°C. The intramolecular 
DNA duplex d(AAAAAA)'d(TTfl'l'l) also melted cooperatively, 
with a Tm  of 48.5°C (not shown). Only at lower concentrations 
of salt did the melting 0fd(AAAA-L-TTrTTr-L-TTlTrT) 
separate into two transitions (A.Moraru-Allen and T.Brown. 
unpublished data). This shows that the triplex is at least as stable 
as the duplex. Increasing the concentration of coralyne shifted the 
melting curve of the triplex to higher temperature, with a 
significant increase (7.8'C) in the Tm  of the transition. In contrast, 
coralyne had a negligible effect on the T in  of the duplex (Table 1). 
Hence, coralyne hinds to triplexes made of d(A) 0 sequences much 
more tightly than to the corresponding duplexes. A similar result 
was obtained for the antiparallel d(TVVfTT-L-AAAAAA-L-Yr-
'FlTl'). In this case, the melting curve was biphasic. as the triple 
helix was rather unstable. However, adding coralyne greatly 
stabilized the lower temperature transition, with no discernible 
effect on the higher temperature (duplex to strand) transition 
(Table 1). Stabilization of the triplex was remarkable: at 30 PM 
coralyne the Tm  increased 24°C. Hence, coralyne can indeed 
greatly stabilize DNA triplexes consisting of TA-T triplets only 
and, furthermore. the stabilization is greater for antiparallel than 
for parallel triplexes. 
In contrast. triplexes consisting of alternating CG'C and TA-T 
triplets were not significantly stabilized by coralyne at either pH 
5 (where the triplex is stable) or at pH 7 (where deprotonation of 
the cytosine results in an unstable triplex) (Table I). Hence. 
coralyne does not bind strongly between CG-C' and TA-T triples 
at micromolar concentrations. 
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Table 1. Effect of coralyne on the melting temperatures of different triplexes. 
Oligonucleotide pH Tm (°C) at n equivalents coralyne 
0 	 0.6 1.2 
ttTm (1.2 -0) 
d(AAAAAAXTTTTTFX flTflT) 7 49.5 	 55 57 7.5 
dAAAAAAXTTVrTF) 7 48.5 	 49 49 0.5 
d(TVTTITXI1TrrTXA,.AAAA) 7 53 	 59 61 8 
d(fl1Tfl'XAAAAAXTTTTTT) 7 14 	 34 38 24 
52 	 52 52 0 
d(AGAGAXTCTCT(-XCTCTCT) 5.5 58 	 59 60 2 
d(GAGAGAXTCTCTC) 5.5 60 	 61.6 62 2 
d(GAGA(MXT('TCTCXCTCTC1') 7 14.4 	 14.9 12.2 -2 
63 	 64 64 1 
Tm  values were obtained from UV melting curves as described in Materials and Methods. X is the hexaethyleneglycot linker. 
Optical spectrophotometry 
It is difficult to determine dissociation constants for ligand 
binding by footprinting or UV melting. We have therefore utilized 
optical spectroscopy. Coralyne is a yellow compound that has 
absorption bands in the near UV that do not overlap with the 
absorption of DNA. Figure 2 shows a UV-Vis difference 
pcctrum for coralyne binding to the intramolecular triplex 
J(AAAAAALmUTLYFnTç) Under the conditions of 
his experiment the DNA and ligand are each -80% in the bound 
orni (see below). The largest differences were at -330 nm, which 
orresponds to an absorption band of the free ligand (not shown). 
n addition, there were two positive bands at 405 and 434 nm, 
which correspond to weak bands of the free ligand. Hence, the 
igand electronic transitions are perturbed on binding to the DNA 
riplex, indicating a substantial change in environment. These 
lifferences are particularly useful for titration, as DNA does not 
tbsorb above 300 rim. A typical titration curve is shown in 
igure 2B and C. At high concentrations of ligand the stoichiornetry 
ppears to be 1:1. In principle, there are up to five essentially 
quivalent intercalation sites in this triple helix. However, as the 
)NA concentration is increased, statistically only one site per triplex 
viii be occupied, although not necessarily the same one on each 
nolecule. The apparent dissociation constant and difference 
bsorption coefficient were determined at two different concentra-
ons of ligand, with essentially the same result. in this instance, 
d was determined as 0.5 h.LM. which is dominated largely by 
inding to the tightest site. A similar Kd value was obtained at 
H 5 in the presence of Mg. showing that binding itself was 
sensitive to pH. In contrast, with d(GAGAGA-L-TCTCTC.. 
.-CTCTCT) at pH 5 much weaker binding was observed (Kd 
S p.M). although the UV difference spectrum was qualitatively 
milar to that obtained with d(AAAAAA-L-mrn..LyrJ 
T). Thus, the TAT/TA-T intercalation sites bind coralyne up to 
ri order of magnitude more tightly than CG'CITA.T or 
'AT/CGC sites (Table 2). This parallels the results obtained by 
V melting and is consistent with the information obtained by 
Nase I footprinting (see above). 
Table 2. UV-Vis difference spectroscopy of coratyne:triplex complexes 
Oligonucleotide 	 pH Az (per mM/cm) Kd (hiM) 
dAAAAAAXTTTTTTXT11Tfl-) 7 24 0.5 
5 20 0.8 
dLiAGAGAXTcIc[( -XCTCTCT) 5 16 5.1 
d(TCTCTCXCICTCTXA('AGAG) 5 22 8.3 
d((iAGAAGXCTTCTCXCTC-jT-C) 5 14 0.2 
7.9 5 1.5 
d(cIAAGAGXCTCTT(XC-n'CTC) 5 8.2 0.4 
d(AGAAGAXTCTTCTXTCUCT) 5 11.3 1.5 
8 6.3 2.8 
Difference spectra were recorded at 25°C as described in Materials and Methods. 
Titrations were carried out at 25°C at a maximum in the difference spectrum 
(332-334 nm). 
Because of the difference in affinity of coralyne for the different 
sequences, we made further oligonucleotides that contain a single 
sequential pair of AT-T/AT-T triplets, namely d(QAAA-L- 
C-L-C'FCITC), d(GAAGAG-L-CTCUCL1'TC) 
and d(AGAAGA-L-TC TCT-L-TCTTCT) where L is hexaethyl-
eneglycol. The neighbouring TA-I triplets should preferentially 
interact with the ligand. The UV-Vis difference spectra were 
qualitatively similar to those obtained with the other oligonucleo-
tides, although the difference absorption coefficient was significant-
ly smaller. For the d(GAGAAG-L-CTTCTCL CTFC) and 
d(GAAGAG-L-CTCTFC..L..CUCTC) triplexes, the binding 
affinity was somewhat stronger than for d(AAAAAA-L-Tfl 
fl-L- I'l't'l]' f) and decreased significantly as the pH was raised 
to 7.9 (Table 2). The difference absorption coefficient was smaller 
at pH 8 than at pH 5 and it is possible that there is a different mode 
of binding to the duplex and (small amount of) triplex under these 
conditions. The d(AGAAGA-L-TCCTLT( - j-) sequence 
showed intermediate affinity for coralyne at pH 5 and was only 
2-fold lower at pH 8. For comparison, we have also determined the 
-1200 	 I 
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Figure 2. UV-Vis difference spectra and titrations of DNA triplexes with 
coralyne. Spectra were recorded at 25'C as described in Materials and 
Methods. (A) UV-Vis difference spectrum with It) pM coralyne and 10 pM 
d(AAAAAAL-TIiT1T-L-T1T1TU)_at pH 7. B) Tiu-4ion of 10.5 LM 
coralyne with d(AAAAAA-L- FITIF l-L-1TITIT). The curve is a best fit for 
Kd = 0.35 pM and also shows an apparent _stoichiometry_of 1:1. (C) Thratton 
of 2.4 pM coralyne with d(AAAAAA-L-Tfl]TEL- ITITItJ, The curve is 
a best fit for Kd = 0.46 PM. 
dissociation constant for naphthoquinoline at pH 5 as 1.3 ± 0.2 l.1M 
using the same method. In comparison, this ligand seems to give 
a stronger DNase I footprint than coralyne (4.5). 
To characterize the nature of the coralyne-DNA complexes 
further, we have used CD. which provides information on 
perturbation of the electronic environment of the ligarid. Figure 3 
shows CD spectra of different triplexes in the absence and 
presence of coralyne. There were substantial changes in the CD 
when coralyne binds to d(AAAAAA-L-TTTTTT-L-flTITI), 
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Figure 3. CD spectra. Spectra Acre recorded at 15 C as described in Materials 
and Methods. (A) 85 JiM d(AAAAAA-L-flTIILL-Tfl1iI) ± 10 IIM 
coralyne in 20 mM NaPi. 100mM KCI. p117. (B) 8.1 pM d(GAGAGA-LIC-
JL-CTCTCT) ± 10 1iM coralyne in 10 mM NaPi, 100 mM KCI, 10 mM 
MgSO4. pH 5.5 
L-CTTCTC-L-CTCTTC), even though the degrees otsaturatiot 
should have been -80 and 50 respectively under these condition 
(cf. Table 2). Fluorescence quenching experiments were consisten 
with coralyne intercalating into TA.T triple helices (7) (see als( 
below). It is possible that the drug does not intercalate into th 
GCC-containing triplexes as well as it does into the all-TA 
triplexes. 
N NI R spectroscopy 
NMR spectra of d(AAAAAA-L-TTITITT-L-TTTTTT) an 
d(GAGAG AL-TCTCTC-L-C1(i'CT) ± coralyne were re 
corded. Stoichiometric binding was observed for the form 
triplex (Fig. 4A). Under the conditions of these experiments th 
concentration of potential sites exceeds the concentration of th 
ligand, so that, on average, only one molecule of coralyne i 
bound per mole of triplex and excess free triplex is present. Th 
large changes in chemical shifts are consistent with intercalatiot 
However, the number of changes in chemical shifts suggests th 
more than one kind of complex is present, i.e. intercalation occui 
at different sites within the DNA triplex, with somewhat differet 
spectra. The relative intensity of the peaks indicates that the 
states are populated to a similar extent. Binding was also observe 
with d( GAGAGA-L-TCTCTC-L-CTCTCT) (not shown), whic 
was expected given a Kd value in the range 5-10 IIM (Table 2). T 
NMR spectrum of the triplex d(AGAAGA-L-TCTTCT-L-TC1 
TCT) was assigned by standard methods and the exchangeab 
protons are shown in Figure 4B. The amino protons of U 
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Hoogsteen cytosines resonated at a very characteristic shift 
(-10.2 and 9.8 (19). We note that one of the two triplexes 
shows evidence of more than one conformation of the triplex 
state. The reasons for this structural heterogeneity are unclear, but 
seem to be a function of the sequence. On adding coralyne. 
initially one set of triple helix-specific resonances shifted up to a 
population of-50 After this, a second ligand began to bind to 
a different site (Fig. 4). This indicates that although the primary 
site (TAT/TA-T) does have the highest affinity, neighbouring 
sites must have affinities that are not much lower. Under the 
conditions of the NMR experiments (-1 mM DNA) ligand 
binding should be essentially stoichiometric and the occupation 
of sites will occur in the ratio of their ligand dissociation constants. 
A 
',. L#d/lSV iVL+CO 
14.5 	14.0 	13.5 	13.0 	12.5 
chemical shift/ppm 
DISCUSSION 
The thermodynamic results in combination with the spectro-
scopic and footprinting data all indicate the same result, namely 
that coralyrie preferentially interacts with TAT triples in triple-
stranded DNA. Further, the apparent dissociation constant from 
d(AAAAAA-L- L..7J'mT) determined by optical 
titration is —0.5 l.IM. This is in close agreement with the value 
estimated from T01  measurements on polydisperse material (7). 
However, our results clearly indicate that this ligand binds nearly 
an order of magnitude less tightly to triplexes containing 
alternating CG-C' and TAT triples. This result is in contrast to the 
previous conclusions (7) based on the effect of the drug on the 
clisproportionation of polymeric d(GA )•d( TC). They found that in 
the absence of magnesium the affinity of coralyne for 
poly td(TC)d(GA).d(C+T) was an order of magnitude greater 
than for poly [d(T)d(A).d(T)] (7). 
The affinity of coralyne for 'single site' triplexes of the kind 
J(AQAAGA-L-TCTTCT-LTCTrCT), while always higher than 
ror the alternating GA sequence, depends on the position of 
~G-Cl triples (Table 2). This is may be a consequence of long 
ange electrostatic interactions between the positively charged 
igand and the positive charge on the protonated cytosine. We 
Nould expect the pK of a terminal GC - C1 to he much lower than 
hat of an internal one (J.-L.Asensio Alvarez. J.Dhesai, S.Bergquist, 
1.Brown and A.N.Lane, unpublished data), such that at pH 5, 
erminal CG.C1  triples are only partially protonated and therefore 
ive rise to less repulsion on average. 
The binding of coralyne to these triplexes is relatively strong 
nd is at least as tight as the best of the unfused aromatic cations. 
)f which the best are the napihoquinolines (3-5.11). and 
onsiderahly tighter than the anthracene-9.1O-clioiies (6). 
The NMR data are useful for characterizing both the starting 
naterial and the end state. It is clear that it is possible to make a 
omplex in which only one unique site per molecule is occupied. 
-lowever. at NMR concentrations this requires an excess of DNA 
ver ligand for the triplexes studied here, leading to a mixture of 
wo complex, overlapping spectra. Nevertheless, it is clear from 
ie data presented here that coralyne does indeed intercalate into 
AT triplexes. in agreement with fluorescence quenching 
xperirnents (7). It is possible that the weaker binding to 
;CC'-containing triplexes (and duplexes) results in a different 
onfonnation, in which the planar chromophore is only partly 
itercalated. This is suggested by the optical spectra and would 
e consistent with charge repulsion between the protonated C in 
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Figure 4. NMR spectra. NMR spectra were recorded at 14.1 T as described in 
Materials and Methods. Assignments were made using NOESY experiments in 
HO at l0C The low field imino and amino proton region of the spectrum is 
shown as a function of coralvne concentration. (A) d(AAA-L-flç. 
L-TTITIT) at pH 7. The triplex concentration was I mM and the coralyne 
concentration was 0.5 mM. Lower spectrum, free triplex: upper spectrum. 
triplex + coralyrie. (B) 'titration of I mM d(AGA(. , LCTCflL'tji) 
at pH 5 with increasing concentrations of coralyne. Ratios of ligand to triplex 
are shown at the left hand side of each spectrum. 
the conformation of the ligand—triplex complex further, it will be 
necessary to improve the sequence selectivity further, so that a 
single, unique complex accounts for >90% of the material in 
solution. The results presented here indicate that this goal should 
be achievable and will allow- us to determine the details of an 
intercalated triplex—drug complex and provide essential information 
about the nature of the molecular interactions, 
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